<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2017.5424</article-id>
<article-id pub-id-type="publisher-id">or-37-03-1321</article-id>
<article-categories>
<subj-group>
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Effects of different mycotoxins on humans, cell genome and their involvement in cancer</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Adam</surname><given-names>Mowaffaq Adam Ahmed</given-names></name>
<xref rid="af1-or-37-03-1321" ref-type="aff"/></contrib>
<contrib contrib-type="author"><name><surname>Tabana</surname><given-names>Yasser M.</given-names></name>
<xref rid="af1-or-37-03-1321" ref-type="aff"/></contrib>
<contrib contrib-type="author"><name><surname>Musa</surname><given-names>Khirun Binti</given-names></name>
<xref rid="af1-or-37-03-1321" ref-type="aff"/></contrib>
<contrib contrib-type="author"><name><surname>Sandai</surname><given-names>Doblin Anak</given-names></name>
<xref rid="af1-or-37-03-1321" ref-type="aff"/>
<xref rid="c1-or-37-03-1321" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-or-37-03-1321">Infectomics Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Penang, Malaysia</aff>
<author-notes>
<corresp id="c1-or-37-03-1321"><italic>Correspondence to</italic>: Dr Doblin Anak Sandai, Infectomics Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, 13200 Kepala Batas, Penang, Malaysia, E-mail: <email>doblin@usm.my</email></corresp>
</author-notes>
<pub-date pub-type="ppub"><month>03</month><year>2017</year></pub-date>
<pub-date pub-type="epub"><day>06</day><month>02</month><year>2017</year></pub-date>
<volume>37</volume>
<issue>3</issue>
<fpage>1321</fpage>
<lpage>1336</lpage>
<history>
<date date-type="received"><day>19</day><month>08</month><year>2016</year></date>
<date date-type="accepted"><day>16</day><month>01</month><year>2017</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2017, Spandidos Publications</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<abstract>
<p>The chemical nature of most of the mycotoxins makes them highly liposoluble compounds that can be absorbed from the site of exposure such as from the gastrointestinal and respiratory tract to the blood stream where it can be dissimilated throughout the body and reach different organs such as the liver and kidneys. Mycotoxins have a strong tendency and ability to penetrate the human and animal cells and reach the cellular genome where it causes a major mutagenic change in the nucleotide sequence which leads to strong and permanent defects in the genome. This defect will eventually be transcribed, translated and lead to the development of cancer. In this review, the chemical and physical nature of mycotoxins, the action of mycotoxins on the cellular genome and its effect on humans, mycotoxins and their carcinogenicity and mycotoxins research gaps are discussed, and new research areas are suggested. The research review posed various questions. What are the different mycotoxins that can cause cancer, what is the role of mycotoxins in causing cancer and what types of cancers can be caused by mycotoxins? These questions have been selected due to the significant increase in the mycotoxin contamination and the cancer incidence rate in the contemporary world. By revealing and understanding the role of mycotoxins in developing cancer, measures to reduce the risks and incidents of cancer could be taken.</p>
</abstract>
<kwd-group>
<kwd>mycotoxins</kwd>
<kwd>cancer</kwd>
<kwd>aflatoxins</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<label>1.</label>
<title>Introduction</title>
<p>Many chemical mutagens were proven to cause mutation and inactivation of the cancer suppressor genes such as P53, BRCA1 and BRCA2. One of the most influential chemical compounds that could cause a mutation in these genes are the mycotoxins (<xref rid="b1-or-37-03-1321" ref-type="bibr">1</xref>). Mycotoxins are carcinogenic toxins that are produced by many <italic>Aspergillus</italic> and <italic>Penicillium</italic> species growing on food commodities (<xref rid="b1-or-37-03-1321" ref-type="bibr">1</xref>). Among the different mycotoxins, aflatoxin B1 has been reported as the highest carcinogenic mycotoxin (<xref rid="b2-or-37-03-1321" ref-type="bibr">2</xref>) and aflatoxin B1 can penetrate the cell membrane and attach to its DNA where it causes irreversible mutations (<xref rid="b2-or-37-03-1321" ref-type="bibr">2</xref>). The chemical nature of aflatoxins makes it a highly liposoluble compound that can be absorbed from the site of exposure such as from the gastrointestinal and respiratory tract to the blood stream where it can move throughout the body (<xref rid="b3-or-37-03-1321" ref-type="bibr">3</xref>). The exposure to these carcinogenic mycotoxins can be through the ingestion of the contaminated food that ends up in the stomach where it gets absorbed or by inhaling the dust particles of aflatoxins B1 from the food that is contaminated with these aflatoxins (<xref rid="b3-or-37-03-1321" ref-type="bibr">3</xref>). Once the aflatoxins enter the cells, they are metabolized by the action of cytochrome P450, a microsomal enzyme to aflatoxin-8, 9-epoxide in the detoxification metabolic pathway for aflatoxins. It is highly reactive and unstable and requires the binding to a DNA or to the protein molecule in order to become more stable (<xref rid="b3-or-37-03-1321" ref-type="bibr">3</xref>). Once the highly unstable aflatoxin-8, 9-epoxide binds to the DNA molecule with high affinity, it forms aflatoxin-N7-guanine that cause a guanine (G) to thymine (T) transversion mutations which will directly affect the cell cycle by affecting the P53 gene which carries the codes for tumor suppressor proteins, meant to inhibit the development of tumors and cancers (<xref rid="b3-or-37-03-1321" ref-type="bibr">3</xref>).</p>
<p>The role of aflatoxin B1 in causing mutation in the humans genome was extensively studied (<xref rid="b2-or-37-03-1321" ref-type="bibr">2</xref>), many other mycotoxins are yet to be investigated to understand their method of action once they are in contact with the humans genome. This is particularly crucial because many mycotoxins have a closely related chemical composition and similar functions inside the human body. The researchers decided on two research questions in this review that accurately describe the objectives of this research: What are the different types of mycotoxins that can cause cancer? What is the role of mycotoxins in causing cancer and what types of cancers can be caused by mycotoxins?</p>
<p>The reason for this review is due to the fact that there is an increase in mycotoxin contamination in the world and by understanding the role of different mycotoxins in the human body and their levels of toxicity and carcinogenicity, many new measures could be followed and many human lives and animals alike could be saved. In addition, there is a gap in cancer studies relating to mycotoxins as it has been only related to liver cancer (<xref rid="b4-or-37-03-1321" ref-type="bibr">4</xref>). Although due to the similarity in nature and functions, mycotoxins can be related to many types of cancer. This review will concentrate on the previously published studies that answer both of our research questions and build on the arguments that support these questions.</p>
</sec>
<sec>
<label>2.</label>
<title>Types of mycotoxins and their natural commodities</title>
<p>In an experiment done by El-Banna <italic>et al</italic> (<xref rid="b5-or-37-03-1321" ref-type="bibr">5</xref>) nearly 1400 <italic>Penicillium</italic> isolates were collected from several cultures, isolated directly from food and feed. Each isolate was identified using Pitt&#x0027;s classification to investigate their mycotoxins production, and 18 different mycotoxins were isolated. Each isolate was allowed to grow on malt extract agar medium and was incubated for the period between one to three weeks at 25&#x00B0;C. The mycotoxins were then extracted using chloroform and filtration, and the produced mycotoxins were concentrated. Finally, the mycotoxins were classified and characterized by mycotoxins analysis using TLC (<xref rid="b6-or-37-03-1321" ref-type="bibr">6</xref>&#x2013;<xref rid="b8-or-37-03-1321" ref-type="bibr">8</xref>). This experiment resulted in the production and the identification of 18 different mycotoxins from one or more species of <italic>Penicillium</italic>. The toxins are as follows: Brevianamid A produced by 3 species, Citreoviridin produced by 2 species, Citrinin (<xref rid="f2-or-37-03-1321" ref-type="fig">Fig. 2</xref>) produced by 3 species, Cyclopiazonic acid produced by 8 species, Fumitremorgin B produced by 1 species, Griseofulvin produced by 6 species, luteoskyrin produced by 1 species, Ochratoxin A produced by 2 species, Patulin produced by 4 species, Penicillic acid produced by 2 species, Penitrem A produced by 1 species, PR-toxin produced by 1 species, Roquefortine produced by 2 species, rugulosin produced by 2 species, Verrucosidin produced by 1 species, Verruculogen produced by 1 species, Viridicarumtoxin produced by produced by 2 species and finally, Xanthomegnin produced by 2 species (<xref rid="b5-or-37-03-1321" ref-type="bibr">5</xref>).</p>
<p>Another group of mycotoxins is produced by <italic>Aspergillus</italic> species, and these mycotoxins are called Aflatoxins (<xref rid="b12-or-37-03-1321" ref-type="bibr">12</xref>). They were found to be extremely toxic and highly cariogenic. Aflatoxins are chemical compounds that are released by the fungi <italic>Asergillus Flavus</italic> and <italic>Aspergillus Parasiticus</italic> as secondary metabolites, and the different laboratory investigations confirmed the high carcinogenicity of these chemical compounds and how they are associated with many cancers such as liver and kidney (<xref rid="b9-or-37-03-1321" ref-type="bibr">9</xref>&#x2013;<xref rid="b12-or-37-03-1321" ref-type="bibr">12</xref>). The different types of aflatoxins include aflatoxin B1 and B2, produced by <italic>Aspergillus Flavus</italic> and <italic>Aspergillus parasiticus</italic>, Aflatoxin G1 and G2, produced by <italic>Aspergillus parasiticus</italic> (<xref rid="b13-or-37-03-1321" ref-type="bibr">13</xref>&#x2013;<xref rid="b16-or-37-03-1321" ref-type="bibr">16</xref>). Among these toxins, it was found the B1 and G1 are the most toxic with the highest carcinogenic effect on animal cells (<xref rid="b9-or-37-03-1321" ref-type="bibr">9</xref>). Food products that can be contaminated with aflatoxins include cereal (maize, sorghum, pearl millet, rice, and wheat), oil seeds (groundnut, soybean, sunflower, and cotton), spices (chilies, black pepper, coriander, turmeric, and ginger), tree nuts (almonds, pistachio, walnuts, and coconut) and milk (<xref rid="b17-or-37-03-1321" ref-type="bibr">17</xref>&#x2013;<xref rid="b22-or-37-03-1321" ref-type="bibr">22</xref>). Moreover, aflatoxins are found in the contaminated tobacco leaves (<xref rid="b23-or-37-03-1321" ref-type="bibr">23</xref>). Aflatoxins can also be present in the dry soil, which can move through underground water with rain and be ingested by humans and animals through drinking water (<xref rid="b24-or-37-03-1321" ref-type="bibr">24</xref>).</p>
<p>Another group of mycotoxins that is produced by <italic>Aspergillus</italic>, <italic>Penicillium</italic> and <italic>Fusarium</italic> were classified and characterized based on the frequency of their accordance with nature and their severity of the diseases they cause. These mycotoxins are Deoxynivalenol (<xref rid="f8-or-37-03-1321" ref-type="fig">Fig. 8</xref>), Fumonisins (<xref rid="f4-or-37-03-1321" ref-type="fig">Fig. 4</xref>), Zearalenone (<xref rid="f10-or-37-03-1321" ref-type="fig">Fig. 10</xref>), T-2 toxin (<xref rid="f7-or-37-03-1321" ref-type="fig">Fig. 7</xref>), and finally certain types of ergot alkaloids. Found mainly on grain crops (<xref rid="b29-or-37-03-1321" ref-type="bibr">29</xref>&#x2013;<xref rid="b31-or-37-03-1321" ref-type="bibr">31</xref>), they were known to develop a set of diseases called Mycotoxicoses, and these diseases include blood toxicity, food poisoning and sometimes cancer (<xref rid="b25-or-37-03-1321" ref-type="bibr">25</xref>&#x2013;<xref rid="b27-or-37-03-1321" ref-type="bibr">27</xref>).</p>
<p>Another group of mycotoxins is produced by the <italic>Fusarium</italic> species and when culturing the <italic>Fusarium moniliforme</italic> cultures on corn, a mycotoxin called Fumonisins was found to be produced (<xref rid="b28-or-37-03-1321" ref-type="bibr">28</xref>). When analyzing fumonisins using liquid chromatography, three types of fumonisins were found namely B1 (FB1), B2 (FB2), and B3 (FB3) and all three types are isolated when allowing the fusarium to grow on corn and the concentrations of fumonisins will range from 800&#x2013;12800 ng total fumonisins/g (<xref rid="b29-or-37-03-1321" ref-type="bibr">29</xref>).</p>
<p>In addition to the aflatoxins, another group of mycotoxins were found to have a similar action on humans and animals, grouped as the Ochratoxins (<xref rid="b30-or-37-03-1321" ref-type="bibr">30</xref>&#x2013;<xref rid="b32-or-37-03-1321" ref-type="bibr">32</xref>). The Ochratoxins are mycotoxins produced by some <italic>Aspergillus</italic> species such as <italic>A. Ochraceus</italic> and <italic>A. Niger</italic>, whereas some <italic>Penicillium</italic> species such as <italic>P. Verrucosum</italic> and <italic>P. Carbonarius</italic> are also found to produce Ochratoxins (<xref rid="b32-or-37-03-1321" ref-type="bibr">32</xref>). Among all the types mentioned, Ochratoxin A is the most common and it has the highest degree of toxicity (<xref rid="b33-or-37-03-1321" ref-type="bibr">33</xref>&#x2013;<xref rid="b35-or-37-03-1321" ref-type="bibr">35</xref>). The Ochratoxins can be found in cereals, coffee, dried fruit, and red wine. It can be accumulated in the meat of animals and thus, meat and meat products can be contaminated with this toxin (<xref rid="b36-or-37-03-1321" ref-type="bibr">36</xref>&#x2013;<xref rid="b39-or-37-03-1321" ref-type="bibr">39</xref>).</p>
<p>As previous literature indicates, fungal strains can be found in many terrestrial habitats which make the availability of different mycotoxins a very common phenomenon. Since many different fungal strains such as <italic>Penicillium</italic>, <italic>Aspergillus</italic> and <italic>Fusarium</italic> species grow very well on commodities such as crops, grains and stored animal feed, the chances of mycotoxins entering the humans or animal biological system are very high, mostly accompanied with many health concerns and medical complications (<xref rid="b40-or-37-03-1321" ref-type="bibr">40</xref>).</p>
</sec>
<sec>
<label>3.</label>
<title>The chemical and physical nature of mycotoxins</title>
<p>Researched confirmed that the most important mycotoxins are Citrine, Aflatoxin B1, Ergot, fumonisins akaloids, Patulin, Trichothecene, Zearalenone and Ochratoxin A and the reason behind their importance is the fact that they are involved in many human and animal diseases which sometimes leads to death (<xref rid="b41-or-37-03-1321" ref-type="bibr">41</xref>).</p>
<sec>
<title/>
<sec>
<title>Aflatoxin B1</title>
<p>Aflatoxins are the most important mycotoxins that are produced mainly by <italic>Aspergillus Flavus</italic> and <italic>Aspergillus Parasiticus</italic> (<xref rid="b42-or-37-03-1321" ref-type="bibr">42</xref>), and they are mainly produced by the aspergillus species (<xref rid="b43-or-37-03-1321" ref-type="bibr">43</xref>&#x2013;<xref rid="b45-or-37-03-1321" ref-type="bibr">45</xref>). There are four types of aflatoxins named B1, B2, G1, and G2 and can be categorized based on two characteristics: Their fluorescence color under UV light (whether it is blue or green), and their mobility during TLC (<xref rid="b41-or-37-03-1321" ref-type="bibr">41</xref>). The chemical formula of the aflatoxin is C<sub>17</sub>H<sub>12</sub>O<sub>6</sub> (<xref rid="f1-or-37-03-1321" ref-type="fig">Fig. 1</xref>) (<xref rid="b46-or-37-03-1321" ref-type="bibr">46</xref>). The biosynthesis of aflatoxins starts with the production of norsolorinic acid which is an anthraquinone precursor joined together by the action of the enzyme II polyketide synthase followed by 15 post-polyketide synthase steps which will yield a series of toxigenic metabolites (<xref rid="b47-or-37-03-1321" ref-type="bibr">47</xref>&#x2013;<xref rid="b52-or-37-03-1321" ref-type="bibr">52</xref>).</p>
</sec>
<sec>
<title>Citrinin</title>
<p>Chemically, citrine is known as (3R,4S)-8-hydroxy-3,4,5-trimethyl-6-oxo-4,6-dihydro-3H-isochromene-7-carboxylic acid (<xref rid="b53-or-37-03-1321" ref-type="bibr">53</xref>) and its chemical formula is C<sub>13</sub>H<sub>14</sub>O<sub>5</sub> (<xref rid="f2-or-37-03-1321" ref-type="fig">Fig. 2</xref>) (<xref rid="b54-or-37-03-1321" ref-type="bibr">54</xref>). It is mainly produced by <italic>Penicillium Citrinum</italic> (<xref rid="b55-or-37-03-1321" ref-type="bibr">55</xref>). Citrinin is connected to the yellow rice disease in Japan and it is a potent nephrotoxin in animals. Its acute toxicity varies with different species (<xref rid="b56-or-37-03-1321" ref-type="bibr">56</xref>,<xref rid="b57-or-37-03-1321" ref-type="bibr">57</xref>).</p>
</sec>
<sec>
<title>Ergot alkaloids</title>
<p>The most important and fascinating Ergot alkaloids is the Ergotamine, produced mainly by Claviceps Sclerotia and its chemical formula is C<sub>13</sub>H<sub>14</sub>O<sub>5</sub> (<xref rid="f3-or-37-03-1321" ref-type="fig">Fig. 3</xref>) (<xref rid="b58-or-37-03-1321" ref-type="bibr">58</xref>). Ergotamine is made up of indole alkaloids that are derived from a tetracyclic ergoline ring system (<xref rid="b59-or-37-03-1321" ref-type="bibr">59</xref>).</p>
</sec>
<sec>
<title>Fumonisins</title>
<p>The most important fumonisins are the fumonisin B1 and they are the product of condensation of alanine into acetate-derived precursor (<xref rid="b60-or-37-03-1321" ref-type="bibr">60</xref>). The chemical formula of the Fumonisin B1 is C<sub>34</sub>H<sub>59</sub>NO<sub>15</sub> (<xref rid="f4-or-37-03-1321" ref-type="fig">Fig. 4</xref>) and it is basically produced by the Fusarium species (<xref rid="b61-or-37-03-1321" ref-type="bibr">61</xref>).</p>
</sec>
<sec>
<title>Ochratoxins</title>
<p>The most important ochratoxin is the Ochratoxin A, which is produced mainly by Aspergillus Ochraceus (<xref rid="b62-or-37-03-1321" ref-type="bibr">62</xref>) and its chemical formula is C<sub>20</sub>H<sub>18</sub>C<sub>l</sub>NO<sub>6</sub> (<xref rid="f5-or-37-03-1321" ref-type="fig">Fig. 5</xref>) (<xref rid="b63-or-37-03-1321" ref-type="bibr">63</xref>).</p>
</sec>
<sec>
<title>Patulin</title>
<p>This mycotoxin is produced by the Penicillium pabulum, and its chemical name is 4-hydroxy-4H-furo[3,2c] pyran-2(6H)-one (<xref rid="b64-or-37-03-1321" ref-type="bibr">64</xref>). The chemical formula is C<sub>7</sub>H<sub>6</sub>O<sub>4</sub> (<xref rid="f6-or-37-03-1321" ref-type="fig">Fig. 6</xref>) (<xref rid="b65-or-37-03-1321" ref-type="bibr">65</xref>). This toxin was once used as an antibiotic until it was proven toxic in the 1960s and classified as a mycotoxin (<xref rid="b64-or-37-03-1321" ref-type="bibr">64</xref>).</p>
</sec>
<sec>
<title>Trichothecenes</title>
<p>This group of mycotoxin contains three major toxins called T-2 toxin (<xref rid="f7-or-37-03-1321" ref-type="fig">Fig. 7</xref>), Deoxynivalenol (<xref rid="f8-or-37-03-1321" ref-type="fig">Fig. 8</xref>) and Satratoxin H (<xref rid="f9-or-37-03-1321" ref-type="fig">Fig. 9</xref>) and they are produced mainly by <italic>Myrothecium, Phomopsis, Trichothecium, Fusarium, Trichoderma</italic> and <italic>Stachybotrys</italic> (<xref rid="b66-or-37-03-1321" ref-type="bibr">66</xref>&#x2013;<xref rid="b68-or-37-03-1321" ref-type="bibr">68</xref>). Chemically, trichothecenes are made up of 12, 13-epoxytrichothene skeletons linked up with an olefinic bond with various side chain substitutions. Trichothecenes can be classified into group A, which has hydrogen or ester type side chain at the C-8 position and include T-2 toxin, and group B which has a ketone and include fusarenon-x, nivalenol, and deoxynivalenol (<xref rid="b69-or-37-03-1321" ref-type="bibr">69</xref>). Satratoxin is another important Trichothecene which is a macrocyclic trichothecene produced mainly by Stachybotrys Atra. Research has proven its toxicity towards humans and animals (<xref rid="b70-or-37-03-1321" ref-type="bibr">70</xref>).</p>
</sec>
<sec>
<title>Zearalenone</title>
<p>This mycotoxin is mainly produced by Fusarium Graminearum and its chemical name is 6-[10-hydroxy-6-oxo-trans-1-undecenyl]-B-resorcyclic acid lactone (<xref rid="b71-or-37-03-1321" ref-type="bibr">71</xref>). The chemical formula of Zearalenone is C<sub>18</sub>H<sub>22</sub>O<sub>5</sub> (<xref rid="f10-or-37-03-1321" ref-type="fig">Fig. 10</xref>) (<xref rid="b72-or-37-03-1321" ref-type="bibr">72</xref>).</p>
<p>Mycotoxin chemical composition makes them strong and stable to a point where they cannot be completely destroyed during the different food processing procedures. They can contaminate the final food product which will eventually enter the humans biological system (<xref rid="b73-or-37-03-1321" ref-type="bibr">73</xref>). When the food that is processed is mainly cereals, the contaminating mycotoxins most likely to be found are Aflatoxins, Ochratoxin A, Fumonisins, Deoxynivalenol and Zearalenone (<xref rid="b74-or-37-03-1321" ref-type="bibr">74</xref>). Mycotoxins can be affected by different food processes such as trimming, cooking, baking, cleaning, canning, alkaline cooking, frying, roasting, flaking, nixtamalization, sorting, milling, extrusion and brewing (<xref rid="b75-or-37-03-1321" ref-type="bibr">75</xref>). With the increase in the temperature, the effect on the mycotoxin will increase but due to its chemical nature, the concentration of the mycotoxins will be reduced. Despite this, mycotoxins cannot be completely eliminated (<xref rid="b73-or-37-03-1321" ref-type="bibr">73</xref>). High temperature that is greater than 150&#x00B0;C during the extrusion was needed to reduce zearalenone greatly and aflatoxins moderately (<xref rid="b76-or-37-03-1321" ref-type="bibr">76</xref>). In the same temperature during the extrusion process, there will be a low reduction of deoxynivalenol and a high reduction of fumonisins. Temperatures 160&#x00B0;C and higher with the addition of glucose was found to reduce fumonisin to even greater levels (<xref rid="b73-or-37-03-1321" ref-type="bibr">73</xref>).</p>
<p>In another experiment, the degradation of aflatoxin was examined in different conditions and it was found that Aflatoxin can be partially or completely degraded by several sterilization techniques such as heat and irradiation. Besides that, aflatoxins can be eliminated by the addition of bisulfate, strong acids, strong bases or oxidizing agent or treatment with strong acids or bases, oxidizing agents or bisulfite. Hydrogen peroxide plus riboflavin denature aflatoxin in milk (<xref rid="b77-or-37-03-1321" ref-type="bibr">77</xref>). Chemical stability of Nivalenol, Deoxynivalenol and Zearalenone related to moisture, pH and heat was studied by Lauren and Smith (<xref rid="b78-or-37-03-1321" ref-type="bibr">78</xref>) and the results showed that Nivalenol and deoxynivalenol are stable in buffer solutions that have the range of PH 1&#x2013;10, but with a PH higher than 12, high salt concentration and a temperature of 80&#x00B0;C for a long period of time, both Nivalenol and deoxynivalenol tend to break down. In the same experiment, both Nivalenol and deoxynivalenol are reduced to 60&#x2013;100&#x0025; by treating the contaminated food with 10, 20 or 50&#x0025; of the food dry weight with bicarbonate solution and raise the temperature up to 80 or 110&#x00B0;C for 2&#x2013;12 days. Finally, in the case of zearalenone, the result shows that it is highly stable and cannot be broken down even when treated with sodium bicarbonate solution at a temperature of 110&#x00B0;C for more than 12 days (<xref rid="b78-or-37-03-1321" ref-type="bibr">78</xref>).</p>
<p>All mycotoxins have at least one benzene ring which gives them thermodynamic and chemical stability, and that is mainly why they require a high temperature to desaturate and to be utilized as less complex compounds (<xref rid="b27-or-37-03-1321" ref-type="bibr">27</xref>,<xref rid="b54-or-37-03-1321" ref-type="bibr">54</xref>,<xref rid="b60-or-37-03-1321" ref-type="bibr">60</xref>,<xref rid="b62-or-37-03-1321" ref-type="bibr">62</xref>,<xref rid="b65-or-37-03-1321" ref-type="bibr">65</xref>,<xref rid="b66-or-37-03-1321" ref-type="bibr">66</xref>,<xref rid="b72-or-37-03-1321" ref-type="bibr">72</xref>,<xref rid="b79-or-37-03-1321" ref-type="bibr">79</xref>,<xref rid="b80-or-37-03-1321" ref-type="bibr">80</xref>). This stability makes mycotoxins highly resistant when it comes to decontamination and sterilization and that in turn will increase the chances of contaminating human food and animal feed (<xref rid="b55-or-37-03-1321" ref-type="bibr">55</xref>,<xref rid="b72-or-37-03-1321" ref-type="bibr">72</xref>,<xref rid="b73-or-37-03-1321" ref-type="bibr">73</xref>,<xref rid="b81-or-37-03-1321" ref-type="bibr">81</xref>). Finally, the chemical and physical nature of mycotoxins makes them a very strong carcinogenic agent that can be related to different cancer types in all countries around the world.</p>
</sec>
</sec>
</sec>
<sec>
<label>4.</label>
<title>The action of mycotoxins on the cellular genome and its effect on humans</title>
<p>The most dangerous mycotoxins are the aflatoxin B1 (<xref rid="f1-or-37-03-1321" ref-type="fig">Fig. 1</xref>) and Ochratoxin A (<xref rid="f5-or-37-03-1321" ref-type="fig">Fig. 5</xref>) for their lethal effect on humans and animal. Aflatoxin B1 has the highest carcinogenicity among all mycotoxins and it is capable of penetrating the cell membrane and attach to its DNA where it makes changes to the genome in order to become more stable (<xref rid="b2-or-37-03-1321" ref-type="bibr">2</xref>,<xref rid="b82-or-37-03-1321" ref-type="bibr">82</xref>,<xref rid="b83-or-37-03-1321" ref-type="bibr">83</xref>). Aflatoxin B1 is considered a liposoluble compound which can be absorbed from the site of exposure and move into the blood stream throughout the body (<xref rid="b84-or-37-03-1321" ref-type="bibr">84</xref>). As soon as the aflatoxins enter the cells, they get metabolized by cytochrome P450, to aflatoxin-8, 9-epoxide which is highly reactive and unstable and requires the binding to a DNA or to the protein molecule in order to become more stable (<xref rid="b85-or-37-03-1321" ref-type="bibr">85</xref>,<xref rid="b86-or-37-03-1321" ref-type="bibr">86</xref>). Once the highly unstable aflatoxin-8, 9-epoxide binds to the DNA molecule with high affinity, it forms aflatoxin-N7-guanine that causes GC to TA transversion mutations. This will directly affect the cell cycle by affecting the P53 gene which encodes tumor suppressor protein that inhibits the development of tumors and cancers (<xref rid="b87-or-37-03-1321" ref-type="bibr">87</xref>,<xref rid="b88-or-37-03-1321" ref-type="bibr">88</xref>).</p>
<p>Ochratoxin (<xref rid="f5-or-37-03-1321" ref-type="fig">Fig. 5</xref>) is another mycotoxin which is given a similar importance as Aflatoxin B1 because of how it targets the kidney (<xref rid="b89-or-37-03-1321" ref-type="bibr">89</xref>). Ochratoxin A is considered a nephrotoxin to animals and humans and is a very strong liver toxin, potent teratogen, carcinogenic and immune suppressant (<xref rid="b90-or-37-03-1321" ref-type="bibr">90</xref>,<xref rid="b91-or-37-03-1321" ref-type="bibr">91</xref>). Ochratoxin A will mainly disturb cellular physiology in several ways, but the primary effects of it are usually associated with the enzymes that are involved in phenylalanine metabolism which inhibits the enzyme involved in the synthesis of the phenylalanine-tRNA complex (<xref rid="b92-or-37-03-1321" ref-type="bibr">92</xref>,<xref rid="b93-or-37-03-1321" ref-type="bibr">93</xref>). Moreover, Ochratoxin A is capable of inhibiting mitochondrial ATP production and is considered a strong stimulant for lipid peroxidation (<xref rid="b35-or-37-03-1321" ref-type="bibr">35</xref>,<xref rid="b94-or-37-03-1321" ref-type="bibr">94</xref>).</p>
<p>Trichothecene mycotoxins are proven to have multiple inhibition effects on eukaryote cells where they inhibit protein, DNA and RNA synthesis, mitochondrial function and effects both cell division and cell membrane of the eukaryotic cells (<xref rid="b95-or-37-03-1321" ref-type="bibr">95</xref>). Trichothecenes are capable of inducing a programmed cell death response within infected cells, causing a reduction in downstream gene products, starting a ribotoxic stress response and activating a mitogen-activated protein kinase (<xref rid="b96-or-37-03-1321" ref-type="bibr">96</xref>). Deoxynivalenol mycotoxin (<xref rid="f8-or-37-03-1321" ref-type="fig">Fig. 8</xref>) usually mediates an inflammatory response by controlling the binding activities of some transcription factors which will results in inducing cytokine gene expression (<xref rid="b97-or-37-03-1321" ref-type="bibr">97</xref>). In animal cells, Trichothecenes are capable of inhibiting protein synthesis, inhibiting RNA and DNA synthesis; altering cellular membrane structure, interfere with mitochondria functions, initiating apoptosis, activation of MAPK and finally, activation of the cytokine (<xref rid="b98-or-37-03-1321" ref-type="bibr">98</xref>&#x2013;<xref rid="b104-or-37-03-1321" ref-type="bibr">104</xref>).</p>
<p>Citrinin (<xref rid="f2-or-37-03-1321" ref-type="fig">Fig. 2</xref>) is considered as one of the strongest nephrotoxins to animals, and the levels of toxicity differ between species (<xref rid="b56-or-37-03-1321" ref-type="bibr">56</xref>). Citrinin can act together with Ochratoxin A, interfere with RNA synthesis and suppress it in rodent kidneys (<xref rid="b105-or-37-03-1321" ref-type="bibr">105</xref>). Citrinin is known to inhibit cytokine expression and reduce the interleukin-4 in T-helper type 1 which would result in increasing the risk of allergies in humans (<xref rid="b106-or-37-03-1321" ref-type="bibr">106</xref>). It is considered genotoxic at high concentrations to cultured human lymphocytes (<xref rid="b107-or-37-03-1321" ref-type="bibr">107</xref>). Finally, Citrinin is considered a nephrotoxin which causes nephropathy and impose oxidative stress, or increase the permeability of mitochondrial membranes (<xref rid="b108-or-37-03-1321" ref-type="bibr">108</xref>). Ergot Alkaloids mycotoxins are a type of Citrinin, and they are known to induce humans ergotism, low nerve fever in humans and have a strong influence on fertility (<xref rid="b109-or-37-03-1321" ref-type="bibr">109</xref>&#x2013;<xref rid="b111-or-37-03-1321" ref-type="bibr">111</xref>). Although certain cleaning processes for grains has overcome the problem of ergotism, it is still considered a significant animal problem which causes symptoms such as abortion, suppression of lactation, hypersensitivity, ataxia and gangrene (<xref rid="b112-or-37-03-1321" ref-type="bibr">112</xref>,<xref rid="b113-or-37-03-1321" ref-type="bibr">113</xref>) and smooth muscle contractions (<xref rid="b114-or-37-03-1321" ref-type="bibr">114</xref>). Despite its toxicity, Ergot Alkaloids mycotoxins and its derivatives are used widely in abortifacient and as a drug to accelerate uterine contractions during labor (<xref rid="b114-or-37-03-1321" ref-type="bibr">114</xref>). They are also used for the treatment of migraine headaches, prolactin inhibitors for the treatment of Parkinsonism and for the treatment of cerebrovascular insufficiency (<xref rid="b59-or-37-03-1321" ref-type="bibr">59</xref>). Unfortunately, the use of ergot alkaloids may result in the development of human ergotism (<xref rid="b115-or-37-03-1321" ref-type="bibr">115</xref>).</p>
<p>Fumonisin B1 (<xref rid="f4-or-37-03-1321" ref-type="fig">Fig. 4</xref>) is an important Fumonisins mycotoxin which was reported to be a hepatotoxic and carcinogenic toxin (<xref rid="b28-or-37-03-1321" ref-type="bibr">28</xref>,<xref rid="b116-or-37-03-1321" ref-type="bibr">116</xref>,<xref rid="b117-or-37-03-1321" ref-type="bibr">117</xref>). In addition, fumonisin B1 was reported to cause apoptosis in the liver of rats (<xref rid="b118-or-37-03-1321" ref-type="bibr">118</xref>) and there is a possibility that it can be linked to esophageal cancer (<xref rid="b119-or-37-03-1321" ref-type="bibr">119</xref>). FB1&#x0027;s main action is to disrupt sphingolipid metabolism which induces lipid peroxidation that will end up altering the cell membrane, causing cell death through apoptosis. It also has the potential of inhibiting protein synthesis and in higher concentration to inhibit DNA synthesis (<xref rid="b120-or-37-03-1321" ref-type="bibr">120</xref>). It was proven to have some carcinogenic activity by stimulating <sup>3</sup>H thymidine incorporation (<xref rid="b121-or-37-03-1321" ref-type="bibr">121</xref>). Fumonisin mycotoxins are involved in the neural tube defects in animals, and it was hypothesized that it can have the same effect on humans. A cluster of anencephaly and spina bifida cases in Texas in the USA is related to fumonisins mycotoxins infection in corn products (<xref rid="b122-or-37-03-1321" ref-type="bibr">122</xref>,<xref rid="b123-or-37-03-1321" ref-type="bibr">123</xref>) and it was evaluated by the International Agency for Research that fumonisins have a cancer risk to humans. Its carcinogenicity is classified as group 2B which means probably carcinogenic (<xref rid="b124-or-37-03-1321" ref-type="bibr">124</xref>). Another mycotoxin that affects humans on a cellular level is Patulin (<xref rid="f6-or-37-03-1321" ref-type="fig">Fig. 6</xref>) which is just as toxic at high concentration in but there is not enough evidence for natural poisoning, and its recorded poisonous effects are inconclusive (<xref rid="b125-or-37-03-1321" ref-type="bibr">125</xref>).</p>
<p>Trichothecene mycotoxins were proven to be extremely potent inhibitors of eukaryotic protein synthesis, and were found to interfere with initiation, elongation, and termination stages of protein synthesis. They are the first mycotoxin from the trichothecene group known to inhibit peptidyl transferase activity during protein synthesis (<xref rid="b126-or-37-03-1321" ref-type="bibr">126</xref>,<xref rid="b127-or-37-03-1321" ref-type="bibr">127</xref>). The way trichothecenes inhibit peptidyl transferase is by binding to the same ribosome-binding site, leading to correlation with different functional groups and subsequently affecting the protein synthesis process (<xref rid="b128-or-37-03-1321" ref-type="bibr">128</xref>). Among all Trichothecene mycotoxins, Deoxynivalenol is the most commonly found mycotoxin in different grains and once they are ingested, are reported to cause nausea, vomiting, and diarrhea with refusal for food and weight loss in animals (<xref rid="b129-or-37-03-1321" ref-type="bibr">129</xref>). Deoxynivalenol was found to have a mitogen-activated protein kinase-mediated IL-8 expression in cloned human monocytes and peripheral blood mononuclear cells where the concentration of deoxynivalenol is from 250 to 1000 ng/ml. This will induce both IL-8 mRNA and IL-8 heteronuclear RNA which is an indicator of IL-8 transcription in human U937 monocytic cell line in a concentration-dependent manner (<xref rid="b130-or-37-03-1321" ref-type="bibr">130</xref>).</p>
<p>Other Trichothecene mycotoxins that were found to have a great toxic effect on humans and animals are T-2 (<xref rid="f7-or-37-03-1321" ref-type="fig">Fig. 7</xref>) and diacetoxyscirpenol. Both were proven to be immunosuppressive in which they reduce resistance towards different infections and microbes (<xref rid="b129-or-37-03-1321" ref-type="bibr">129</xref>,<xref rid="b131-or-37-03-1321" ref-type="bibr">131</xref>). T-2 mycotoxin was proven to induce apoptosis at 10 ng/ml concentration (<xref rid="b132-or-37-03-1321" ref-type="bibr">132</xref>) and was reported to inhibit the platelet aggregation and the release of dense bodies with a change in the membrane permeability (<xref rid="b133-or-37-03-1321" ref-type="bibr">133</xref>). On the other hand, diacetoxyscirpenol is capable of inhibiting protein synthesis, has high immunomodulatory effects (<xref rid="b134-or-37-03-1321" ref-type="bibr">134</xref>) and was reported to cause alimentary intoxication, food poisoning and induce hematological symptoms (<xref rid="b135-or-37-03-1321" ref-type="bibr">135</xref>). Moreover, it was proven that T-2 and diacetoxyscirpenol are capable of causing several dermatological, gastrointestinal, and neurologic symptoms in humans and animals (<xref rid="b136-or-37-03-1321" ref-type="bibr">136</xref>). Finally, T-2 and diacetoxyscirpenol are hypothesized to be associated with a humans disease called alimentary toxic aleukia in which the infected person will have skin inflammation, continuous vomiting, and damage to hematopoietic tissues that gives rise to blood cells and in advanced stages, cause central nervous system disorders, oral cavity, and severe bleeding from the nose, mouth, and vagina (<xref rid="b111-or-37-03-1321" ref-type="bibr">111</xref>).</p>
<p>Zearalenone mycotoxins (F-2) (<xref rid="f10-or-37-03-1321" ref-type="fig">Fig. 10</xref>) are a unique mycotoxin that is biologically potent but is hardly toxic and resembles 17&#x03B2;-estradiol, which is an ovary hormone which humans produce to help the ovaries bind to estrogen receptors in the target cells. Therefore, it can be classified as a non-steroidal estrogen or mycoestroge (<xref rid="b137-or-37-03-1321" ref-type="bibr">137</xref>) and used to reduce the postmenopausal symptoms in women (<xref rid="b138-or-37-03-1321" ref-type="bibr">138</xref>). The major effects of Zearalenone are on the reproduction in females, where it affects reproductive organs and their function, eventually leading to a medical condition called hyperestrogenism (<xref rid="b137-or-37-03-1321" ref-type="bibr">137</xref>). Zearalenone in its reduced form, zearalenol, is known to increase estrogenic activity (<xref rid="b139-or-37-03-1321" ref-type="bibr">139</xref>) but it was proven to cause disrupted conception, abortion, and other problems in female pigs (<xref rid="b140-or-37-03-1321" ref-type="bibr">140</xref>) and that can be hypothesized for humans as well.</p>
</sec>
<sec>
<label>5.</label>
<title>Mycotoxins and their carcinogenicity</title>
<p>The effects of mycotoxins on humans and animals will vary based on the nature of the toxins. While several are considered to be mutagenic; it was proven that Aflatoxin B1, Ochratoxin A and Sterigmatocystin are strong carcinogens (<xref rid="b17-or-37-03-1321" ref-type="bibr">17</xref>). In a study made to identify the DNA-attacking ability of carcinogenic mycotoxins, six Penicillium toxins that include patulin, Citrinin, penicillic acid negative-luteoskyrin, positive-rugulosin, and PR-toxin, 5 aspergillus toxins including O-acetylsterigmatocystin, sterigmatocystin, O-acetyldihydrosterigmatocystin aflatoxin B1 and aflatoxin G1, and two fusarium toxins that include zearalenol-b and zearalenone, all these mycotoxins were found to have destructive ability towards genomic DNA (<xref rid="b141-or-37-03-1321" ref-type="bibr">141</xref>). Although these 13 mycotoxins have the ability to attack the genomic DNA, 8 of them were found to be highly carcinogenic, including penicillic acid, citrinin, patulin, negative-luteoskyrin, positive-rugulosin, sterigmatocystin, aflatoxins B1, and G1 (<xref rid="b141-or-37-03-1321" ref-type="bibr">141</xref>).</p>
<p>In another experiment conducted on mice, the effect of luteoskyrin and cyclochlorotine mycotoxins was investigated, and it was found that both toxins have hepatotoxic and hepatocarcinogenic activities on rats (<xref rid="b142-or-37-03-1321" ref-type="bibr">142</xref>) with a hypothetical possibility to affect humans in a similar fashion. Fumonisin mycotoxins were found to be carcinogenic in rats due to their action in inhibiting ceramide synthase <italic>in vitro</italic> which in turn would enhance the production of tumor necrosis factor &#x03B1; (TNF&#x03B1;). This leads to the initiation of cells apoptosis (<xref rid="b143-or-37-03-1321" ref-type="bibr">143</xref>). In addition, an experiment was conducted using 28 mycotoxins to investigate their action against hepatocytes of rats and mice. The results of the experiment showed that unknown carcinogenic mycotoxins such as 5,6-dimethoxysterigmatocystin, versicolorins A and B, averufin, xanthomegnin, luteosporin, and chrysazin, known carcinogenic mycotoxins such as aflatoxin B1 (<xref rid="f1-or-37-03-1321" ref-type="fig">Fig. 1</xref>), sterigmatocystin, luteoskyrin, Ochratoxin A (<xref rid="f5-or-37-03-1321" ref-type="fig">Fig. 5</xref>), azaserine, mitomycin C, and actinomycin D have the tendency to elicit DNA repair synthesis, which suggest the possibility of these mycotoxins to be genotoxic carcinogens (<xref rid="b144-or-37-03-1321" ref-type="bibr">144</xref>). On the other hand, some carcinogenic mycotoxins such as penicillic acid, patulin, griseofulvin, and rugulosin were not found to elicit DNA repair synthesis and suggest the possibility of these mycotoxins being nongenotoxic carcinogens (<xref rid="b144-or-37-03-1321" ref-type="bibr">144</xref>).</p>
<sec>
<title/>
<sec>
<title>Aflatoxin B1</title>
<p>Aflatoxin B1 has a ubiquitous nature and is considered a toxic metabolite, making it a serious public health concern. Furthermore, aflatoxin B1 (<xref rid="f1-or-37-03-1321" ref-type="fig">Fig. 1</xref>) toxin contamination is related to liver diseases (<xref rid="b145-or-37-03-1321" ref-type="bibr">145</xref>). Aflatoxin B1 is said to have an active role in causing hepatic and extrahepatic carcinogenesis in both humans and animals by inducing a DNA single strand break (<xref rid="b146-or-37-03-1321" ref-type="bibr">146</xref>) and through bio activation of Aflatoxin B1 to its epoxide metabolite. As a result, it will interact with the DNA molecule which will finally lead to neoplastic transformation of the cells (<xref rid="b147-or-37-03-1321" ref-type="bibr">147</xref>). The activation of Aflatoxin B1 is accomplished by two approaches, chemical and enzymatic in which the Aflatoxin B1 will be biologically active. The chemical activation of the Aflatoxin B1 will be through the chemical oxidation of dimethyldioxirane whereas the enzymatic activation will be through the cytochrome P450. Combined, they are a mixed-function oxidase that will give rise to a mixture of exo and endo-8, 9-epoxides (<xref rid="b148-or-37-03-1321" ref-type="bibr">148</xref>). The exo-8, 9-epoxides will interact with the DNA molecule by attacking the nitrogen atom at the 7 position (N7) of guanine at the C8 of the epoxide by the Sn2 reaction. This process initiates the trans adduct that will lead to the development of a malignant cell. They are considered to be carcinogenic agents (<xref rid="b149-or-37-03-1321" ref-type="bibr">149</xref>,<xref rid="b150-or-37-03-1321" ref-type="bibr">150</xref>). On the other hand, it is not capable of interacting with DNA molecules. Hence, it is not considered a carcinogenic agent (<xref rid="b148-or-37-03-1321" ref-type="bibr">148</xref>).</p>
<p>It was reported that almost half of the hepatocellular carcinomas (HCC) were reported in the part of the world that witnessed high levels of Aflatoxin B1 contamination in food where a mutation in the 249th codon of the P53 tumor suppressing gene (<xref rid="b151-or-37-03-1321" ref-type="bibr">151</xref>). The mutation caused in this codon is in the form of transversion in the third position of this codon and will cause the insertion of serine at the 249 in the mutant protein (<xref rid="b152-or-37-03-1321" ref-type="bibr">152</xref>). In addition to the G--&#x003E;T transversion, Aflatoxin B1 will cause G--&#x003E;T and C--&#x003E;A transversions into adjacent codons but with reduced frequency but it was proven only as G--&#x003E;T transversion at 249 codon. It turns out that the mutant serine 249 p53 protein are responsible for the mutation at p53 in HCC from aflatoxin B1 in the areas that were reported to have aflatoxin B1 contamination in the food (<xref rid="b153-or-37-03-1321" ref-type="bibr">153</xref>). This confirmed that aflatoxin B1 is hepatocarcinogenic (<xref rid="b154-or-37-03-1321" ref-type="bibr">154</xref>). In another study, there was an increase of the hepatocellular carcinoma in Mozambique and Transkei, and several parts of Asia (<xref rid="b155-or-37-03-1321" ref-type="bibr">155</xref>) including China (<xref rid="b156-or-37-03-1321" ref-type="bibr">156</xref>) and Africa including Kenya (<xref rid="b153-or-37-03-1321" ref-type="bibr">153</xref>).</p>
<p>Inhalation of aflatoxin B1 is thought to cause primary lung cancer due to the activation of it to its biologically active form 8, 9-epoxide where the rate of 8, 9-epoxide was measured using AFB1-glutathione (AFB1-GSH) conjugate by HPLC with aflatoxin b1 at a concentration of 124 &#x00B5;m. Rates of activation were less than in the liver cells most probably due to the CYP-containing cells that are less abundant in the lungs than in the liver (<xref rid="b157-or-37-03-1321" ref-type="bibr">157</xref>). In another study, the X-ray cross-complementing group 1 protein (XRCC1) which is involved in the repair mechanism of the single strand DNA was investigated in the presence of aflatoxin. A substitution of guanine to adenine was found at codon 399 and that in turn was found to increase the risks of adenocarcinoma of the lung (<xref rid="b158-or-37-03-1321" ref-type="bibr">158</xref>). The presence of aflatoxin B1 has been confirmed in two cases of human lung cancer using thin-layer chromatography and fluorescence microscopy (<xref rid="b159-or-37-03-1321" ref-type="bibr">159</xref>,<xref rid="b160-or-37-03-1321" ref-type="bibr">160</xref>). Finally, the expression of GSTM1-1 that is responsible for the production of cytosolic Glutathione S-transferases helps in detoxifying several carcinogenic electrophiles in the presence of polycyclic aromatic hydrocarbons that serves as the main compound, yielding substrates for these enzymes, and naturally was affected by the presence of Aflatoxin B1, which leads to inactivation of GSTM1-1 and increased risk factor for lung cancer (<xref rid="b161-or-37-03-1321" ref-type="bibr">161</xref>).</p>
</sec>
<sec>
<title>Ochratoxin A</title>
<p>Ochratoxin A (<xref rid="f5-or-37-03-1321" ref-type="fig">Fig. 5</xref>) was reported to be associated with different effects on humans and animals but their nephrocarcinogenicity was found to be the most important effect, and that made it a major public health concern. In an experiment conducted on male Fischer rats that were fed Ochratoxin B1, a renal tumor was discovered within the first six months, and the tumor incidents increased by 25&#x0025;. This is because the genes responsible for kidney injury and cell regeneration were significantly influenced by the action of Ochratoxin A (<xref rid="b162-or-37-03-1321" ref-type="bibr">162</xref>). Ochratoxin A was found to cause an alteration of gene expression that resulted in affecting calcium homeostasis which disrupts the different pathways regulated by the HNF4&#x03B1; and Nrf2 in the kidney (<xref rid="b163-or-37-03-1321" ref-type="bibr">163</xref>). In addition, Ochratoxin A was found to have a small influence on the expression of genes involved in DNA synthesis and repair and ones induced as a result of DNA damage. There was minimal to no influence at all on the genes that are responsible for apoptosis (<xref rid="b163-or-37-03-1321" ref-type="bibr">163</xref>,<xref rid="b164-or-37-03-1321" ref-type="bibr">164</xref>). Ochratoxin was also found to effect Nrf2-regulated genes in the kidney that is required for the chemical detoxication and antioxidant defense within the cell. That in turn affects the cell&#x0027;s defense mechanism while also causing an increase in the kidney oxidative stress, which contributes to the Ochratoxin A carcinogenic nature (<xref rid="b165-or-37-03-1321" ref-type="bibr">165</xref>). Ochratoxin A is suggested to have a renal carcinogenesis effect on the kidneys and its mode of action is by the means of direct genotoxicity through covalent DNA adduct formation. This information should be taken into consideration for Ochratoxin A for OTA human risk assessment (<xref rid="b166-or-37-03-1321" ref-type="bibr">166</xref>).</p>
<p>The alteration caused by Ochratoxin A could lead to single cell death in kidney and stimulates cell proliferation and an enlarged cellular nucleus which indicates blocked nuclear division during mitosis. Exposure to Ochratoxin A could also lead to overexpression of mitosis regulators such as mitotic protein kinases Polo-like kinase 1, Aurora B and cyclin-dependent kinase 1, cyclins and cyclin-dependent kinase inhibitors, topoisomerase II and surviving (<xref rid="b167-or-37-03-1321" ref-type="bibr">167</xref>). Ochratoxin A (<xref rid="f5-or-37-03-1321" ref-type="fig">Fig. 5</xref>) is classified as a ubiquitous nephrotoxic mycotoxin and it was reported to be responsible for human Balkan endemic nephropathy and involved in urinary tract tumors. For this reason, it was classified by the Agency for Research on Cancer as a possible carcinogen belonging to group 2B (<xref rid="b168-or-37-03-1321" ref-type="bibr">168</xref>). Ochratoxin A has a genotoxic activity on the cell DNA followed by oxidative metabolism, which plays a major role in Ochratoxin mediated carcinogenesis. It can be divided into direct modes of action where Ochratoxin A is involved in covalent DNA adduction and indirect modes where Ochratoxin A is involved in oxidative DNA damage (<xref rid="b169-or-37-03-1321" ref-type="bibr">169</xref>). Ochratoxin OTA is a genotoxic carcinogen because of their ability to oxidase DNA lesions and the direct DNA adducts through quinone formation (<xref rid="b170-or-37-03-1321" ref-type="bibr">170</xref>). Ochratoxin A was proven to increase phosphorylation of atypical-PKC which in turn leads to a downstream activation of ERK1 and ERK 2 and their substrate ELK1, ELK2 and p90RSK where PKC and the MEK-ERK MAP-kinase pathways are activated by Ochratoxin A involved in cell proliferation, cell survival, anti-apoptotic activity and most importantly renal cancer development (<xref rid="b171-or-37-03-1321" ref-type="bibr">171</xref>).</p>
<p>A study on rodents supported the involvement of Ochratoxin A mycotoxin in developing breast cancer through genetic damage, and the study hypothesized the possibility of the Ochratoxin A in causing breast cancer. The validity of that hypothesis relates to data that show an increase in breast cancer cases when a number of people in a population migrate from one geographic area to another (<xref rid="b172-or-37-03-1321" ref-type="bibr">172</xref>). Ochratoxin A was hypothesized to be involved in testicular cancer which is one the most common cancer affecting young men due to adducts in testicular DNA where the consumption of Ochratoxin during pregnancy and during young childhood would cause lesions in the testicular DNA during puberty. These lesions will develop into testicular cancer (<xref rid="b173-or-37-03-1321" ref-type="bibr">173</xref>&#x2013;<xref rid="b175-or-37-03-1321" ref-type="bibr">175</xref>).</p>
</sec>
<sec>
<title>Citrinin</title>
<p>Citrinin (<xref rid="f2-or-37-03-1321" ref-type="fig">Fig. 2</xref>) is considered as nephrotoxic mycotoxin (<xref rid="b176-or-37-03-1321" ref-type="bibr">176</xref>), and traces of Citrinin were found in contaminated food in areas known to have endemic nephropathy, diseases that are associated with urinary tract cancer. It produced micronuclei and DNA migration and had the potential of inducing micronuclei in HepG2 (human-derived liver cell line), and can cause DNA damage, effectively increasing the risk of cancer in humans (<xref rid="b177-or-37-03-1321" ref-type="bibr">177</xref>). Citrinin was proved to induce chromosomal aberrations in both humans and rat liver microsomes. In addition, Citrinin can also cause complex translocations with the cellular DNA in a high frequency, and is capable of inducing defects in chromosomal coiling (<xref rid="b178-or-37-03-1321" ref-type="bibr">178</xref>), which may lead to the formation of DNA adducts (<xref rid="b179-or-37-03-1321" ref-type="bibr">179</xref>). In an experiment performed to assess the effect of Citrinin on viability and DNA fragmentation and chromosome aberrations in mouse bone marrow cells and cultured Vero cells, Citrinin was found to be a weak cytotoxic. However, it causes DNA fragmentation and chromosome aberrations that may lead to cancer, apoptosis, and carcinogenesis (<xref rid="b180-or-37-03-1321" ref-type="bibr">180</xref>). Citrinin was found to inhibit cell-free microtubule polymerization and it has an aneuploidogenic activity. Citrinin is also a source of mitotic arrest and CREST-positive micronuclei where it will induce the formation of micronuclei containing whole chromosomes or chromatids (<xref rid="b181-or-37-03-1321" ref-type="bibr">181</xref>). Finally, some strong evidence suggests that Citrinin is involved in the development of Balkan endemic nephropathy and associated urinary tract tumors (<xref rid="b182-or-37-03-1321" ref-type="bibr">182</xref>).</p>
</sec>
<sec>
<title>Fumonisins</title>
<p>Fumonisin (<xref rid="f4-or-37-03-1321" ref-type="fig">Fig. 4</xref>) is a potential cancer causing agent in humans (<xref rid="b183-or-37-03-1321" ref-type="bibr">183</xref>). An experiment was conducted on 25 rats where their food was mixed with Fumonisin B1 for a period ranged from 6 to 26 months and the result of the experiment confirmed that Fumonisin B1 is hepatocarcinogenic and hepatotoxic (<xref rid="b184-or-37-03-1321" ref-type="bibr">184</xref>,<xref rid="b185-or-37-03-1321" ref-type="bibr">185</xref>). Fumonisins are capable of inhibiting the biosynthesis of sphingosine and the complex sphingolipids by inhibiting the enzyme ceramide synthase and that, in turn, will lead to the increase of free sphinganine and the free sphingoid bases which are toxic to cells. In cultured cells that are treated with Fumonisin B1, the accumulation of bioactive long-chain sphingoid bases and depletion of complex sphingolipids essential for cell growth and development lead to inhibiting the growth, increasing cell death, and influence on mitogenicity that would lead to the development of cancer in fibroblast cell line 3T3 (<xref rid="b186-or-37-03-1321" ref-type="bibr">186</xref>).</p>
<p>Fumonisins were found correlated with incidence of esophageal cancer in both Southern and Northern Africa and China, neurodegenerative disease (<xref rid="b187-or-37-03-1321" ref-type="bibr">187</xref>,<xref rid="b188-or-37-03-1321" ref-type="bibr">188</xref>) and leukoencephalomalacia in horses (<xref rid="b28-or-37-03-1321" ref-type="bibr">28</xref>). It was proven that fumonisin B1 are involved in the development of renal carcinomas in male rats, and liver cancer in female mice which could occur in humans as well (<xref rid="b189-or-37-03-1321" ref-type="bibr">189</xref>). Finally, Fumonisin B1 was found to cause inhibition in the production of ceramide synthase <italic>in vitro</italic> which in turn enhances tumor necrosis factor &#x03B1;, production and cause apoptosis (<xref rid="b143-or-37-03-1321" ref-type="bibr">143</xref>). Finally, Fumonisins mycotoxins were found to contribute to the development of neural tube defects among Mexican-American woman in south Texas, and was characterized by defects in the brain, spine, or spinal cord of fetus in the first month of pregnancy (<xref rid="b190-or-37-03-1321" ref-type="bibr">190</xref>).</p>
</sec>
<sec>
<title>Patulin</title>
<p>Patulin (<xref rid="f6-or-37-03-1321" ref-type="fig">Fig. 6</xref>) and its precursor 6-methylsalicylic acid are derived from Acetyl-CoA which makes them polyketides and carcinogenic mycotoxins (<xref rid="b191-or-37-03-1321" ref-type="bibr">191</xref>,<xref rid="b192-or-37-03-1321" ref-type="bibr">192</xref>). They are capable of causing gene mutations in different mammalian cells (<xref rid="b193-or-37-03-1321" ref-type="bibr">193</xref>). The administration of patulin subcutaneously twice a week for 15 months showed the development of malignant tumor cells in the area of administration which proved the carcinogenic effect of this mycotoxin. It can by hypothesized in humans as well (<xref rid="b64-or-37-03-1321" ref-type="bibr">64</xref>,<xref rid="b194-or-37-03-1321" ref-type="bibr">194</xref>&#x2013;<xref rid="b196-or-37-03-1321" ref-type="bibr">196</xref>) although the carcinogenic effect of patulin was not confirmed by Osswald <italic>at al</italic> (<xref rid="b197-or-37-03-1321" ref-type="bibr">197</xref>), patulin was confirmed to be toxic to the mice born to patulin treated mothers and deaths occurred in both males and females. Patulin is found to be mutagenic, carcinogenic and teratogenic and it has the tendency to induce intestinal injuries (<xref rid="b198-or-37-03-1321" ref-type="bibr">198</xref>) and it has the ability to attack cellular DNA in bacteria (<xref rid="b199-or-37-03-1321" ref-type="bibr">199</xref>) and humans (<xref rid="b141-or-37-03-1321" ref-type="bibr">141</xref>), that can lead to the development of tumors, and cancer.</p>
<p>It was proposed that the toxicity of patulin for intestinal cells involves an inactivation of the active site of protein tyrosine phosphatase (PTP). The protein tyrosine phosphatase is a key regulator of intestinal epithelial barrier function, and the active site of PTP contains a cysteine residue (Cys215) which is important and required for phosphatase activity. On the other hand, the sulfhydryl-reacting compounds such as acetaldehyde decrease the transepithelial resistance (TER) through a covalent modification of cysteine residue Cys215 of the protein tyrosine phosphatase and this toxicity can lead to damage in the intestinal cells that eventually may lead to intestinal and stomach cancer (<xref rid="b198-or-37-03-1321" ref-type="bibr">198</xref>) and this evidence can be used to hypothesize and indicate the involvement of patulin in the development of intestinal and stomach cancer in humans. Patulin was found to inhibited the cell-free microtubule polymerization, it has the ability to bind covalently to reactive thiol groups of microtubule proteins, and deactivates the protein. It induces the formation of micronuclei that contains the whole chromosomes or chromatids, it also induces the formation of micronuclei containing acentric chromosomal fragments, and that indicates its clastogenic ability, and finally, Patulin has both aneuploidogenic and clastogenic properties that could contribute to the carcinogenicity of this mycotoxin in the long-term studies which in turn could be hypothesized in humans as well (<xref rid="b181-or-37-03-1321" ref-type="bibr">181</xref>).</p>
</sec>
<sec>
<title>Trichothecenes</title>
<p>T-2 (<xref rid="f7-or-37-03-1321" ref-type="fig">Fig. 7</xref>) are mycotoxins that belong to Trichothecene mycotoxin and is considered as immunosuppressive, cytotoxic and lymphocytic and carcinogenic mycotoxin in mammalian cells (<xref rid="b17-or-37-03-1321" ref-type="bibr">17</xref>) although the work of Ueno <italic>et al</italic> (<xref rid="b200-or-37-03-1321" ref-type="bibr">200</xref>) on Salmonella typhimurium suggested that trichothecenes have failed to demonstrate mutagenicity. T-2 is capable of inducing breaks in the DNA of lymphocytes when administrated <italic>in vivo</italic> and <italic>in vitro</italic> and once fibroblast cells are treated with this mycotoxin incorporation with <sup>3</sup>H thymidine, unscheduled DNA synthesis will take place (<xref rid="b201-or-37-03-1321" ref-type="bibr">201</xref>). The susceptibility of newborn and immature animals to T-2 are more compared to adults and it causes a high degree of edema and dermal toxicities through the direct attack of trichothecenes on the capillary vessels (<xref rid="b202-or-37-03-1321" ref-type="bibr">202</xref>). In the presence of aflatoxin B1 (<xref rid="f1-or-37-03-1321" ref-type="fig">Fig. 1</xref>), the trichothecenes nivalenol, will enhance the aflatoxin B1-induced hepatocarcinogenesis and T-2 lack any hepatocarcinogenesis ability and that was confirmed by an investigation in the presence of GST-P-positive foci that acts as a marker for the presence of hepatocarcinogenesis (<xref rid="b203-or-37-03-1321" ref-type="bibr">203</xref>). Although it was proposed (<xref rid="b204-or-37-03-1321" ref-type="bibr">204</xref>) that under the experimental conditions in both <italic>in vivo</italic> and <italic>in vitro</italic>, no damage took place in the hepatic DNA, T-2 has the ability to decrease responses to mitogens in human lymphocytes <italic>in vitro</italic> (<xref rid="b205-or-37-03-1321" ref-type="bibr">205</xref>).</p>
<p>The exposure to trichothecene mycotoxin can activate apoptosis in both <italic>in vitro</italic> and <italic>in vivo</italic> within many organs that include the lymphoid organs, the hematopoietic tissues, with in the liver and the intestine, in the bone marrow and finally the thymus (<xref rid="b95-or-37-03-1321" ref-type="bibr">95</xref>,<xref rid="b206-or-37-03-1321" ref-type="bibr">206</xref>,<xref rid="b207-or-37-03-1321" ref-type="bibr">207</xref>) and it inhibits the protein synthesis (<xref rid="b206-or-37-03-1321" ref-type="bibr">206</xref>,<xref rid="b208-or-37-03-1321" ref-type="bibr">208</xref>) and it was found to induce cellular necrosis and karyorrhexis in the dividing tissues of the intestinal mucosa, bone marrow, spleen, testis, and finally, the ovary (<xref rid="b208-or-37-03-1321" ref-type="bibr">208</xref>).</p>
<p>Another trichothecene mycotoxin that has the ability to increase the frequency of inducing mutation and cancer is Nivalenol. Nivalenol can also be involved in casing sister chromatid exchange in Chinese hamster cells and it can case DNA damage making it a potential genotoxic agent (<xref rid="b205-or-37-03-1321" ref-type="bibr">205</xref>) which can be hypothesized in humans as well. Nivalenol acute toxicity can lead to bone marrow toxicity and Nivalenol chronic toxicity would lead to leucopenia (<xref rid="b209-or-37-03-1321" ref-type="bibr">209</xref>). Unfortunately, there is no clear evidence of Nivalenol carcinogenicity in experimental animals or humans and an investigation was carried on cell lines <italic>in vitro</italic> (<xref rid="b205-or-37-03-1321" ref-type="bibr">205</xref>,<xref rid="b210-or-37-03-1321" ref-type="bibr">210</xref>).</p>
<p>Diacetoxyscirpenol mycotoxin is another group of trichothecene mycotoxin which is known to inhibit the proliferation and Ig production in the mitogen-stimulated human lymphocytes (<xref rid="b211-or-37-03-1321" ref-type="bibr">211</xref>) and it causes esophageal hyperplasia but is not capable of inducing cancer in rats (<xref rid="b212-or-37-03-1321" ref-type="bibr">212</xref>) and despite its toxicity, it was used as a chemotherapeutic agent for cancer treatment (<xref rid="b132-or-37-03-1321" ref-type="bibr">132</xref>).</p>
<p>Finally, FUS-X in another group of trichothecene mycotoxin which is capable of causing an immunosuppressive response, carcinogenicity, cytotoxicity in experimental animals and possibly in humans as well (<xref rid="b208-or-37-03-1321" ref-type="bibr">208</xref>). FUS-X is toxic to many cell types such as murine thymocytes, lymphocytes, and gastric epithelial cells but they have a high degree of toxicity to human hepatoblastoma cells (<xref rid="b213-or-37-03-1321" ref-type="bibr">213</xref>). It can initiate apoptosis in mouse thymocytes <italic>in vivo</italic> as well as <italic>in vitro</italic> (<xref rid="b214-or-37-03-1321" ref-type="bibr">214</xref>,<xref rid="b215-or-37-03-1321" ref-type="bibr">215</xref>) that can be hypothesized in humans as well. Although FUS-X was confirmed to be carcinogenic in animals (<xref rid="b208-or-37-03-1321" ref-type="bibr">208</xref>), no clear evidence is available on its carcinogenicity in humans (<xref rid="b213-or-37-03-1321" ref-type="bibr">213</xref>). FUS-X is highly cytotoxic to several type of cells (<xref rid="b216-or-37-03-1321" ref-type="bibr">216</xref>,<xref rid="b217-or-37-03-1321" ref-type="bibr">217</xref>). It is suggested that it has teratogenicity or chromosomal effects, but no strong evidence is available to support this hypothesis (<xref rid="b213-or-37-03-1321" ref-type="bibr">213</xref>) although (<xref rid="b214-or-37-03-1321" ref-type="bibr">214</xref>) has demonstrated that FUS-X has genotoxic potentials when administered or exposed at low levels. Bony <italic>et al</italic> (<xref rid="b210-or-37-03-1321" ref-type="bibr">210</xref>) concluded that due to the lack of strong evidence on FUS-X carcinogenicity in both animal and man, FUS-X is not considered as a carcinogenic agent.</p>
</sec>
<sec>
<title>Zearalenone</title>
<p>Zearalenone (<xref rid="f10-or-37-03-1321" ref-type="fig">Fig. 10</xref>) shows hormonal activity in many animal species which makes it genotoxic, carcinogenic or both at the same time (<xref rid="b218-or-37-03-1321" ref-type="bibr">218</xref>), and it can impose changes in the reproductive organs and systems of many laboratory animals such as mice, rats and different domestic animals such as horses (<xref rid="b205-or-37-03-1321" ref-type="bibr">205</xref>). Due to this ability, it is hypothesized that Zearalenone can be involved in causing reproductive organ cancer in both humans and animal. Zearalenone was found to be carcinogenic in mice and capable of causing hepatocellular adenomas and pituitary tumors (<xref rid="b205-or-37-03-1321" ref-type="bibr">205</xref>). More work is needed in order to confirm its carcinogenicity in humans. Despite its toxicity and carcinogenicity, Zearalenone is used to increase the meat production in cattle in some countries, and it is forbidden in other countries like some European countries (<xref rid="b218-or-37-03-1321" ref-type="bibr">218</xref>). That is most probably due to the lack of evidence or data that supports its toxicity and carcinogenicity in humans and animal (<xref rid="b219-or-37-03-1321" ref-type="bibr">219</xref>).</p>
<p>A high incident of esophageal cancer was reported in areas known to have mycotoxin contamination that includes zearalenone and the ability of this mycotoxin in inducing hyperkeratotic papillomatous in the forestomach of a rat esophageal squamous epithelium (<xref rid="b220-or-37-03-1321" ref-type="bibr">220</xref>) suggested the involvement of this mycotoxin in causing and developing a tumor in the digestive tract (<xref rid="b221-or-37-03-1321" ref-type="bibr">221</xref>&#x2013;<xref rid="b224-or-37-03-1321" ref-type="bibr">224</xref>). When cultured Vero cells and mouse bone marrow were treated with zearalenone, the mycotoxin induces the formation of micronuclei, the development of clastogenicity and induces genotoxicity (<xref rid="b225-or-37-03-1321" ref-type="bibr">225</xref>). Zearalenone has a DNA-attacking ability (<xref rid="b141-or-37-03-1321" ref-type="bibr">141</xref>).</p>
<p>In an experiment to demonstrate the effect of estrogen present in the feed of animals, Zearalenone was found to induce mammary tumor in C3HA<sup>vy</sup>fB mice and further studies need to be conducted in order to confirm wether Zearalenone has cancer inducing ability or carcinogenic effects on target organs like diethylstilbestrol and the steroidal estrogens (<xref rid="b226-or-37-03-1321" ref-type="bibr">226</xref>). A study was conducted on NTP mouse where the mice were given a dose of Zearalenone through food, and the result of this study showed the ability of Zearalenone in inducing hepatocellular adenomas in the female mice. Zearalenone was also found to cause DNA damage in Bacillus subtilis and it showed DNA adducts in female mice kidney and liver (<xref rid="b227-or-37-03-1321" ref-type="bibr">227</xref>,<xref rid="b228-or-37-03-1321" ref-type="bibr">228</xref>). Finally, it was shown that the results of this study confirmed the genotoxicity and the ability of zearalenone to induce hepatocellular adenomas in mice but not in rats (<xref rid="b227-or-37-03-1321" ref-type="bibr">227</xref>). Since there is evidence to prove that these result can relate to humans, these results can be used to hypothesize the involvement of Zearalenone in developing liver, kidney and other types of cancer in humans.</p>
</sec>
</sec>
</sec>
<sec>
<label>6.</label>
<title>Mycotoxin research gaps and the recommended new research areas</title>
<p>Many studies were conducted on the effect of mycotoxins on the biological system and their carcinogenicity-toxicity as mentioned before in this study but unfortunately, many of these studies were done on animal models and the action of mycotoxins in human biological systems were simply hypothesized and no solid data were generated for many mycotoxins. As mentioned earlier, food products that can be contaminated with mycotoxins include cereal (maize, sorghum, pearl millet, rice, and wheat), oil seeds (ground nut, soybean, sunflower, cotton), spices (chilies, black pepper, coriander, turmeric, and ginger), tree nuts (almonds, pistachio, walnuts, and coconut) and finally milk (<xref rid="b27-or-37-03-1321" ref-type="bibr">27</xref>,<xref rid="b229-or-37-03-1321" ref-type="bibr">229</xref>&#x2013;<xref rid="b232-or-37-03-1321" ref-type="bibr">232</xref>). In addition, aflatoxins are found in the contaminated tobacco leaves (<xref rid="b233-or-37-03-1321" ref-type="bibr">233</xref>). Finally, aflatoxins can be present in dry soil, which can move to the underground water with rain and be ingested by humans and animals through the drinking water (<xref rid="b234-or-37-03-1321" ref-type="bibr">234</xref>). All these food sources and food products are the basic food items for people around the world which make their contamination with mycotoxin considered as a major health concern for their high carcinogenic-toxic nature and potential in both animals and humans biological system (<xref rid="b40-or-37-03-1321" ref-type="bibr">40</xref>).</p>
<p>It is well known that the availability of safe and edible food is essential for sustaining humans and animal life and the fact that food shortage was the reason behind provoking many wars, people started to store and preserve food on large scale for longer time to avoid any shortage that aid in storing and transporting food items in different forms of packages and containers. That happened right before the Second World War and continues to grow exponentially after that (<xref rid="b235-or-37-03-1321" ref-type="bibr">235</xref>). As the food industry became bigger after the Second World War (<xref rid="b236-or-37-03-1321" ref-type="bibr">236</xref>), packaging and distribution importance grew exponentially, and both processes became more susceptible to different weather conditions and the exposure to different microorganisms that may lead to food spoilage and contamination with different microorganisms including fungi and the mycotoxins they produce (<xref rid="b237-or-37-03-1321" ref-type="bibr">237</xref>,<xref rid="b238-or-37-03-1321" ref-type="bibr">238</xref>). An increase in the rates of testicular cancer incidences across Europe was observed post Second World War (<xref rid="b239-or-37-03-1321" ref-type="bibr">239</xref>) and the reasons for it was not clear. It can hypothesized that the reasons for it can be linked to the increase in the stored food contamination with mycotoxins that can lead to testicular cancer (<xref rid="b173-or-37-03-1321" ref-type="bibr">173</xref>,<xref rid="b174-or-37-03-1321" ref-type="bibr">174</xref>).</p>
<p>During and after the 2nd World War, there was an increase in the incidents of lung cancer in Coastal Georgia specifically between males working in the shipyards in a warm and humid conditions (<xref rid="b240-or-37-03-1321" ref-type="bibr">240</xref>). Due to the high humidity, tobacco leaves were contaminated with Aspergillus Flavus that produces aflatoxin B1 (<xref rid="b23-or-37-03-1321" ref-type="bibr">23</xref>) which is a highly carcinogenic substance that was associated with different cancer types including lung cancer (<xref rid="b161-or-37-03-1321" ref-type="bibr">161</xref>). No solid data were generated to support the induction of human lung cancer by aflatoxin B1 but it can be hypothesized that their involvement induce lung cancer since aflatoxin B1 inactivates GSTM1-1 that is responsible for the production of cytosolic Glutathione S-transferases that helps in detoxifying several carcinogenic electrophiles that cause lung cancer, hence additional lab experiments need to be conducted to confirm this involvement. Moreover, aflatoxin B1 was suggested to cause primary lung cancer also through the activation of GSTM1-1 (<xref rid="b161-or-37-03-1321" ref-type="bibr">161</xref>) and this mycotoxin can be inhaled and cause a direct effect on the lung cells (<xref rid="b157-or-37-03-1321" ref-type="bibr">157</xref>) and that can indicate the effect of mycotoxin in causing lung cancer, but very limited data were collected in this area and further studies need to be conducted.</p>
<p>Another study was conducted in Norway where it was found that the rates of breast cancer increased greatly during and after World War II and the reasons were not conclusive, and they linked the increase in the breast cancer rate to the change in the people&#x0027;s lifestyle (<xref rid="b241-or-37-03-1321" ref-type="bibr">241</xref>). The fact that eating habits and food storage and transportation changed greatly during and after World War II, the possibility of food contamination increased greatly and fungal contamination started to become a common phenomenon in stored food and mycotoxin contamination could spread widely. Mycotoxins such as Aflatoxin B1 (<xref rid="f1-or-37-03-1321" ref-type="fig">Fig. 1</xref>) and Ochratoxin A (<xref rid="f5-or-37-03-1321" ref-type="fig">Fig. 5</xref>) were confirmed to suppress tumor suppressor genes BRCA1, BRCA2 and P52 (<xref rid="b2-or-37-03-1321" ref-type="bibr">2</xref>,<xref rid="b172-or-37-03-1321" ref-type="bibr">172</xref>). A hypothesis can be made to conclude the involvement of mycotoxin in inducing breast cancer around the world, but there is a huge gap in this area and additional laboratory work need to be established to confirm it. In addition, HER-1, HER-2 and the c-myc oncogenes were found to be overexpressed in many breast cancer cases (<xref rid="b242-or-37-03-1321" ref-type="bibr">242</xref>&#x2013;<xref rid="b244-or-37-03-1321" ref-type="bibr">244</xref>) and that can also be related to the involvement of mycotoxins since they have the ability to impose different changes in the human genome but further studies need to be conducted.</p>
<p>Patulin (<xref rid="f6-or-37-03-1321" ref-type="fig">Fig. 6</xref>) causes an inactivation of the active site of protein tyrosine phosphatase (PTP) and this protein is a key regulator of intestinal epithelial barrier function and the active site of PTP contains a cysteine residue (Cys215). This is important and required for phosphatase activity and sulfhydryl-reacting compounds such as acetaldehyde decrease the transepithelial resistance (TER) through a covalent modification of cysteine residue Cys215 of the protein tyrosine phosphatase. This toxicity can lead to damage in the intestinal cells that eventually may lead to intestinal and stomach cancer.</p>
<p>Some mycotoxins such as Fumonisins can cause neurodegenerative disease (<xref rid="b187-or-37-03-1321" ref-type="bibr">187</xref>,<xref rid="b188-or-37-03-1321" ref-type="bibr">188</xref>). Their mode of action can be further studied to detect if they are involved in causing brain cancer and tumors by studying their effect on different genes in the brain. Fumonisins were also found to be involved in the development of neural tube defects among Mexican-American woman in south Texas which is characterized by defects in the brain, spine, or spinal cord of fetus in the first month of pregnancy (<xref rid="b190-or-37-03-1321" ref-type="bibr">190</xref>) this involvement can also be used to hypothesize the involvement of Fumonisins in causing brain cancer in humans and further studies need to be conducted to support and confirm this hypothesis.</p>
<p>Zearalenone mycotoxin (F-2) major effects will be on the reproduction ability in females where they effects the reproductive organs, and their functions which will eventually lead to a medical condition called hyperestrogenism (<xref rid="b137-or-37-03-1321" ref-type="bibr">137</xref>) and this phenomenon can be studied further to uncover if F-2 can be involved in developing ovary cancer. Finally, Fumonisin B1 was found to cause inhibition in the production of ceramide synthase which will lead to enhancing tumor necrosis factor &#x03B1;, production leading to apoptosis (<xref rid="b143-or-37-03-1321" ref-type="bibr">143</xref>) and the ability of this mycotoxin to induce apoptosis can be used to detect the involvement of this mycotoxin in causing skin cancer.</p>
</sec>
<sec sec-type="conclusions">
<label>7.</label>
<title>Conclusions</title>
<p>Many mycotoxins have the ability of causing major changes to the human genome which may result in the development of cancer, and many other mycotoxins are capable of causing highly toxic effects on the biological systems they enter. The different mycotoxins that can cause cancer are Aflatoxin B1, Citrinin, Fumonisins, Patulin, Trichothecene and Zearalenone. The role of mycotoxins in causing cancer will vary with the type of mycotoxin and it will depend on the mode of action within the biological system.</p>
<p>Aflatoxin B1 (<xref rid="f1-or-37-03-1321" ref-type="fig">Fig. 1</xref>) can penetrate the cell membrane and attach to its DNA where it causes irreversible mutations. As soon as aflatoxin B1 enters the cells, they are metabolized by cytochrome P450, to aflatoxin-8, 9-epoxide which is highly reactive and unstable and requires the binding to a DNA or to the protein molecule in order to become more stable and it will form aflatoxin-N7-guanine that cause GC to TA transversion mutations which will directly affect the cell cycle by affecting the P53 gene which encodes for tumor suppressor protein that inhibits the development of cancer.</p>
<p>Ochratoxin A (<xref rid="f5-or-37-03-1321" ref-type="fig">Fig. 5</xref>) can cause an alteration of gene expression that results in affecting calcium homeostasis which will disrupt the different pathways regulated by the HNF4&#x03B1; and Nrf2 in the kidney, influence the expression of genes that are involved in DNA synthesis and repair, in response to DNA damage and it has a very small influence on the genes that are responsible for apoptosis. Ochratoxin A can cause genotoxicity by forming a DNA adduct and single cell death. Furthermore, Ochratoxin A can increase phosphorylation of a typical-PKC which in turn will lead to a downstream activation of ERK1 and ERK 2 and their substrate ELK1, ELK2 and p90RSK where PKC and the MEK-ERK MAP-kinase pathways activated by Ochratoxin A are involved in cell proliferation, cell survival, anti-apoptotic activity and most importantly renal cancer development. Ochratoxin A is suggested to have a renal carcinogenesis effect. Its mode of action is by means of direct genotoxicity through covalent DNA adduct formation. The effects of aflatoxin B1 and Ochratoxin A in causing breast cancer and lung cancer are demonstrated in only a few studies and additional studies need to be conducted in order to confirm the course of action which will help in controlling and reducing the rates of these cancers which are considered as the most common cancers in the world.</p>
<p>Citrinin produced micronuclei and DNA migration and it has the potential of inducing micronuclei. Citrinin would cause DNA damage which would increase the risk of cancer in humans. Citrinin can induce chromosomal aberrations in both human and rat livers and it can cause complex translocations within the cellular DNA at a high frequency and it is capable of inducing defects in chromosomal coiling which may lead to the formation of DNA adducts. Apart from this, it can cause DNA fragmentation and apoptosis and finally, it can cause a mitotic arrest and CREST-positive micronuclei where it will induce the formation of micronuclei containing a whole chromosome or chromatids and will eventually lead to cancer development.</p>
<p>Fumonisins (<xref rid="f4-or-37-03-1321" ref-type="fig">Fig. 4</xref>) are capable of inhibiting the biosynthesis of sphingosine and the complex sphingolipids by inhibiting the enzyme ceramide synthase. That, in turn, will lead to the increase in free sphinganine and the free sphingoid bases which are toxic in cells, and that will inhibit the growth, increase cell death, and initiate involvement in mitogenicity that would lead to the development of cancer.</p>
<p>Patulin (<xref rid="f6-or-37-03-1321" ref-type="fig">Fig. 6</xref>) will cause an inactivation of the active site of protein tyrosine phosphatase (PTP) and this protein is a key regulator of intestinal epithelial barrier function. The active site of PTP contains a cysteine residue (Cys215) which is important and required for phosphatase activity and sulfhydryl-reacting compounds such as acetaldehyde. Acetaldehyde decreases the transepithelial resistance (TER) through a covalent modification of cysteine residue Cys215 of the protein tyrosine phosphatase and this toxicity can lead to damage in the intestinal cells that may eventually lead to intestinal and stomach cancer.</p>
<p>T-2, a trichothecene mycotoxin is capable of inducing breaks in the DNA of lymphocytes when administered <italic>in vivo</italic> and <italic>in vitro</italic> once the fibroblast cells are treated with this mycotoxin combined with <sup>3</sup>H thymidine. In addition, Nivalenol, a trichothecene mycotoxin is also involved in causing chromatid exchange in cells and it can cause DNA damage and that makes it a potential genotoxic agent. Finally, trichothecene mycotoxin can inhibit the proliferation and Ig production in the mitogen-stimulated human lymphocytes and it can induce apoptosis, the migration of sister chromatids as well as cause protein synthesis inhibition. The action of T-2 and Nivalenol on a cellular level can be responsible for the development of tumors and cancer.</p>
<p>Zearalenone (<xref rid="f10-or-37-03-1321" ref-type="fig">Fig. 10</xref>) shows hormonal activity in many animal species which makes it genotoxic, carcinogenic or both at the same time, and it can impose changes in the reproductive organs and systems of many laboratory animals such as mice and rats and different domestic animals such as horses. Thus, Zearalenone is capable of causing reproductive organ cancer in both man and animal.</p>
<p>The cancers that can be caused by mycotoxins include liver cancer, kidney cancer, esophageal cancer, lung cancer, renal cancer, breast cancer, testicular cancer, stomach cancer and reproductive organ cancer. Considering the danger caused by mycotoxins, additional investigations need to be conducted to confirm the ability of each mycotoxin in inducing cancer, as stated above.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The first author would like to sincerely thank Universiti Sains Malaysia for the USM Postgraduate Fellowship. All authors acknowledge the Universiti Sains Malaysia for Research University Team Grant (RUT) grant nos: 1001/CIPPT/812196 and 304/CIPPT/6313241.</p>
</ack>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item><term>TLC</term><def><p>thin-layer chromatography</p></def></def-item>
<def-item><term>HCC</term><def><p>hepatocellular carcinoma</p></def></def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="b1-or-37-03-1321"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sulaiman</surname><given-names>MR</given-names></name><name><surname>Chye</surname><given-names>FY</given-names></name><name><surname>Hamid</surname><given-names>AA</given-names></name><name><surname>Yatim</surname><given-names>AM</given-names></name></person-group><article-title>The occurrence of aflatoxins in raw shelled peanut samples from three districts of Perak, Malaysia</article-title><source>Electronic Journal of Environmental and Food Chemistry</source><volume>6</volume><fpage>2045</fpage><lpage>2052</lpage><year>2007</year><uri>http://eprints.ums.edu.my/3769/</uri></element-citation></ref>
<ref id="b2-or-37-03-1321"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moradi</surname><given-names>S</given-names></name><name><surname>Azari</surname><given-names>H</given-names></name><name><surname>Anarkoli</surname><given-names>IJ</given-names></name><name><surname>Qasemi-Panahi</surname><given-names>B</given-names></name><name><surname>Elhami</surname><given-names>S</given-names></name><name><surname>Forouharmehr</surname><given-names>A</given-names></name></person-group><article-title>Effect of aflatoxin B1 on BRCA1 and BRCA2 genes expression under in vitro cultured cell line of normal Human Mammary Epithelial Cells (HMEC)</article-title><month>Jan</month><year>2015</year><uri>https://www.researchgate.net/publication/268226306_Effect_of_aflatoxin_B1_on_BRCA1_and_BRCA2_genes_expression_under_in_vitro_cultured_cell_line_of_normal_Human_Mammary_Epithelial_Cells_HMEC</uri></element-citation></ref>
<ref id="b3-or-37-03-1321"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bbosa</surname><given-names>GS</given-names></name><name><surname>Kitya</surname><given-names>D</given-names></name><name><surname>Lubega</surname><given-names>A</given-names></name><name><surname>Ogwal-Okeng</surname><given-names>J</given-names></name><name><surname>Anokbonggo</surname><given-names>WW</given-names></name><name><surname>Kyegombe</surname><given-names>DB</given-names></name></person-group><article-title>Review of the biological and health effects of aflatoxins on body organs and body systems</article-title><source>Aflatoxins - Recent Advances and Future Prospects</source><person-group person-group-type="editor"><name><surname>Razzaghi-Abyaneh</surname><given-names>M</given-names></name></person-group><comment>InTech. doi: 10.5772/51201</comment></element-citation></ref>
<ref id="b4-or-37-03-1321"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohd-Redzwan</surname><given-names>S</given-names></name><name><surname>Jamaluddin</surname><given-names>R</given-names></name><name><surname>Abd-Mutalib</surname><given-names>MS</given-names></name><name><surname>Ahmad</surname><given-names>Z</given-names></name></person-group><article-title>A mini review on aflatoxin exposure in Malaysia: Past, present and future</article-title><source>Front Microbiol</source><volume>4</volume><fpage>334</fpage><year>2013</year><pub-id pub-id-type="doi">10.3389/fmicb.2013.00334</pub-id><pub-id pub-id-type="pmid">24312084</pub-id><pub-id pub-id-type="pmcid">3826065</pub-id></element-citation></ref>
<ref id="b5-or-37-03-1321"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-banna</surname><given-names>AA</given-names></name><name><surname>Pitt</surname><given-names>J</given-names></name><name><surname>Leistner</surname><given-names>L</given-names></name></person-group><article-title>Production of mycotoxins by Penicillium species</article-title><source>Syst Appl Microbiol</source><volume>10</volume><fpage>42</fpage><lpage>46</lpage><year>1987</year><comment>doi: 10.1016/S0723-2020(87)80008&#x2013;5</comment><pub-id pub-id-type="doi">10.1016/S0723-2020(87)80008-5</pub-id></element-citation></ref>
<ref id="b6-or-37-03-1321"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frisvad</surname><given-names>JC</given-names></name><name><surname>Filtenborg</surname><given-names>O</given-names></name><name><surname>Thrane</surname><given-names>U</given-names></name></person-group><article-title>Analysis and screening for mycotoxins and other secondary metabolites in fungal cultures by thin-layer chromatography and high-performance liquid chromatography</article-title><source>Arch Environ Contam Toxicol</source><volume>18</volume><fpage>331</fpage><lpage>335</lpage><year>1989</year><pub-id pub-id-type="doi">10.1007/BF01062357</pub-id><pub-id pub-id-type="pmid">2730153</pub-id></element-citation></ref>
<ref id="b7-or-37-03-1321"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>Thin-layer chromatography of mycotoxins and comparison with other chromatographic methods</article-title><source>J Chromatogr A</source><volume>815</volume><fpage>3</fpage><lpage>20</lpage><year>1998</year><pub-id pub-id-type="doi">10.1016/S0021-9673(98)00204-0</pub-id><pub-id pub-id-type="pmid">9718702</pub-id></element-citation></ref>
<ref id="b8-or-37-03-1321"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Gaag</surname><given-names>B</given-names></name><name><surname>Spath</surname><given-names>S</given-names></name><name><surname>Dietrich</surname><given-names>H</given-names></name><name><surname>Stigter</surname><given-names>E</given-names></name><name><surname>Boonzaaijer</surname><given-names>G</given-names></name><name><surname>van Osenbruggen</surname><given-names>T</given-names></name><name><surname>Koopal</surname><given-names>K</given-names></name></person-group><article-title>Biosensors and multiple mycotoxin analysis</article-title><source>Food Control</source><volume>14</volume><fpage>251</fpage><lpage>254</lpage><year>2003</year><pub-id pub-id-type="doi">10.1016/S0956-7135(03)00008-2</pub-id></element-citation></ref>
<ref id="b9-or-37-03-1321"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>WH</given-names></name><name><surname>Greenblatt</surname><given-names>M</given-names></name><name><surname>Lijinsky</surname><given-names>W</given-names></name></person-group><article-title>Carcinogenesis in rats by aflatoxins B1, G1, and B2</article-title><source>Cancer Res</source><volume>29</volume><fpage>2206</fpage><lpage>2211</lpage><year>1969</year><pub-id pub-id-type="pmid">4318833</pub-id></element-citation></ref>
<ref id="b10-or-37-03-1321"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Creppy</surname><given-names>EE</given-names></name></person-group><article-title>Update of survey, regulation and toxic effects of mycotoxins in Europe</article-title><source>Toxicol Lett</source><volume>127</volume><fpage>19</fpage><lpage>28</lpage><year>2002</year><pub-id pub-id-type="doi">10.1016/S0378-4274(01)00479-9</pub-id><pub-id pub-id-type="pmid">12052637</pub-id></element-citation></ref>
<ref id="b11-or-37-03-1321"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghoshal</surname><given-names>AK</given-names></name><name><surname>Farber</surname><given-names>E</given-names></name></person-group><article-title>The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens</article-title><source>Carcinogenesis</source><volume>5</volume><fpage>1367</fpage><lpage>1370</lpage><year>1984</year><pub-id pub-id-type="doi">10.1093/carcin/5.10.1367</pub-id><pub-id pub-id-type="pmid">6488458</pub-id></element-citation></ref>
<ref id="b12-or-37-03-1321"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kensler</surname><given-names>TW</given-names></name><name><surname>Egner</surname><given-names>PA</given-names></name><name><surname>Davidson</surname><given-names>NE</given-names></name><name><surname>Roebuck</surname><given-names>BD</given-names></name><name><surname>Pikul</surname><given-names>A</given-names></name><name><surname>Groopman</surname><given-names>JD</given-names></name></person-group><article-title>Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: Role of induction of glutathione S-transferases</article-title><source>Cancer Res</source><volume>46</volume><fpage>3924</fpage><lpage>3931</lpage><year>1986</year><pub-id pub-id-type="pmid">2873884</pub-id></element-citation></ref>
<ref id="b13-or-37-03-1321"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>ND</given-names></name><name><surname>Diener</surname><given-names>UL</given-names></name><name><surname>Eldridge</surname><given-names>DW</given-names></name></person-group><article-title>Production of aflatoxins B1 and G1 by Aspergillus flavus in a semisynthetic medium</article-title><source>Appl Microbiol</source><volume>14</volume><fpage>378</fpage><lpage>380</lpage><year>1966</year><pub-id pub-id-type="pmid">5970823</pub-id><pub-id pub-id-type="pmcid">546720</pub-id></element-citation></ref>
<ref id="b14-or-37-03-1321"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorner</surname><given-names>JW</given-names></name><name><surname>Cole</surname><given-names>RJ</given-names></name><name><surname>Diener</surname><given-names>UL</given-names></name></person-group><article-title>The relationship of Aspergillus flavus and Aspergillus parasiticus with reference to production of aflatoxins and cyclopiazonic acid</article-title><source>Mycopathologia</source><volume>87</volume><fpage>13</fpage><lpage>15</lpage><year>1984</year><pub-id pub-id-type="doi">10.1007/BF00436617</pub-id><pub-id pub-id-type="pmid">6436707</pub-id></element-citation></ref>
<ref id="b15-or-37-03-1321"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farag</surname><given-names>RS</given-names></name><name><surname>Daw</surname><given-names>ZY</given-names></name><name><surname>Abo-Raya</surname><given-names>SH</given-names></name></person-group><article-title>Influence of some spice essential oils on Aspergillus parasiticus growth and production of aflatoxins in a synthetic medium</article-title><source>J Food Sci</source><volume>54</volume><fpage>74</fpage><lpage>76</lpage><year>1989</year><comment>doi: 10.1111/j.1365-2621.1989.tb08571.x</comment><pub-id pub-id-type="doi">10.1111/j.1365-2621.1989.tb08571.x</pub-id></element-citation></ref>
<ref id="b16-or-37-03-1321"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mateles</surname><given-names>RI</given-names></name><name><surname>Adye</surname><given-names>JC</given-names></name></person-group><article-title>Production of aflatoxins in submerged culture</article-title><source>Appl Microbiol</source><volume>13</volume><fpage>208</fpage><lpage>211</lpage><year>1965</year><pub-id pub-id-type="pmid">14325880</pub-id><pub-id pub-id-type="pmcid">1058222</pub-id></element-citation></ref>
<ref id="b17-or-37-03-1321"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>FS</given-names></name></person-group><article-title>Mycotoxins: food contamination, mechanism, carcinogenic potential and preventive measures</article-title><source>Mutat Res</source><volume>259</volume><fpage>291</fpage><lpage>306</lpage><year>1991</year><comment>doi: 10.1016/0165-1218(91)90124&#x2013;5</comment><pub-id pub-id-type="doi">10.1016/0165-1218(91)90124-5</pub-id><pub-id pub-id-type="pmid">2017214</pub-id></element-citation></ref>
<ref id="b18-or-37-03-1321"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jelinek</surname><given-names>CF</given-names></name><name><surname>Pohland</surname><given-names>AE</given-names></name><name><surname>Wood</surname><given-names>GE</given-names></name></person-group><article-title>Worldwide occurrence of mycotoxins in foods and feeds - an update</article-title><source>J Assoc Off Anal Chem</source><volume>72</volume><fpage>223</fpage><lpage>230</lpage><year>1989</year><pub-id pub-id-type="pmid">2651391</pub-id></element-citation></ref>
<ref id="b19-or-37-03-1321"><label>19</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Krogh</surname><given-names>P</given-names></name></person-group><source>Mycotoxins in food</source><publisher-name>Academic Press Ltd.</publisher-name><publisher-loc>London</publisher-loc><year>1987</year></element-citation></ref>
<ref id="b20-or-37-03-1321"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>XM</given-names></name></person-group><article-title>Contamination of aflatoxins in different kinds of foods in China</article-title><source>Biomed Environ Sci</source><volume>20</volume><fpage>483</fpage><lpage>487</lpage><year>2007</year><pub-id pub-id-type="pmid">18348407</pub-id></element-citation></ref>
<ref id="b21-or-37-03-1321"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rustom</surname><given-names>IY</given-names></name></person-group><article-title>Aflatoxin in food and feed: Occurrence, legislation and inactivation by physical methods</article-title><source>Food Chem</source><volume>59</volume><fpage>57</fpage><lpage>67</lpage><year>1997</year><pub-id pub-id-type="doi">10.1016/S0308-8146(96)00096-9</pub-id></element-citation></ref>
<ref id="b22-or-37-03-1321"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabata</surname><given-names>S</given-names></name><name><surname>Kamimura</surname><given-names>H</given-names></name><name><surname>Ibe</surname><given-names>A</given-names></name><name><surname>Hashimoto</surname><given-names>H</given-names></name><name><surname>Iida</surname><given-names>M</given-names></name><name><surname>Tamura</surname><given-names>Y</given-names></name><name><surname>Nishima</surname><given-names>T</given-names></name></person-group><article-title>Aflatoxin contamination in foods and foodstuffs in Tokyo: 1986&#x2013;1990</article-title><source>J AOAC Int</source><volume>76</volume><fpage>32</fpage><lpage>35</lpage><year>1993</year><pub-id pub-id-type="pmid">8448440</pub-id></element-citation></ref>
<ref id="b23-or-37-03-1321"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>KS</given-names></name></person-group><article-title>Aflatoxin, tobacco, ammonia and the p53 tumor-suppressor gene: Cancer&#x0027;s missing link?</article-title><source>MedGenMed</source><volume>1</volume><fpage>E10</fpage><year>1999</year></element-citation></ref>
<ref id="b24-or-37-03-1321"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>RA</given-names></name><name><surname>Blankenship</surname><given-names>PD</given-names></name><name><surname>Cole</surname><given-names>RJ</given-names></name><name><surname>Sanders</surname><given-names>TH</given-names></name></person-group><article-title>Effects of soil moisture and temperature on preharvest invasion of peanuts by the Aspergillus flavus group and subsequent aflatoxin development</article-title><source>Appl Environ Microbiol</source><volume>45</volume><fpage>628</fpage><lpage>633</lpage><year>1983</year><pub-id pub-id-type="pmid">6402980</pub-id><pub-id pub-id-type="pmcid">242335</pub-id></element-citation></ref>
<ref id="b25-or-37-03-1321"><label>25</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Desjardins</surname><given-names>AE</given-names></name></person-group><chapter-title>Fusarium mycotoxins: chemistry, genetics, and biology</chapter-title><source>American Phytopathological Society</source><publisher-name>APS Press</publisher-name><publisher-loc>St. Paul, MN</publisher-loc><year>2006</year></element-citation></ref>
<ref id="b26-or-37-03-1321"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Placinta</surname><given-names>C</given-names></name><name><surname>D&#x0027;mello</surname><given-names>J</given-names></name><name><surname>Macdonald</surname><given-names>A</given-names></name></person-group><article-title>A review of worldwide contamination of cereal grains and animal feed with Fusarium mycotoxins</article-title><source>Anim Feed Sci Technol</source><volume>78</volume><fpage>21</fpage><lpage>37</lpage><year>1999</year><pub-id pub-id-type="doi">10.1016/S0377-8401(98)00278-8</pub-id></element-citation></ref>
<ref id="b27-or-37-03-1321"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>JL</given-names></name></person-group><article-title>Some major mycotoxins and their mycotoxicoses - an overview</article-title><source>Int J Food Microbiol</source><volume>119</volume><fpage>3</fpage><lpage>10</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2007.07.019</pub-id><pub-id pub-id-type="pmid">17719115</pub-id></element-citation></ref>
<ref id="b28-or-37-03-1321"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelderblom</surname><given-names>WC</given-names></name><name><surname>Jaskiewicz</surname><given-names>K</given-names></name><name><surname>Marasas</surname><given-names>WF</given-names></name><name><surname>Thiel</surname><given-names>PG</given-names></name><name><surname>Horak</surname><given-names>RM</given-names></name><name><surname>Vleggaar</surname><given-names>R</given-names></name><name><surname>Kriek</surname><given-names>NP</given-names></name></person-group><article-title>Fumonisins - novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme</article-title><source>Appl Environ Microbiol</source><volume>54</volume><fpage>1806</fpage><lpage>1811</lpage><year>1988</year><pub-id pub-id-type="pmid">2901247</pub-id><pub-id pub-id-type="pmcid">202749</pub-id></element-citation></ref>
<ref id="b29-or-37-03-1321"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sydenham</surname><given-names>EW</given-names></name><name><surname>Shephard</surname><given-names>GS</given-names></name><name><surname>Thiel</surname><given-names>PG</given-names></name><name><surname>Stockenstr&#x00F6;m</surname><given-names>S</given-names></name><name><surname>Snijman</surname><given-names>PW</given-names></name><name><surname>Van Schalkwyk</surname><given-names>DJ</given-names></name></person-group><article-title>Liquid chromatographic determination of fumonisins B1, B2, and B3 in corn: AOAC-IUPAC Collaborative Study</article-title><source>J AOAC Int</source><volume>79</volume><fpage>688</fpage><lpage>696</lpage><year>1996</year><pub-id pub-id-type="pmid">8634538</pub-id></element-citation></ref>
<ref id="b30-or-37-03-1321"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gimeno</surname><given-names>A</given-names></name></person-group><article-title>Thin layer chromatographic determination of aflatoxins, ochratoxins, sterigmatocystin, zearalenone, citrinin, T-2 toxin, diacetoxyscirpenol, penicillic acid, patulin, and penitrem A</article-title><source>J Assoc Off Anal Chem</source><volume>62</volume><fpage>579</fpage><lpage>585</lpage><year>1979</year><pub-id pub-id-type="pmid">479082</pub-id></element-citation></ref>
<ref id="b31-or-37-03-1321"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petzinger</surname><given-names>E</given-names></name><name><surname>Weidenbach</surname><given-names>A</given-names></name></person-group><article-title>Mycotoxins in the food chain: The role of ochratoxins</article-title><source>Livest Prod Sci</source><volume>76</volume><fpage>245</fpage><lpage>250</lpage><year>2002</year><pub-id pub-id-type="doi">10.1016/S0301-6226(02)00124-0</pub-id></element-citation></ref>
<ref id="b32-or-37-03-1321"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trenk</surname><given-names>HL</given-names></name><name><surname>Butz</surname><given-names>ME</given-names></name><name><surname>Chu</surname><given-names>FS</given-names></name></person-group><article-title>Production of ochratoxins in different cereal products by Aspergillus ochraceus</article-title><source>Appl Microbiol</source><volume>21</volume><fpage>1032</fpage><lpage>1035</lpage><year>1971</year><pub-id pub-id-type="pmid">5564676</pub-id><pub-id pub-id-type="pmcid">377337</pub-id></element-citation></ref>
<ref id="b33-or-37-03-1321"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavin</surname><given-names>C</given-names></name><name><surname>Delatour</surname><given-names>T</given-names></name><name><surname>Marin-Kuan</surname><given-names>M</given-names></name><name><surname>Holzh&#x00E4;user</surname><given-names>D</given-names></name><name><surname>Higgins</surname><given-names>L</given-names></name><name><surname>Bezen&#x00E7;on</surname><given-names>C</given-names></name><name><surname>Guignard</surname><given-names>G</given-names></name><name><surname>Junod</surname><given-names>S</given-names></name><name><surname>Richoz-Payot</surname><given-names>J</given-names></name><name><surname>Gremaud</surname><given-names>E</given-names></name><etal/></person-group><article-title>Reduction in antioxidant defenses may contribute to Ochratoxin A toxicity and carcinogenicity</article-title><source>Toxicol Sci</source><volume>96</volume><fpage>30</fpage><lpage>39</lpage><year>2007</year><pub-id pub-id-type="doi">10.1093/toxsci/kfl169</pub-id><pub-id pub-id-type="pmid">17110534</pub-id></element-citation></ref>
<ref id="b34-or-37-03-1321"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink-Gremmels</surname><given-names>J</given-names></name><name><surname>Jahn</surname><given-names>A</given-names></name><name><surname>Blom</surname><given-names>MJ</given-names></name></person-group><article-title>Toxicity and metabolism of Ochratoxin A</article-title><source>Nat Toxins</source><volume>3</volume><fpage>214</fpage><lpage>220, discussion 221</lpage><year>1995</year><pub-id pub-id-type="doi">10.1002/nt.2620030408</pub-id><pub-id pub-id-type="pmid">7582619</pub-id></element-citation></ref>
<ref id="b35-or-37-03-1321"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahimtula</surname><given-names>AD</given-names></name><name><surname>B&#x00E9;r&#x00E9;ziat</surname><given-names>J-C</given-names></name><name><surname>Bussacchini-Griot</surname><given-names>V</given-names></name><name><surname>Bartsch</surname><given-names>H</given-names></name></person-group><article-title>Lipid peroxidation as a possible cause of Ochratoxin A toxicity</article-title><source>Biochem Pharmacol</source><volume>37</volume><fpage>4469</fpage><lpage>4477</lpage><year>1988</year><pub-id pub-id-type="doi">10.1016/0006-2952(88)90662-4</pub-id><pub-id pub-id-type="pmid">3202889</pub-id></element-citation></ref>
<ref id="b36-or-37-03-1321"><label>36</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Battilani</surname><given-names>P</given-names></name><name><surname>Giorni</surname><given-names>P</given-names></name><name><surname>Pietri</surname><given-names>A</given-names></name></person-group><chapter-title>Epidemiology of toxin-producing fungi and Ochratoxin A occurrence in grape</chapter-title><source>Epidemiology of Mycotoxin Producing Fungi</source><publisher-name>Springer</publisher-name><fpage>715</fpage><lpage>722</lpage><year>2003</year><comment>doi: 10.1007/978-94-017-1452-5_6</comment><pub-id pub-id-type="doi">10.1007/978-94-017-1452-5_6</pub-id></element-citation></ref>
<ref id="b37-or-37-03-1321"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czerwiecki</surname><given-names>L</given-names></name><name><surname>Czajkowska</surname><given-names>D</given-names></name><name><surname>Witkowska-Gwiazdowska</surname><given-names>A</given-names></name></person-group><article-title>On Ochratoxin A and fungal flora in Polish cereals from conventional and ecological farms. Part 2: Occurrence of Ochratoxin A and fungi in cereals in 1998</article-title><source>Food Addit Contam</source><volume>19</volume><fpage>1051</fpage><lpage>1057</lpage><year>2002</year><pub-id pub-id-type="doi">10.1080/02652030110113726</pub-id><pub-id pub-id-type="pmid">12456276</pub-id></element-citation></ref>
<ref id="b38-or-37-03-1321"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duarte</surname><given-names>SC</given-names></name><name><surname>Pena</surname><given-names>A</given-names></name><name><surname>Lino</surname><given-names>CM</given-names></name></person-group><article-title>A review on Ochratoxin A occurrence and effects of processing of cereal and cereal derived food products</article-title><source>Food Microbiol</source><volume>27</volume><fpage>187</fpage><lpage>198</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.fm.2009.11.016</pub-id><pub-id pub-id-type="pmid">20141935</pub-id></element-citation></ref>
<ref id="b39-or-37-03-1321"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shotwell</surname><given-names>OL</given-names></name><name><surname>Hesseltine</surname><given-names>CW</given-names></name><name><surname>Goulden</surname><given-names>ML</given-names></name></person-group><article-title>Ochratoxin A: Occurrence as natural contaminant of a corn sample</article-title><source>Appl Microbiol</source><volume>17</volume><fpage>765</fpage><lpage>766</lpage><year>1969</year><pub-id pub-id-type="pmid">5785964</pub-id><pub-id pub-id-type="pmcid">377798</pub-id></element-citation></ref>
<ref id="b40-or-37-03-1321"><label>40</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>L&#x00F3;pez-Garc&#x00ED;a</surname><given-names>R</given-names></name></person-group><chapter-title>Mycotoxin management: an international challenge</chapter-title><source>Ensuring Global Food Safety: Exploring Global Harmonization</source><person-group person-group-type="editor"><name><surname>Boisrobert</surname><given-names>C</given-names></name><etal/></person-group><publisher-name>Elsevier</publisher-name><fpage>209</fpage><lpage>216</lpage><year>2009</year></element-citation></ref>
<ref id="b41-or-37-03-1321"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>JW</given-names></name><name><surname>Klich</surname><given-names>M</given-names></name></person-group><article-title>Mycotoxins</article-title><source>Clin Microbiol Rev</source><volume>16</volume><fpage>497</fpage><lpage>516</lpage><year>2003</year><comment>doi: 10.1128/CMR.16.3.497-516.2003</comment><pub-id pub-id-type="doi">10.1128/CMR.16.3.497-516.2003</pub-id><pub-id pub-id-type="pmid">12857779</pub-id><pub-id pub-id-type="pmcid">164220</pub-id></element-citation></ref>
<ref id="b42-or-37-03-1321"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Squire</surname><given-names>RA</given-names></name></person-group><article-title>Ranking animal carcinogens: A proposed regulatory approach</article-title><source>Science</source><volume>214</volume><fpage>877</fpage><lpage>880</lpage><year>1981</year><pub-id pub-id-type="doi">10.1126/science.7302565</pub-id><pub-id pub-id-type="pmid">7302565</pub-id></element-citation></ref>
<ref id="b43-or-37-03-1321"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>T</given-names></name><name><surname>Wicklow</surname><given-names>DT</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name></person-group><article-title>Aflatoxin and cyclopiazonic acid production by a sclerotium-producing Aspergillus tamarii strain</article-title><source>Appl Environ Microbiol</source><volume>62</volume><fpage>4036</fpage><lpage>4038</lpage><year>1996</year><pub-id pub-id-type="pmid">8899995</pub-id><pub-id pub-id-type="pmcid">168224</pub-id></element-citation></ref>
<ref id="b44-or-37-03-1321"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klich</surname><given-names>MA</given-names></name><name><surname>Mullaney</surname><given-names>EJ</given-names></name><name><surname>Daly</surname><given-names>CB</given-names></name><name><surname>Cary</surname><given-names>JW</given-names></name></person-group><article-title>Molecular and physiological aspects of aflatoxin and sterigmatocystin biosynthesis by Aspergillus tamarii and A. ochraceoroseus</article-title><source>Appl Microbiol Biotechnol</source><volume>53</volume><fpage>605</fpage><lpage>609</lpage><year>2000</year><pub-id pub-id-type="doi">10.1007/s002530051664</pub-id><pub-id pub-id-type="pmid">10855723</pub-id></element-citation></ref>
<ref id="b45-or-37-03-1321"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>SW</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Horn</surname><given-names>BW</given-names></name><name><surname>Goto</surname><given-names>T</given-names></name></person-group><article-title>Aspergillus bombycis, a new aflatoxigenic species and genetic variation in its sibling species, A. nomius</article-title><source>Mycologia</source><volume>93</volume><fpage>689</fpage><lpage>703</lpage><year>2001</year><pub-id pub-id-type="doi">10.2307/3761823</pub-id></element-citation></ref>
<ref id="b46-or-37-03-1321"><label>46</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Heathcote</surname><given-names>JG</given-names></name><name><surname>Hibbert</surname><given-names>J</given-names></name></person-group><source>Aflatoxins: Chemical and Biological aspects</source><publisher-name>Elsevier Scientific Publishing Co.</publisher-name><publisher-loc>Amsterdam</publisher-loc><year>1978</year></element-citation></ref>
<ref id="b47-or-37-03-1321"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>JW</given-names></name><name><surname>Chang</surname><given-names>PK</given-names></name><name><surname>Bhatnagar</surname><given-names>D</given-names></name></person-group><article-title>One gene to whole pathway: The role of norsolorinic acid in aflatoxin research</article-title><source>Adv Appl Microbiol</source><volume>45</volume><fpage>1</fpage><lpage>15</lpage><year>1997</year><pub-id pub-id-type="doi">10.1016/S0065-2164(08)70260-0</pub-id><pub-id pub-id-type="pmid">9381965</pub-id></element-citation></ref>
<ref id="b48-or-37-03-1321"><label>48</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cleveland</surname><given-names>TE</given-names></name><name><surname>Bhatnagar</surname><given-names>D</given-names></name></person-group><chapter-title>Molecular strategies for reducing aflatoxin levels in crops before harvest</chapter-title><source>Molecular Approaches to Improving Food Quality and Safety</source><publisher-name>Springer</publisher-name><fpage>205</fpage><lpage>228</lpage><year>1992</year><comment>doi: 10.1007/978-1-4684-8070-2_9</comment><pub-id pub-id-type="doi">10.1007/978-1-4684-8070-2_9</pub-id></element-citation></ref>
<ref id="b49-or-37-03-1321"><label>49</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hicks</surname><given-names>JK</given-names></name><name><surname>Shimizu</surname><given-names>K</given-names></name><name><surname>Keller</surname><given-names>NP</given-names></name></person-group><chapter-title>Genetics and biosynthesis of aflatoxins and sterigmatocystin. The Mycota XI</chapter-title><source>Agricultural Applications</source><person-group person-group-type="editor"><name><surname>Kempken</surname><given-names>F</given-names></name></person-group><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin</publisher-loc><fpage>55</fpage><lpage>69</lpage><year>2002</year><pub-id pub-id-type="doi">10.1007/978-3-662-03059-2_4</pub-id></element-citation></ref>
<ref id="b50-or-37-03-1321"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>GA</given-names></name><name><surname>Brown</surname><given-names>MP</given-names></name></person-group><article-title>Genetics and physiology of aflatoxin biosynthesis</article-title><source>Annu Rev Phytopathol</source><volume>36</volume><fpage>329</fpage><lpage>362</lpage><year>1998</year><pub-id pub-id-type="doi">10.1146/annurev.phyto.36.1.329</pub-id><pub-id pub-id-type="pmid">15012504</pub-id></element-citation></ref>
<ref id="b51-or-37-03-1321"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Townsend</surname><given-names>C</given-names></name></person-group><article-title>Progress toward a biosynthetic rationale of the aflatoxin pathway</article-title><source>Pure Appl Chem</source><volume>58</volume><fpage>227</fpage><lpage>238</lpage><year>1986</year><pub-id pub-id-type="doi">10.1351/pac198658020227</pub-id></element-citation></ref>
<ref id="b52-or-37-03-1321"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trail</surname><given-names>F</given-names></name><name><surname>Mahanti</surname><given-names>N</given-names></name><name><surname>Linz</surname><given-names>J</given-names></name></person-group><article-title>Molecular biology of aflatoxin biosynthesis</article-title><source>Microbiology</source><volume>141</volume><fpage>755</fpage><lpage>765</lpage><year>1995</year><pub-id pub-id-type="doi">10.1099/13500872-141-4-755</pub-id><pub-id pub-id-type="pmid">7773383</pub-id></element-citation></ref>
<ref id="b53-or-37-03-1321"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hackbart</surname><given-names>H</given-names></name><name><surname>Prietto</surname><given-names>L</given-names></name><name><surname>Primel</surname><given-names>EG</given-names></name><name><surname>Garda-Buffon</surname><given-names>J</given-names></name><name><surname>Badiale-Furlong</surname><given-names>E</given-names></name></person-group><article-title>Simultaneous extraction and detection of Ochratoxin A and citrinin in rice</article-title><source>J Braz Chem Soc</source><volume>23</volume><fpage>103</fpage><lpage>109</lpage><year>2012</year><pub-id pub-id-type="doi">10.1590/S0103-50532012000100015</pub-id></element-citation></ref>
<ref id="b54-or-37-03-1321"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aleo</surname><given-names>MD</given-names></name><name><surname>Wyatt</surname><given-names>RD</given-names></name><name><surname>Schnellmann</surname><given-names>RG</given-names></name></person-group><article-title>The role of altered mitochondrial function in citrinin-induced toxicity to rat renal proximal tubule suspensions</article-title><source>Toxicol Appl Pharmacol</source><volume>109</volume><fpage>455</fpage><lpage>463</lpage><year>1991</year><pub-id pub-id-type="doi">10.1016/0041-008X(91)90008-3</pub-id><pub-id pub-id-type="pmid">1853344</pub-id></element-citation></ref>
<ref id="b55-or-37-03-1321"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manabe</surname><given-names>M</given-names></name></person-group><article-title>Fermented foods and mycotoxins</article-title><source>J Jpn Assoc Mycotoxicol</source><volume>51</volume><fpage>25</fpage><lpage>29</lpage><year>2001</year><pub-id pub-id-type="doi">10.2520/myco.51.25</pub-id></element-citation></ref>
<ref id="b56-or-37-03-1321"><label>56</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Carlton</surname><given-names>WW</given-names></name><name><surname>Tuite</surname><given-names>J</given-names></name></person-group><chapter-title>Metabolites of P. viridicatum toxicology</chapter-title><source>Mycotoxins in Human and Animal Health</source><person-group person-group-type="editor"><name><surname>Mehlman</surname><given-names>MA</given-names></name></person-group><publisher-name>Pathotox Publications, Inc.</publisher-name><publisher-loc>Park Forest South, IL</publisher-loc><fpage>525</fpage><lpage>555</lpage><year>1977</year></element-citation></ref>
<ref id="b57-or-37-03-1321"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>M</given-names></name><name><surname>Enomoto</surname><given-names>M</given-names></name><name><surname>Tatsuno</surname><given-names>T</given-names></name><name><surname>Uraguchi</surname><given-names>K</given-names></name></person-group><article-title>Yellowed Rice Toxins: Luteoskyrin and Related Compounds, Chlorine-Containing Compounds, and Citrinin</article-title><source>Ajl, Samuel J Microb Toxins</source><year>1971</year></element-citation></ref>
<ref id="b58-or-37-03-1321"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>JL</given-names></name></person-group><article-title>Mycotoxins - an overview</article-title><source>Romer Labs&#x0027; Guide To Mycotoxins</source><year>2012</year></element-citation></ref>
<ref id="b59-or-37-03-1321"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>J</given-names></name><name><surname>Bentley</surname><given-names>R</given-names></name></person-group><article-title>Pride and prejudice: The story of ergot</article-title><source>Perspect Biol Med</source><volume>42</volume><fpage>333</fpage><lpage>355</lpage><year>1999</year><pub-id pub-id-type="doi">10.1353/pbm.1999.0026</pub-id></element-citation></ref>
<ref id="b60-or-37-03-1321"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweeney</surname><given-names>MJ</given-names></name><name><surname>Dobson</surname><given-names>AD</given-names></name></person-group><article-title>Molecular biology of mycotoxin biosynthesis</article-title><source>FEMS Microbiol Lett</source><volume>175</volume><fpage>149</fpage><lpage>163</lpage><year>1999</year><pub-id pub-id-type="doi">10.1111/j.1574-6968.1999.tb13614.x</pub-id><pub-id pub-id-type="pmid">10386364</pub-id></element-citation></ref>
<ref id="b61-or-37-03-1321"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lia</surname><given-names>Y</given-names></name><name><surname>Lou</surname><given-names>L</given-names></name><name><surname>Cerny</surname><given-names>RL</given-names></name><name><surname>Butchko</surname><given-names>RA</given-names></name><name><surname>Proctor</surname><given-names>RH</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Du</surname><given-names>L</given-names></name></person-group><article-title>Tricarballylic ester formation during biosynthesis of fumonisin mycotoxins in Fusarium verticillioides</article-title><source>Mycology</source><volume>4</volume><fpage>179</fpage><lpage>186</lpage><year>2013</year><pub-id pub-id-type="doi">10.1080/21501203.2013.874540</pub-id><pub-id pub-id-type="pmid">24587959</pub-id></element-citation></ref>
<ref id="b62-or-37-03-1321"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Merwe</surname><given-names>KJ</given-names></name><name><surname>Steyn</surname><given-names>PS</given-names></name><name><surname>Fourie</surname><given-names>L</given-names></name><name><surname>Scott</surname><given-names>DB</given-names></name><name><surname>Theron</surname><given-names>JJ</given-names></name></person-group><article-title>Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh</article-title><source>Nature</source><volume>205</volume><fpage>1112</fpage><lpage>1113</lpage><year>1965</year><pub-id pub-id-type="doi">10.1038/2051112a0</pub-id><pub-id pub-id-type="pmid">5833211</pub-id></element-citation></ref>
<ref id="b63-or-37-03-1321"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Tao</surname><given-names>W</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Jin</surname><given-names>J</given-names></name></person-group><article-title>Determination of Ochratoxin A by polyclonal antibodies based sensitive time-resolved fluoroimmunoassay</article-title><source>Arch Toxicol</source><volume>80</volume><fpage>481</fpage><lpage>485</lpage><year>2006</year><pub-id pub-id-type="doi">10.1007/s00204-006-0112-2</pub-id><pub-id pub-id-type="pmid">16688427</pub-id></element-citation></ref>
<ref id="b64-or-37-03-1321"><label>64</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ciegler</surname><given-names>A</given-names></name><name><surname>Detroy</surname><given-names>RW</given-names></name><name><surname>Lillehoj</surname><given-names>EB</given-names></name></person-group><chapter-title>Patulin, penicillic acid, and other carcinogenic lactones</chapter-title><source>Microbial Toxins</source><person-group person-group-type="editor"><name><surname>Ciegler</surname><given-names>A</given-names></name><name><surname>Kadis</surname><given-names>S</given-names></name><name><surname>Ajl</surname><given-names>SJ</given-names></name></person-group><volume>6</volume><publisher-name>Academic Press</publisher-name><publisher-loc>New York</publisher-loc><fpage>409</fpage><lpage>434</lpage><year>1971</year></element-citation></ref>
<ref id="b65-or-37-03-1321"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekiguchi</surname><given-names>J</given-names></name><name><surname>Gaucher</surname><given-names>GM</given-names></name></person-group><article-title>Identification of phyllostine as an intermediate of the patulin pathway in Penicillium urticae</article-title><source>Biochemistry</source><volume>17</volume><fpage>1785</fpage><lpage>1791</lpage><year>1978</year><pub-id pub-id-type="doi">10.1021/bi00602a033</pub-id><pub-id pub-id-type="pmid">418806</pub-id></element-citation></ref>
<ref id="b66-or-37-03-1321"><label>66</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Cole</surname><given-names>RJ</given-names></name><name><surname>Cox</surname><given-names>RH</given-names></name></person-group><chapter-title>The trichothecenes</chapter-title><source>Handbook of Toxic Fungal Metabolites</source><publisher-name>Academic Press</publisher-name><publisher-loc>New York</publisher-loc><fpage>152</fpage><lpage>263</lpage><year>1981</year><pub-id pub-id-type="doi">10.1016/B978-0-12-179760-7.50010-3</pub-id></element-citation></ref>
<ref id="b67-or-37-03-1321"><label>67</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>PM</given-names></name></person-group><chapter-title>The natural occurrence of trichothecenes</chapter-title><source>Trichothecene mycotoxicosis: Pathophysiologic effects</source><person-group person-group-type="editor"><name><surname>Beasley</surname><given-names>VR</given-names></name></person-group><volume>1</volume><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton, FL</publisher-loc><fpage>1</fpage><lpage>26</lpage><year>1989</year></element-citation></ref>
<ref id="b68-or-37-03-1321"><label>68</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Ueno</surname><given-names>Y</given-names></name></person-group><chapter-title>Trichothecenes</chapter-title><source>Chemical, Biological and Toxicological Aspects</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam</publisher-loc><year>1983</year></element-citation></ref>
<ref id="b69-or-37-03-1321"><label>69</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Marasas</surname><given-names>WFO</given-names></name><name><surname>Nelson</surname><given-names>PE</given-names></name><name><surname>Toussoun</surname><given-names>TA</given-names></name></person-group><chapter-title>Toxigenic Fusarium species</chapter-title><source>Identity and mycotoxicology</source><publisher-loc>University Park</publisher-loc><publisher-name>Pennsylvania State University Press</publisher-name><year>1984</year></element-citation></ref>
<ref id="b70-or-37-03-1321"><label>70</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hinkley</surname><given-names>SF</given-names></name><name><surname>Jarvis</surname><given-names>BB</given-names></name></person-group><chapter-title>15 Chromatographic method for Stachybotrys toxins</chapter-title><source>Mycotoxin Protocols</source><volume>157</volume><publisher-name>Humana Press</publisher-name><fpage>173</fpage><lpage>194</lpage><year>2001</year><pub-id pub-id-type="doi">10.1385/1-59259-064-0:173</pub-id></element-citation></ref>
<ref id="b71-or-37-03-1321"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urry</surname><given-names>W</given-names></name><name><surname>Wehrmeister</surname><given-names>H</given-names></name><name><surname>Hodge</surname><given-names>E</given-names></name><name><surname>Hidy</surname><given-names>P</given-names></name></person-group><article-title>The structure of zearalenone</article-title><source>Tetrahedron Lett</source><volume>7</volume><fpage>3109</fpage><lpage>3114</lpage><year>1966</year><pub-id pub-id-type="doi">10.1016/S0040-4039(01)99923-X</pub-id></element-citation></ref>
<ref id="b72-or-37-03-1321"><label>72</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cousin</surname><given-names>MA</given-names></name><name><surname>Riley</surname><given-names>RT</given-names></name><name><surname>Pestka</surname><given-names>JJ</given-names></name></person-group><source>Foodborne Mycotoxins: Chemistry, Biology, Ecology, and Toxicology</source><publisher-name>Caister Academic Press</publisher-name><publisher-loc>Norfolk</publisher-loc><year>2005</year></element-citation></ref>
<ref id="b73-or-37-03-1321"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bullerman</surname><given-names>LB</given-names></name><name><surname>Bianchini</surname><given-names>A</given-names></name></person-group><article-title>Stability of mycotoxins during food processing</article-title><source>Int J Food Microbiol</source><volume>119</volume><fpage>140</fpage><lpage>146</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2007.07.035</pub-id><pub-id pub-id-type="pmid">17804104</pub-id></element-citation></ref>
<ref id="b74-or-37-03-1321"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visconti</surname><given-names>A</given-names></name><name><surname>Pascale</surname><given-names>M</given-names></name></person-group><article-title>REVIEW: An overview on Fusarium mycotoxins in the durum wheat pasta production chain</article-title><source>Cereal Chem</source><volume>87</volume><fpage>21</fpage><lpage>27</lpage><year>2010</year><pub-id pub-id-type="doi">10.1094/CCHEM-87-1-0021</pub-id></element-citation></ref>
<ref id="b75-or-37-03-1321"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabak</surname><given-names>B</given-names></name></person-group><article-title>The fate of mycotoxins during thermal food processing</article-title><source>J Sci Food Agric</source><volume>89</volume><fpage>549</fpage><lpage>554</lpage><year>2009</year><pub-id pub-id-type="doi">10.1002/jsfa.3491</pub-id></element-citation></ref>
<ref id="b76-or-37-03-1321"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>P</given-names></name></person-group><article-title>Effects of food processing on mycotoxins</article-title><source>J Food Prot</source><volume>47</volume><fpage>489</fpage><lpage>499</lpage><year>1984</year><pub-id pub-id-type="doi">10.4315/0362-028X-47.6.489</pub-id></element-citation></ref>
<ref id="b77-or-37-03-1321"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doyle</surname><given-names>M</given-names></name><name><surname>Applebaum</surname><given-names>R</given-names></name><name><surname>Brackett</surname><given-names>R</given-names></name><name><surname>Marth</surname><given-names>E</given-names></name></person-group><article-title>Physical, chemical and biological degradation of mycotoxins in foods and agricultural commodities</article-title><source>J Food Prot</source><volume>45</volume><fpage>964</fpage><lpage>971</lpage><year>1982</year><pub-id pub-id-type="doi">10.4315/0362-028X-45.10.964</pub-id></element-citation></ref>
<ref id="b78-or-37-03-1321"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauren</surname><given-names>DR</given-names></name><name><surname>Smith</surname><given-names>WA</given-names></name></person-group><article-title>Stability of the fusarium mycotoxins nivalenol, deoxynivalenol and zearalenone in ground maize under typical cooking environments</article-title><source>Food Addit Contam</source><volume>18</volume><fpage>1011</fpage><lpage>1016</lpage><year>2001</year><pub-id pub-id-type="doi">10.1080/02652030110052283</pub-id><pub-id pub-id-type="pmid">11665729</pub-id></element-citation></ref>
<ref id="b79-or-37-03-1321"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gund</surname><given-names>P</given-names></name></person-group><article-title>Guanidine, trimethylenemethane, and Y-delocalization</article-title><source>Can acyclic compounds have aromatic stability? J Chem Educ</source><volume>49</volume><fpage>100</fpage><year>1972</year></element-citation></ref>
<ref id="b80-or-37-03-1321"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverstein</surname><given-names>RM</given-names></name><name><surname>Bassler</surname><given-names>GC</given-names></name></person-group><article-title>Spectrometric identification of organic compounds</article-title><source>J Chem Educ</source><volume>39</volume><fpage>546</fpage><year>1962</year><pub-id pub-id-type="doi">10.1021/ed039p546</pub-id></element-citation></ref>
<ref id="b81-or-37-03-1321"><label>81</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Abbas</surname><given-names>HK</given-names></name></person-group><source>Aflatoxin and Food Safety</source><publisher-name>CRC Press</publisher-name><year>2005</year><comment>doi: 10.1201/9781420028171</comment><pub-id pub-id-type="doi">10.1201/9781420028171</pub-id></element-citation></ref>
<ref id="b82-or-37-03-1321"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarvis</surname><given-names>BB</given-names></name><name><surname>Miller</surname><given-names>JD</given-names></name></person-group><article-title>Mycotoxins as harmful indoor air contaminants</article-title><source>Appl Microbiol Biotechnol</source><volume>66</volume><fpage>367</fpage><lpage>372</lpage><year>2005</year><pub-id pub-id-type="doi">10.1007/s00253-004-1753-9</pub-id><pub-id pub-id-type="pmid">15565335</pub-id></element-citation></ref>
<ref id="b83-or-37-03-1321"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serra</surname><given-names>R</given-names></name><name><surname>Braga</surname><given-names>A</given-names></name><name><surname>Ven&#x00E2;ncio</surname><given-names>A</given-names></name></person-group><article-title>Mycotoxin-producing and other fungi isolated from grapes for wine production, with particular emphasis on Ochratoxin A</article-title><source>Res Microbiol</source><volume>156</volume><fpage>515</fpage><lpage>521</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.resmic.2004.12.005</pub-id><pub-id pub-id-type="pmid">15862450</pub-id></element-citation></ref>
<ref id="b84-or-37-03-1321"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agag</surname><given-names>B</given-names></name></person-group><article-title>Mycotoxins in foods and feeds: 1-aflatoxins</article-title><source>Assiut Univ Bull Environ Res</source><volume>7</volume><fpage>173</fpage><lpage>205</lpage><year>2004</year></element-citation></ref>
<ref id="b85-or-37-03-1321"><label>85</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Eaton</surname><given-names>DL</given-names></name><name><surname>Groopman</surname><given-names>JD</given-names></name></person-group><source>Toxicology of Aflatoxins: Human Health, Veterinary, and Agricultural Significance</source><publisher-name>Elsevier</publisher-name><year>2013</year></element-citation></ref>
<ref id="b86-or-37-03-1321"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>XY</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>SL</given-names></name><name><surname>Cai</surname><given-names>QS</given-names></name><name><surname>Wang</surname><given-names>JS</given-names></name><name><surname>Hong</surname><given-names>JY</given-names></name></person-group><article-title>Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract</article-title><source>Int J Cancer</source><volume>118</volume><fpage>2665</fpage><lpage>2671</lpage><year>2006</year><pub-id pub-id-type="doi">10.1002/ijc.21665</pub-id><pub-id pub-id-type="pmid">16385575</pub-id></element-citation></ref>
<ref id="b87-or-37-03-1321"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baertschi</surname><given-names>SW</given-names></name><name><surname>Raney</surname><given-names>KD</given-names></name><name><surname>Stone</surname><given-names>MP</given-names></name><name><surname>Harris</surname><given-names>TM</given-names></name></person-group><article-title>Preparation of the 8, 9-epoxide of the mycotoxin aflatoxin B1: The ultimate carcinogenic species</article-title><source>J Am Chem Soc</source><volume>110</volume><fpage>7929</fpage><lpage>7931</lpage><year>1988</year><pub-id pub-id-type="doi">10.1021/ja00231a083</pub-id></element-citation></ref>
<ref id="b88-or-37-03-1321"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yates</surname><given-names>MS</given-names></name><name><surname>Kwak</surname><given-names>M-K</given-names></name><name><surname>Egner</surname><given-names>PA</given-names></name><name><surname>Groopman</surname><given-names>JD</given-names></name><name><surname>Bodreddigari</surname><given-names>S</given-names></name><name><surname>Sutter</surname><given-names>TR</given-names></name><name><surname>Baumgartner</surname><given-names>KJ</given-names></name><name><surname>Roebuck</surname><given-names>BD</given-names></name><name><surname>Liby</surname><given-names>KT</given-names></name><name><surname>Yore</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole</article-title><source>Cancer Res</source><volume>66</volume><fpage>2488</fpage><lpage>2494</lpage><year>2006</year><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-3823</pub-id><pub-id pub-id-type="pmid">16489057</pub-id></element-citation></ref>
<ref id="b89-or-37-03-1321"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boorman</surname><given-names>GA</given-names></name><name><surname>McDonald</surname><given-names>MR</given-names></name><name><surname>Imoto</surname><given-names>S</given-names></name><name><surname>Persing</surname><given-names>R</given-names></name></person-group><article-title>Renal lesions induced by Ochratoxin A exposure in the F344 rat</article-title><source>Toxicol Pathol</source><volume>20</volume><fpage>236</fpage><lpage>245</lpage><year>1992</year><pub-id pub-id-type="doi">10.1177/019262339202000210</pub-id><pub-id pub-id-type="pmid">1475584</pub-id></element-citation></ref>
<ref id="b90-or-37-03-1321"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>Y-M</given-names></name><name><surname>Jeon</surname><given-names>J-J</given-names></name><name><surname>Yea</surname><given-names>S-J</given-names></name><name><surname>Kim</surname><given-names>Y-H</given-names></name><name><surname>Yun</surname><given-names>S-H</given-names></name><name><surname>Lee</surname><given-names>Y-W</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name></person-group><article-title>Double-stranded RNA mycovirus from Fusarium graminearum</article-title><source>Appl Environ Microbiol</source><volume>68</volume><fpage>2529</fpage><lpage>2534</lpage><year>2002</year><pub-id pub-id-type="doi">10.1128/AEM.68.5.2529-2534.2002</pub-id><pub-id pub-id-type="pmid">11976130</pub-id><pub-id pub-id-type="pmcid">127521</pub-id></element-citation></ref>
<ref id="b91-or-37-03-1321"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuiper-Goodman</surname><given-names>T</given-names></name><name><surname>Scott</surname><given-names>PM</given-names></name></person-group><article-title>Risk assessment of the mycotoxin Ochratoxin A</article-title><source>Biomed Environ Sci</source><volume>2</volume><fpage>179</fpage><lpage>248</lpage><year>1989</year><pub-id pub-id-type="pmid">2692617</pub-id></element-citation></ref>
<ref id="b92-or-37-03-1321"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunge</surname><given-names>I</given-names></name><name><surname>Heller</surname><given-names>K</given-names></name><name><surname>R&#x00F6;schenthaler</surname><given-names>R</given-names></name></person-group><article-title>Isolation and purification of Ochratoxin A</article-title><source>Zeitschrift f&#x00FC;rLebensmitteluntersuchung und-Forschung</source><volume>168</volume><fpage>457</fpage><lpage>458</lpage><year>1979</year><comment>doi: 10.1007/BF01479260</comment><pub-id pub-id-type="doi">10.1007/BF01479260</pub-id></element-citation></ref>
<ref id="b93-or-37-03-1321"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marquardt</surname><given-names>RR</given-names></name><name><surname>Frohlich</surname><given-names>AA</given-names></name></person-group><article-title>A review of recent advances in understanding ochratoxicosis</article-title><source>J Anim Sci</source><volume>70</volume><fpage>3968</fpage><lpage>3988</lpage><year>1992</year><pub-id pub-id-type="doi">10.2527/1992.70123968x</pub-id><pub-id pub-id-type="pmid">1474034</pub-id></element-citation></ref>
<ref id="b94-or-37-03-1321"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meisner</surname><given-names>H</given-names></name><name><surname>Meisner</surname><given-names>P</given-names></name></person-group><article-title>Ochratoxin A, an in vivo inhibitor of renal phosphoenolpyruvate carboxykinase</article-title><source>Arch Biochem Biophys</source><volume>208</volume><fpage>146</fpage><lpage>153</lpage><year>1981</year><pub-id pub-id-type="doi">10.1016/0003-9861(81)90133-8</pub-id><pub-id pub-id-type="pmid">7259174</pub-id></element-citation></ref>
<ref id="b95-or-37-03-1321"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>O</given-names></name><name><surname>Ansari</surname><given-names>K</given-names></name><name><surname>Doohan</surname><given-names>FM</given-names></name></person-group><article-title>Effects of trichothecene mycotoxins on eukaryotic cells: A review</article-title><source>Food Addit Contam</source><volume>22</volume><fpage>369</fpage><lpage>378</lpage><year>2005</year><pub-id pub-id-type="doi">10.1080/02652030500058403</pub-id><pub-id pub-id-type="pmid">16019807</pub-id></element-citation></ref>
<ref id="b96-or-37-03-1321"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desmond</surname><given-names>OJ</given-names></name><name><surname>Manners</surname><given-names>JM</given-names></name><name><surname>Stephens</surname><given-names>AE</given-names></name><name><surname>Maclean</surname><given-names>DJ</given-names></name><name><surname>Schenk</surname><given-names>PM</given-names></name><name><surname>Gardiner</surname><given-names>DM</given-names></name><name><surname>Munn</surname><given-names>AL</given-names></name><name><surname>Kazan</surname><given-names>K</given-names></name></person-group><article-title>The Fusarium mycotoxin deoxynivalenol elicits hydrogen peroxide production, programmed cell death and defence responses in wheat</article-title><source>Mol Plant Pathol</source><volume>9</volume><fpage>435</fpage><lpage>445</lpage><year>2008</year><pub-id pub-id-type="doi">10.1111/j.1364-3703.2008.00475.x</pub-id><pub-id pub-id-type="pmid">18705859</pub-id></element-citation></ref>
<ref id="b97-or-37-03-1321"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pestka</surname><given-names>JJ</given-names></name></person-group><article-title>Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal immune response with systemic repercussions</article-title><source>Toxicol Lett</source><fpage>140</fpage><lpage>141</lpage><comment>287&#x2013;295</comment><year>2003</year></element-citation></ref>
<ref id="b98-or-37-03-1321"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunner</surname><given-names>DL</given-names></name><name><surname>Morris</surname><given-names>ER</given-names></name></person-group><article-title>Alteration of multiple cell membrane functions in L-6 myoblasts by T-2 toxin: An important mechanism of action</article-title><source>Toxicol Appl Pharmacol</source><volume>92</volume><fpage>113</fpage><lpage>121</lpage><year>1988</year><pub-id pub-id-type="doi">10.1016/0041-008X(88)90233-5</pub-id><pub-id pub-id-type="pmid">3341021</pub-id></element-citation></ref>
<ref id="b99-or-37-03-1321"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diamond</surname><given-names>M</given-names></name><name><surname>Reape</surname><given-names>TJ</given-names></name><name><surname>Rocha</surname><given-names>O</given-names></name><name><surname>Doyle</surname><given-names>SM</given-names></name><name><surname>Kacprzyk</surname><given-names>J</given-names></name><name><surname>Doohan</surname><given-names>FM</given-names></name><name><surname>McCabe</surname><given-names>PF</given-names></name></person-group><article-title>The fusarium mycotoxin deoxynivalenol can inhibit plant apoptosis-like programmed cell death</article-title><source>PLoS One</source><volume>8</volume><fpage>e69542</fpage><year>2013</year><pub-id pub-id-type="doi">10.1371/journal.pone.0069542</pub-id><pub-id pub-id-type="pmid">23922734</pub-id><pub-id pub-id-type="pmcid">3724914</pub-id></element-citation></ref>
<ref id="b100-or-37-03-1321"><label>100</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>B</given-names></name></person-group><chapter-title>Inhibition of protein synthesis by trichothecenes</chapter-title><source>Mycotoxins in Human and Animal Health</source><person-group person-group-type="editor"><name><surname>Meky</surname><given-names>FA</given-names></name><name><surname>Hardie</surname><given-names>LJ</given-names></name><name><surname>Evans</surname><given-names>SW</given-names></name><name><surname>Wild</surname><given-names>CP</given-names></name></person-group><publisher-name>Pathotox Publications</publisher-name><publisher-loc>Park Forest South, IL</publisher-loc><fpage>263</fpage><lpage>273</lpage><year>2001</year></element-citation></ref>
<ref id="b101-or-37-03-1321"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>WL</given-names></name><name><surname>Wannemacher</surname><given-names>RW</given-names><suffix>Jr</suffix></name></person-group><article-title>Detection and quantitation of T-2 mycotoxin with a simplified protein synthesis inhibition assay</article-title><source>Appl Environ Microbiol</source><volume>48</volume><fpage>1176</fpage><lpage>1180</lpage><year>1984</year><pub-id pub-id-type="pmid">6517584</pub-id><pub-id pub-id-type="pmcid">241705</pub-id></element-citation></ref>
<ref id="b102-or-37-03-1321"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wannemacher</surname><given-names>RW</given-names></name><name><surname>Wiener</surname><given-names>SL</given-names></name><name><surname>Sidell</surname><given-names>FR</given-names></name><name><surname>Takafuji</surname><given-names>ET</given-names></name><name><surname>Franz</surname><given-names>DR</given-names></name></person-group><article-title>Trichothecene mycotoxins</article-title><source>Medical Aspects of Chemical and Biological Warfare</source><fpage>655</fpage><lpage>676</lpage><year>1997</year></element-citation></ref>
<ref id="b103-or-37-03-1321"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>G-H</given-names></name><name><surname>Jarvis</surname><given-names>BB</given-names></name><name><surname>Chung</surname><given-names>Y-J</given-names></name><name><surname>Pestka</surname><given-names>JJ</given-names></name></person-group><article-title>Apoptosis induction by the satratoxins and other trichothecene mycotoxins: Relationship to ERK p38 MAPK, and SAPK/JNK activation</article-title><source>Toxicol Appl Pharmacol</source><volume>164</volume><fpage>149</fpage><lpage>160</lpage><year>2000</year><pub-id pub-id-type="doi">10.1006/taap.1999.8888</pub-id><pub-id pub-id-type="pmid">10764628</pub-id></element-citation></ref>
<ref id="b104-or-37-03-1321"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>H-R</given-names></name><name><surname>Islam</surname><given-names>Z</given-names></name><name><surname>Pestka</surname><given-names>JJ</given-names></name></person-group><article-title>Rapid, sequential activation of mitogen-activated protein kinases and transcription factors precedes proinflammatory cytokine mRNA expression in spleens of mice exposed to the trichothecene vomitoxin</article-title><source>Toxicol Sci</source><volume>72</volume><fpage>130</fpage><lpage>142</lpage><year>2003</year><pub-id pub-id-type="doi">10.1093/toxsci/kfg006</pub-id><pub-id pub-id-type="pmid">12604842</pub-id></element-citation></ref>
<ref id="b105-or-37-03-1321"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sansing</surname><given-names>GA</given-names></name><name><surname>Lillehoj</surname><given-names>EB</given-names></name><name><surname>Detroy</surname><given-names>RW</given-names></name><name><surname>Miller</surname><given-names>MA</given-names></name></person-group><article-title>Synergistic toxic effects of citrinin, Ochratoxin A and penicillic acid in mice</article-title><source>Toxicon</source><volume>14</volume><fpage>213</fpage><lpage>220</lpage><year>1976</year><pub-id pub-id-type="doi">10.1016/0041-0101(76)90009-X</pub-id><pub-id pub-id-type="pmid">941175</pub-id></element-citation></ref>
<ref id="b106-or-37-03-1321"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wichmann</surname><given-names>G</given-names></name><name><surname>Herbarth</surname><given-names>O</given-names></name><name><surname>Lehmann</surname><given-names>I</given-names></name></person-group><article-title>The mycotoxins citrinin, gliotoxin, and patulin affect interferon-&#x03B3; rather than interleukin-4 production in human blood cells</article-title><source>Environ Toxicol</source><volume>17</volume><fpage>211</fpage><lpage>218</lpage><year>2002</year><pub-id pub-id-type="doi">10.1002/tox.10050</pub-id><pub-id pub-id-type="pmid">12112629</pub-id></element-citation></ref>
<ref id="b107-or-37-03-1321"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x00F6;nmez-Altuntas</surname><given-names>H</given-names></name><name><surname>Dumlupinar</surname><given-names>G</given-names></name><name><surname>Imamoglu</surname><given-names>N</given-names></name><name><surname>Hamurcu</surname><given-names>Z</given-names></name><name><surname>Liman</surname><given-names>BC</given-names></name></person-group><article-title>Effects of the mycotoxin citrinin on micronucleus formation in a cytokinesis-block genotoxicity assay in cultured human lymphocytes</article-title><source>J Appl Toxicol</source><volume>27</volume><fpage>337</fpage><lpage>341</lpage><year>2007</year><pub-id pub-id-type="doi">10.1002/jat.1209</pub-id><pub-id pub-id-type="pmid">17265422</pub-id></element-citation></ref>
<ref id="b108-or-37-03-1321"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flajs</surname><given-names>D</given-names></name><name><surname>Peraica</surname><given-names>M</given-names></name></person-group><article-title>Toxicological properties of citrinin</article-title><source>Arh Hig Rada Toksikol</source><volume>60</volume><fpage>457</fpage><lpage>464</lpage><year>2009</year><pub-id pub-id-type="doi">10.2478/10004-1254-60-2009-1992</pub-id><pub-id pub-id-type="pmid">20061247</pub-id></element-citation></ref>
<ref id="b109-or-37-03-1321"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhat</surname><given-names>R</given-names></name><name><surname>Rai</surname><given-names>RV</given-names></name><name><surname>Karim</surname><given-names>AA</given-names></name></person-group><article-title>Mycotoxins in food and feed: present status and future concerns</article-title><source>Compr Rev Food Sci Food Saf</source><volume>9</volume><fpage>57</fpage><lpage>81</lpage><year>2010</year><comment>doi: 10.1111/j.1541-4337.2009.00094.x</comment><pub-id pub-id-type="doi">10.1111/j.1541-4337.2009.00094.x</pub-id></element-citation></ref>
<ref id="b110-or-37-03-1321"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matossian</surname><given-names>MK</given-names></name></person-group><article-title>Mold poisoning: An unrecognized English health problem, 1550&#x2013;1800</article-title><source>Med Hist</source><volume>25</volume><fpage>73</fpage><lpage>84</lpage><year>1981</year><pub-id pub-id-type="doi">10.1017/S0025727300034116</pub-id><pub-id pub-id-type="pmid">7012476</pub-id><pub-id pub-id-type="pmcid">1138987</pub-id></element-citation></ref>
<ref id="b111-or-37-03-1321"><label>111</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Matossian</surname><given-names>MK</given-names></name></person-group><source>Poisons of the Past: Molds, Epidemics, and History</source><publisher-name>Yale University Press</publisher-name><publisher-loc>New Haven and London</publisher-loc><year>1989</year><comment>Arch Nat Hist</comment><volume>18</volume><fpage>145</fpage><comment>Available online: Jul 2010</comment><uri>http://dx.doi.org/10.3366/anh.1991.18.1.145</uri></element-citation></ref>
<ref id="b112-or-37-03-1321"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binder</surname><given-names>EM</given-names></name></person-group><article-title>Managing the risk of mycotoxins in modern feed production</article-title><source>Anim Feed Sci Technol</source><volume>133</volume><fpage>149</fpage><lpage>166</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.anifeedsci.2006.08.008</pub-id></element-citation></ref>
<ref id="b113-or-37-03-1321"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>K</given-names></name><name><surname>Hoseney</surname><given-names>RC</given-names></name></person-group><article-title>Ergot on cereal grains</article-title><source>Crit Rev Food Sci Nutr</source><volume>11</volume><fpage>311</fpage><lpage>354</lpage><year>1979</year><pub-id pub-id-type="doi">10.1080/10408397909527267</pub-id></element-citation></ref>
<ref id="b114-or-37-03-1321"><label>114</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Riddle</surname><given-names>JM</given-names></name></person-group><source>Eve&#x0027;s Herbs: A History of Contraception and Abortion in the West</source><publisher-name>Harvard University Press</publisher-name><year>1999</year></element-citation></ref>
<ref id="b115-or-37-03-1321"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caballero-Granado</surname><given-names>FJ</given-names></name><name><surname>Viciana</surname><given-names>P</given-names></name><name><surname>Cordero</surname><given-names>E</given-names></name><name><surname>G&#x00F3;mez-Vera</surname><given-names>MJ</given-names></name><name><surname>del Nozal</surname><given-names>M</given-names></name><name><surname>L&#x00F3;pez-Cort&#x00E9;s</surname><given-names>LF</given-names></name></person-group><article-title>Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient</article-title><source>Antimicrob Agents Chemother</source><volume>41</volume><fpage>1207</fpage><year>1997</year><pub-id pub-id-type="pmid">9145904</pub-id><pub-id pub-id-type="pmcid">163885</pub-id></element-citation></ref>
<ref id="b116-or-37-03-1321"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberts</surname><given-names>JF</given-names></name><name><surname>Gelderblom</surname><given-names>WC</given-names></name><name><surname>Thiel</surname><given-names>PG</given-names></name><name><surname>Marasas</surname><given-names>WF</given-names></name><name><surname>Van Schalkwyk</surname><given-names>DJ</given-names></name><name><surname>Behrend</surname><given-names>Y</given-names></name></person-group><article-title>Effects of temperature and incubation period on production of fumonisin B1 by Fusarium moniliforme</article-title><source>Appl Environ Microbiol</source><volume>56</volume><fpage>1729</fpage><lpage>1733</lpage><year>1990</year><pub-id pub-id-type="pmid">2383011</pub-id><pub-id pub-id-type="pmcid">184501</pub-id></element-citation></ref>
<ref id="b117-or-37-03-1321"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelderblom</surname><given-names>WC</given-names></name><name><surname>Smuts</surname><given-names>CM</given-names></name><name><surname>Abel</surname><given-names>S</given-names></name><name><surname>Snyman</surname><given-names>SD</given-names></name><name><surname>Cawood</surname><given-names>ME</given-names></name><name><surname>van der Westhuizen</surname><given-names>L</given-names></name><name><surname>Swanevelder</surname><given-names>S</given-names></name></person-group><article-title>Effect of fumonisin B1 on protein and lipid synthesis in primary rat hepatocytes</article-title><source>Food Chem Toxicol</source><volume>34</volume><fpage>361</fpage><lpage>369</lpage><year>1996</year><pub-id pub-id-type="doi">10.1016/0278-6915(96)00107-X</pub-id><pub-id pub-id-type="pmid">8641662</pub-id></element-citation></ref>
<ref id="b118-or-37-03-1321"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pozzi</surname><given-names>CR</given-names></name><name><surname>Corr&#x00EA;a</surname><given-names>B</given-names></name><name><surname>Xavier</surname><given-names>JG</given-names></name><name><surname>Direito</surname><given-names>GM</given-names></name><name><surname>Orsi</surname><given-names>RB</given-names></name><name><surname>Matarazzo</surname><given-names>SV</given-names></name></person-group><article-title>Effects of prolonged oral administration of fumonisin B1 and aflatoxin B1 in rats</article-title><source>Mycopathologia</source><volume>151</volume><fpage>21</fpage><lpage>27</lpage><year>2001</year><pub-id pub-id-type="doi">10.1023/A:1010954119980</pub-id><pub-id pub-id-type="pmid">11502059</pub-id></element-citation></ref>
<ref id="b119-or-37-03-1321"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sydenham</surname><given-names>EW</given-names></name><name><surname>Shephard</surname><given-names>GS</given-names></name><name><surname>Thiel</surname><given-names>PG</given-names></name><name><surname>Marasas</surname><given-names>WF</given-names></name><name><surname>Stockenstrom</surname><given-names>S</given-names></name></person-group><article-title>Fumonisin contamination of commercial corn-based human foodstuffs</article-title><source>J Agric Food Chem</source><volume>39</volume><fpage>2014</fpage><lpage>2018</lpage><year>1991</year><pub-id pub-id-type="doi">10.1021/jf00011a028</pub-id></element-citation></ref>
<ref id="b120-or-37-03-1321"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouadio</surname><given-names>JH</given-names></name><name><surname>Mobio</surname><given-names>TA</given-names></name><name><surname>Baudrimont</surname><given-names>I</given-names></name><name><surname>Moukha</surname><given-names>S</given-names></name><name><surname>Dano</surname><given-names>SD</given-names></name><name><surname>Creppy</surname><given-names>EE</given-names></name></person-group><article-title>Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, zearalenone or fumonisin B1 in human intestinal cell line Caco-2</article-title><source>Toxicology</source><volume>213</volume><fpage>56</fpage><lpage>65</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.tox.2005.05.010</pub-id><pub-id pub-id-type="pmid">16019124</pub-id></element-citation></ref>
<ref id="b121-or-37-03-1321"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tolleson</surname><given-names>WH</given-names></name><name><surname>Melchior</surname><given-names>WB</given-names><suffix>Jr</suffix></name><name><surname>Morris</surname><given-names>SM</given-names></name><name><surname>McGarrity</surname><given-names>LJ</given-names></name><name><surname>Domon</surname><given-names>OE</given-names></name><name><surname>Muskhelishvili</surname><given-names>L</given-names></name><name><surname>James</surname><given-names>SJ</given-names></name><name><surname>Howard</surname><given-names>PC</given-names></name></person-group><article-title>Apoptotic and anti-proliferative effects of fumonisin B1 in human keratinocytes, fibroblasts, esophageal epithelial cells and hepatoma cells</article-title><source>Carcinogenesis</source><volume>17</volume><fpage>239</fpage><lpage>249</lpage><year>1996</year><pub-id pub-id-type="doi">10.1093/carcin/17.2.239</pub-id><pub-id pub-id-type="pmid">8625445</pub-id></element-citation></ref>
<ref id="b122-or-37-03-1321"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hendricks</surname><given-names>KA</given-names></name><name><surname>Simpson</surname><given-names>JS</given-names></name><name><surname>Larsen</surname><given-names>RD</given-names></name></person-group><article-title>Neural tube defects along the Texas-Mexico border, 1993&#x2013;1995</article-title><source>Am J Epidemiol</source><volume>149</volume><fpage>1119</fpage><lpage>1127</lpage><year>1999</year><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a009766</pub-id><pub-id pub-id-type="pmid">10369506</pub-id></element-citation></ref>
<ref id="b123-or-37-03-1321"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Missmer</surname><given-names>S</given-names></name><name><surname>Hendricks</surname><given-names>K</given-names></name><name><surname>Suarez</surname><given-names>L</given-names></name><name><surname>Larsen</surname><given-names>R</given-names></name><name><surname>Rothman</surname><given-names>I</given-names></name></person-group><article-title>Fumonisins and neural tube defects</article-title><source>Epidemiology</source><volume>11</volume><fpage>183</fpage><lpage>184</lpage><year>2000</year></element-citation></ref>
<ref id="b124-or-37-03-1321"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rheeder</surname><given-names>JP</given-names></name><name><surname>Marasas</surname><given-names>WF</given-names></name><name><surname>Vismer</surname><given-names>HF</given-names></name></person-group><article-title>Production of fumonisin analogs by Fusarium species</article-title><source>Appl Environ Microbiol</source><volume>68</volume><fpage>2101</fpage><lpage>2105</lpage><year>2002</year><pub-id pub-id-type="doi">10.1128/AEM.68.5.2101-2105.2002</pub-id><pub-id pub-id-type="pmid">11976077</pub-id><pub-id pub-id-type="pmcid">127586</pub-id></element-citation></ref>
<ref id="b125-or-37-03-1321"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trucksess</surname><given-names>MW</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name></person-group><article-title>Solid-phase extraction method for patulin in apple juice and unfiltered apple juice</article-title><source>J AOAC Int</source><volume>82</volume><fpage>1109</fpage><lpage>1113</lpage><year>1999</year><pub-id pub-id-type="pmid">10513012</pub-id></element-citation></ref>
<ref id="b126-or-37-03-1321"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stafford</surname><given-names>ME</given-names></name><name><surname>McLaughlin</surname><given-names>CS</given-names></name></person-group><article-title>Trichodermin, a possible inhibitor of the termination process of protein synthesis</article-title><source>J Cell Physiol</source><volume>82</volume><fpage>121</fpage><lpage>128</lpage><year>1973</year><pub-id pub-id-type="doi">10.1002/jcp.1040820114</pub-id><pub-id pub-id-type="pmid">4580903</pub-id></element-citation></ref>
<ref id="b127-or-37-03-1321"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>C-M</given-names></name><name><surname>Campbell</surname><given-names>IM</given-names></name><name><surname>McLaughlin</surname><given-names>CS</given-names></name><name><surname>Vaughan</surname><given-names>MH</given-names></name></person-group><article-title>Letter: Binding of trichodermin to mammalian ribosomes and its inhibition by other 12,13-epoxytrichothecenes</article-title><source>Mol Cell Biochem</source><volume>3</volume><fpage>215</fpage><lpage>219</lpage><year>1974</year><pub-id pub-id-type="doi">10.1007/BF01686646</pub-id><pub-id pub-id-type="pmid">4839101</pub-id></element-citation></ref>
<ref id="b128-or-37-03-1321"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>JW</given-names></name><name><surname>Klich</surname><given-names>M</given-names></name></person-group><article-title>Mycotoxins</article-title><source>Clin Microbiol Rev</source><volume>16</volume><fpage>497</fpage><lpage>516</lpage><year>2003</year><pub-id pub-id-type="doi">10.1128/CMR.16.3.497-516.2003</pub-id><pub-id pub-id-type="pmid">12857779</pub-id><pub-id pub-id-type="pmcid">164220</pub-id></element-citation></ref>
<ref id="b129-or-37-03-1321"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotter</surname><given-names>BA</given-names></name></person-group><article-title>Invited review: Toxicology of deoxynivalenol (vomitoxin)</article-title><source>J Toxicol Environ Health A</source><volume>48</volume><fpage>1</fpage><lpage>34</lpage><year>1996</year><pub-id pub-id-type="doi">10.1080/009841096161447</pub-id></element-citation></ref>
<ref id="b130-or-37-03-1321"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>Z</given-names></name><name><surname>Gray</surname><given-names>JS</given-names></name><name><surname>Pestka</surname><given-names>JJ</given-names></name></person-group><article-title>p38 Mitogen-activated protein kinase mediates IL-8 induction by the ribotoxin deoxynivalenol in human monocytes</article-title><source>Toxicol Appl Pharmacol</source><volume>213</volume><fpage>235</fpage><lpage>244</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.taap.2005.11.001</pub-id><pub-id pub-id-type="pmid">16364386</pub-id></element-citation></ref>
<ref id="b131-or-37-03-1321"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zain</surname><given-names>ME</given-names></name></person-group><article-title>Impact of mycotoxins on humans and animals</article-title><source>J Saudi Chem Soc</source><volume>15</volume><fpage>129</fpage><lpage>144</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.jscs.2010.06.006</pub-id></element-citation></ref>
<ref id="b132-or-37-03-1321"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>Y</given-names></name><name><surname>Umemori</surname><given-names>K</given-names></name><name><surname>Niimi</surname><given-names>E</given-names></name><name><surname>Tanuma</surname><given-names>S</given-names></name><name><surname>Nagata</surname><given-names>S</given-names></name><name><surname>Sugamata</surname><given-names>M</given-names></name><name><surname>Ihara</surname><given-names>T</given-names></name><name><surname>Sekijima</surname><given-names>M</given-names></name><name><surname>Kawai</surname><given-names>K</given-names></name><name><surname>Ueno</surname><given-names>I</given-names></name><etal/></person-group><article-title>Induction of apoptosis by T-2 toxin and other natural toxins in HL-60 human promyelotic leukemia cells</article-title><source>Nat Toxins</source><volume>3</volume><fpage>129</fpage><lpage>137</lpage><year>1995</year><pub-id pub-id-type="doi">10.1002/nt.2620030303</pub-id><pub-id pub-id-type="pmid">7648021</pub-id></element-citation></ref>
<ref id="b133-or-37-03-1321"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarom</surname><given-names>R</given-names></name><name><surname>More</surname><given-names>R</given-names></name><name><surname>Eldor</surname><given-names>A</given-names></name><name><surname>Yagen</surname><given-names>B</given-names></name></person-group><article-title>The effect of T-2 toxin on human platelets</article-title><source>Toxicol Appl Pharmacol</source><volume>73</volume><fpage>210</fpage><lpage>217</lpage><year>1984</year><pub-id pub-id-type="doi">10.1016/0041-008X(84)90326-0</pub-id><pub-id pub-id-type="pmid">6710522</pub-id></element-citation></ref>
<ref id="b134-or-37-03-1321"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudakin</surname><given-names>DL</given-names></name></person-group><article-title>Trichothecenes in the environment: Relevance to human health</article-title><source>Toxicol Lett</source><volume>143</volume><fpage>97</fpage><lpage>107</lpage><year>2003</year><pub-id pub-id-type="doi">10.1016/S0378-4274(03)00116-4</pub-id><pub-id pub-id-type="pmid">12749813</pub-id></element-citation></ref>
<ref id="b135-or-37-03-1321"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lautraite</surname><given-names>S</given-names></name><name><surname>Parent-Massin</surname><given-names>D</given-names></name><name><surname>Rio</surname><given-names>B</given-names></name><name><surname>Hoellinger</surname><given-names>H</given-names></name></person-group><article-title>Comparison of toxicity induced by T-2 toxin on human and rat granulo-monocytic progenitors with an in vitro model</article-title><source>Hum Exp Toxicol</source><volume>14</volume><fpage>672</fpage><lpage>678</lpage><year>1995</year><pub-id pub-id-type="doi">10.1177/096032719501400808</pub-id><pub-id pub-id-type="pmid">7576835</pub-id></element-citation></ref>
<ref id="b136-or-37-03-1321"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>DM</given-names></name><name><surname>Ghannoum</surname><given-names>MA</given-names></name></person-group><article-title>Indoor mold, toxigenic fungi, and Stachybotrys chartarum: Infectious disease perspective</article-title><source>Clin Microbiol Rev</source><volume>16</volume><fpage>144</fpage><lpage>172</lpage><year>2003</year><pub-id pub-id-type="doi">10.1128/CMR.16.1.144-172.2003</pub-id><pub-id pub-id-type="pmid">12525430</pub-id><pub-id pub-id-type="pmcid">145304</pub-id></element-citation></ref>
<ref id="b137-or-37-03-1321"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuiper-Goodman</surname><given-names>T</given-names></name><name><surname>Scott</surname><given-names>PM</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name></person-group><article-title>Risk assessment of the mycotoxin zearalenone</article-title><source>Regul Toxicol Pharmacol</source><volume>7</volume><fpage>253</fpage><lpage>306</lpage><year>1987</year><pub-id pub-id-type="doi">10.1016/0273-2300(87)90037-7</pub-id><pub-id pub-id-type="pmid">2961013</pub-id></element-citation></ref>
<ref id="b138-or-37-03-1321"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utian</surname><given-names>WH</given-names></name></person-group><article-title>Comparative trial of P1496, a new non-steroidal oestrogen analogue</article-title><source>BMJ</source><volume>1</volume><fpage>579</fpage><lpage>581</lpage><year>1973</year><pub-id pub-id-type="doi">10.1136/bmj.1.5853.579</pub-id><pub-id pub-id-type="pmid">4348475</pub-id><pub-id pub-id-type="pmcid">1589861</pub-id></element-citation></ref>
<ref id="b139-or-37-03-1321"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shier</surname><given-names>WT</given-names></name><name><surname>Shier</surname><given-names>AC</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Mirocha</surname><given-names>CJ</given-names></name></person-group><article-title>Structure-activity relationships for human estrogenic activity in zearalenone mycotoxins</article-title><source>Toxicon</source><volume>39</volume><fpage>1435</fpage><lpage>1438</lpage><year>2001</year><pub-id pub-id-type="doi">10.1016/S0041-0101(00)00259-2</pub-id><pub-id pub-id-type="pmid">11384734</pub-id></element-citation></ref>
<ref id="b140-or-37-03-1321"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanora</surname><given-names>A</given-names></name><name><surname>Maes</surname><given-names>D</given-names></name></person-group><article-title>The role of mycotoxins in pig reproduction: a review</article-title><source>Vet Med Czech</source><volume>54</volume><fpage>565</fpage><lpage>576</lpage><year>2009</year></element-citation></ref>
<ref id="b141-or-37-03-1321"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>Y</given-names></name><name><surname>Kubota</surname><given-names>K</given-names></name></person-group><article-title>DNA-attacking ability of carcinogenic mycotoxins in recombination-deficient mutant cells of Bacillus subtilis</article-title><source>Cancer Res</source><volume>36</volume><fpage>445</fpage><lpage>451</lpage><year>1976</year><pub-id pub-id-type="pmid">816461</pub-id></element-citation></ref>
<ref id="b142-or-37-03-1321"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uraguchi</surname><given-names>K</given-names></name><name><surname>Saito</surname><given-names>M</given-names></name><name><surname>Noguchi</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Enomoto</surname><given-names>M</given-names></name><name><surname>Tatsuno</surname><given-names>T</given-names></name></person-group><article-title>Chronic toxicity and carcinogenicity in mice of the purified mycotoxins, luteoskyrin and cyclochlorotine</article-title><source>Food Cosmet Toxicol</source><volume>10</volume><fpage>193</fpage><lpage>207</lpage><year>1972</year><pub-id pub-id-type="doi">10.1016/S0015-6264(72)80197-4</pub-id><pub-id pub-id-type="pmid">4342127</pub-id></element-citation></ref>
<ref id="b143-or-37-03-1321"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voss</surname><given-names>KA</given-names></name><name><surname>Howard</surname><given-names>PC</given-names></name><name><surname>Riley</surname><given-names>RT</given-names></name><name><surname>Sharma</surname><given-names>RP</given-names></name><name><surname>Bucci</surname><given-names>TJ</given-names></name><name><surname>Lorentzen</surname><given-names>RJ</given-names></name></person-group><article-title>Carcinogenicity and mechanism of action of fumonisin B1: A mycotoxin produced by Fusarium moniliforme (= F. verticillioides)</article-title><source>Cancer Detect Prev</source><volume>26</volume><fpage>1</fpage><lpage>9</lpage><year>2002</year><pub-id pub-id-type="doi">10.1016/S0361-090X(02)00011-9</pub-id><pub-id pub-id-type="pmid">12088196</pub-id></element-citation></ref>
<ref id="b144-or-37-03-1321"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>H</given-names></name><name><surname>Kawai</surname><given-names>K</given-names></name><name><surname>Ohbayashi</surname><given-names>F</given-names></name><name><surname>Kuniyasu</surname><given-names>T</given-names></name><name><surname>Yamazaki</surname><given-names>M</given-names></name><name><surname>Hamasaki</surname><given-names>T</given-names></name><name><surname>Williams</surname><given-names>GM</given-names></name></person-group><article-title>Genotoxicity of a variety of mycotoxins in the hepatocyte primary culture/DNA repair test using rat and mouse hepatocytes</article-title><source>Cancer Res</source><volume>44</volume><fpage>2918</fpage><lpage>2923</lpage><year>1984</year><pub-id pub-id-type="pmid">6722817</pub-id></element-citation></ref>
<ref id="b145-or-37-03-1321"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newberne</surname><given-names>PM</given-names></name></person-group><article-title>Mycotoxins: Toxicity, carcinogenicity, and the influence of various nutritional conditions</article-title><source>Environ Health Perspect</source><volume>9</volume><fpage>1</fpage><lpage>32</lpage><year>1974</year><pub-id pub-id-type="doi">10.1289/ehp.7491</pub-id><pub-id pub-id-type="pmid">4620330</pub-id><pub-id pub-id-type="pmcid">1475399</pub-id></element-citation></ref>
<ref id="b146-or-37-03-1321"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gradelet</surname><given-names>S</given-names></name><name><surname>Astorg</surname><given-names>P</given-names></name><name><surname>Le</surname><given-names>B</given-names></name><name><surname>on</surname><given-names>A-M</given-names></name><name><surname>Berg&#x00E8;s</surname><given-names>R</given-names></name><name><surname>Suschetet</surname><given-names>M</given-names></name></person-group><article-title>Modulation of aflatoxin B1 carcinogenicity, genotoxicity and metabolism in rat liver by dietary carotenoids: Evidence for a protective effect of CYP1A inducers</article-title><source>Cancer Lett</source><volume>114</volume><fpage>221</fpage><lpage>223</lpage><year>1997</year><pub-id pub-id-type="doi">10.1016/S0304-3835(97)04668-5</pub-id><pub-id pub-id-type="pmid">9103297</pub-id></element-citation></ref>
<ref id="b147-or-37-03-1321"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massey</surname><given-names>TE</given-names></name><name><surname>Stewart</surname><given-names>RK</given-names></name><name><surname>Daniels</surname><given-names>JM</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name></person-group><article-title>Biochemical and molecular aspects of mammalian susceptibility to aflatoxin B1 carcinogenicity</article-title><source>Proc Soc Exp Biol Med</source><volume>208</volume><fpage>213</fpage><lpage>227</lpage><year>1995</year><pub-id pub-id-type="doi">10.3181/00379727-208-43852A</pub-id><pub-id pub-id-type="pmid">7878060</pub-id></element-citation></ref>
<ref id="b148-or-37-03-1321"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname><given-names>RS</given-names></name><name><surname>Coles</surname><given-names>BF</given-names></name><name><surname>Raney</surname><given-names>KD</given-names></name><name><surname>Thier</surname><given-names>R</given-names></name><name><surname>Guengerich</surname><given-names>FP</given-names></name><name><surname>Harris</surname><given-names>TM</given-names></name></person-group><article-title>DNA adduction by the potent carcinogen aflatoxin B1: Mechanistic studies</article-title><source>J Am Chem Soc</source><volume>116</volume><fpage>1603</fpage><lpage>1609</lpage><year>1994</year><pub-id pub-id-type="doi">10.1021/ja00084a001</pub-id></element-citation></ref>
<ref id="b149-or-37-03-1321"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>WW</given-names></name><name><surname>Guengerich</surname><given-names>FP</given-names></name></person-group><article-title>Reaction of aflatoxin B1 exo-8,9-epoxide with DNA: Kinetic analysis of covalent binding and DNA-induced hydrolysis</article-title><source>Proc Natl Acad Sci USA</source><volume>94</volume><fpage>6121</fpage><lpage>6125</lpage><year>1997</year><pub-id pub-id-type="doi">10.1073/pnas.94.12.6121</pub-id><pub-id pub-id-type="pmid">9177180</pub-id><pub-id pub-id-type="pmcid">21012</pub-id></element-citation></ref>
<ref id="b150-or-37-03-1321"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>SC</given-names></name><name><surname>Howard</surname><given-names>PW</given-names></name><name><surname>Forrow</surname><given-names>SM</given-names></name><name><surname>Hartley</surname><given-names>JA</given-names></name><name><surname>Adams</surname><given-names>LJ</given-names></name><name><surname>Jenkins</surname><given-names>TC</given-names></name><name><surname>Kelland</surname><given-names>LR</given-names></name><name><surname>Thurston</surname><given-names>DE</given-names></name></person-group><article-title>Design, synthesis, and evaluation of a novel sequence-selective epoxide-containing DNA cross-linking agent based on the pyrrolo[2,1-c][1,4]benzodiazepine system</article-title><source>J Med Chem</source><volume>42</volume><fpage>4028</fpage><lpage>4041</lpage><year>1999</year><pub-id pub-id-type="doi">10.1021/jm981124d</pub-id><pub-id pub-id-type="pmid">10514273</pub-id></element-citation></ref>
<ref id="b151-or-37-03-1321"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollstein</surname><given-names>M</given-names></name><name><surname>Sidransky</surname><given-names>D</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Harris</surname><given-names>CC</given-names></name></person-group><article-title>p53 mutations in human cancers</article-title><source>Science</source><volume>253</volume><fpage>49</fpage><lpage>53</lpage><year>1991</year><pub-id pub-id-type="doi">10.1126/science.1905840</pub-id><pub-id pub-id-type="pmid">1905840</pub-id></element-citation></ref>
<ref id="b152-or-37-03-1321"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Goetchius</surname><given-names>MP</given-names></name><name><surname>Campbell</surname><given-names>TC</given-names></name><name><surname>Combs</surname><given-names>GF</given-names><suffix>Jr.</suffix></name></person-group><article-title>Effects of dietary selenium and vitamin E on hepatic mixed-function oxidase activities and in vivo covalent binding of aflatoxin B1 in rats</article-title><source>J Nutr</source><volume>112</volume><fpage>324</fpage><lpage>331</lpage><year>1982</year><pub-id pub-id-type="pmid">6799626</pub-id></element-citation></ref>
<ref id="b153-or-37-03-1321"><label>153</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peers</surname><given-names>FG</given-names></name><name><surname>Linsell</surname><given-names>CA</given-names></name></person-group><article-title>Dietary aflatoxins and liver cancer - a population based study in Kenya</article-title><source>Br J Cancer</source><volume>27</volume><fpage>473</fpage><lpage>484</lpage><year>1973</year><pub-id pub-id-type="doi">10.1038/bjc.1973.60</pub-id><pub-id pub-id-type="pmid">4721221</pub-id><pub-id pub-id-type="pmcid">2008812</pub-id></element-citation></ref>
<ref id="b154-or-37-03-1321"><label>154</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar</surname><given-names>F</given-names></name><name><surname>Hussain</surname><given-names>SP</given-names></name><name><surname>Cerutti</surname><given-names>P</given-names></name></person-group><article-title>Aflatoxin B1 induces the transversion of G-&#x003E;T in codon 249 of the p53 tumor suppressor gene in human hepatocytes</article-title><source>Proc Natl Acad Sci USA</source><volume>90</volume><fpage>8586</fpage><lpage>8590</lpage><year>1993</year><pub-id pub-id-type="doi">10.1073/pnas.90.18.8586</pub-id><pub-id pub-id-type="pmid">8397412</pub-id><pub-id pub-id-type="pmcid">47402</pub-id></element-citation></ref>
<ref id="b155-or-37-03-1321"><label>155</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Rensburg</surname><given-names>SJ</given-names></name><name><surname>Cook-Mozaffari</surname><given-names>P</given-names></name><name><surname>Van Schalkwyk</surname><given-names>DJ</given-names></name><name><surname>van der Watt</surname><given-names>JJ</given-names></name><name><surname>Vincent</surname><given-names>TJ</given-names></name><name><surname>Purchase</surname><given-names>IF</given-names></name></person-group><article-title>Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei</article-title><source>Br J Cancer</source><volume>51</volume><fpage>713</fpage><lpage>726</lpage><year>1985</year><pub-id pub-id-type="doi">10.1038/bjc.1985.107</pub-id><pub-id pub-id-type="pmid">2986667</pub-id><pub-id pub-id-type="pmcid">1977043</pub-id></element-citation></ref>
<ref id="b156-or-37-03-1321"><label>156</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>JS</given-names></name></person-group><article-title>Fumonisin B1 contamination of home-grown corn in high-risk areas for esophageal and liver cancer in China</article-title><source>Food Addit Contam</source><volume>24</volume><fpage>181</fpage><lpage>185</lpage><year>2007</year><pub-id pub-id-type="doi">10.1080/02652030601013471</pub-id><pub-id pub-id-type="pmid">17364919</pub-id></element-citation></ref>
<ref id="b157-or-37-03-1321"><label>157</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>JD</given-names></name><name><surname>Eaton</surname><given-names>DL</given-names></name><name><surname>Guengerich</surname><given-names>FP</given-names></name><name><surname>Coulombe</surname><given-names>RA</given-names><suffix>Jr.</suffix></name></person-group><article-title>Aflatoxin B1 activation in human lung</article-title><source>Toxicol Appl Pharmacol</source><volume>144</volume><fpage>88</fpage><lpage>95</lpage><year>1997</year><pub-id pub-id-type="doi">10.1006/taap.1997.8117</pub-id><pub-id pub-id-type="pmid">9169073</pub-id></element-citation></ref>
<ref id="b158-or-37-03-1321"><label>158</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Divine</surname><given-names>KK</given-names></name><name><surname>Gilliland</surname><given-names>FD</given-names></name><name><surname>Crowell</surname><given-names>RE</given-names></name><name><surname>Stidley</surname><given-names>CA</given-names></name><name><surname>Bocklage</surname><given-names>TJ</given-names></name><name><surname>Cook</surname><given-names>DL</given-names></name><name><surname>Belinsky</surname><given-names>SA</given-names></name></person-group><article-title>The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung</article-title><source>Mutat Res</source><volume>461</volume><fpage>273</fpage><lpage>278</lpage><year>2001</year><pub-id pub-id-type="doi">10.1016/S0921-8777(00)00059-8</pub-id><pub-id pub-id-type="pmid">11104903</pub-id></element-citation></ref>
<ref id="b159-or-37-03-1321"><label>159</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dvorackova</surname><given-names>I</given-names></name><name><surname>Stora</surname><given-names>C</given-names></name><name><surname>Ayraud</surname><given-names>N</given-names></name></person-group><article-title>Evidence of aflatoxin B1 in two cases of lung cancer in man</article-title><source>J Cancer Res Clin Oncol</source><volume>100</volume><fpage>221</fpage><lpage>224</lpage><year>1981</year><pub-id pub-id-type="doi">10.1007/BF00403368</pub-id><pub-id pub-id-type="pmid">6790552</pub-id></element-citation></ref>
<ref id="b160-or-37-03-1321"><label>160</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Miao</surname><given-names>X</given-names></name><name><surname>Liang</surname><given-names>G</given-names></name><name><surname>Hao</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>F</given-names></name><name><surname>Wei</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer</article-title><source>Cancer Res</source><volume>65</volume><fpage>722</fpage><lpage>726</lpage><year>2005</year><pub-id pub-id-type="pmid">15705867</pub-id></element-citation></ref>
<ref id="b161-or-37-03-1321"><label>161</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ketterer</surname><given-names>B</given-names></name><name><surname>Harris</surname><given-names>JM</given-names></name><name><surname>Talaska</surname><given-names>G</given-names></name><name><surname>Meyer</surname><given-names>DJ</given-names></name><name><surname>Pemble</surname><given-names>SE</given-names></name><name><surname>Taylor</surname><given-names>JB</given-names></name><name><surname>Lang</surname><given-names>NP</given-names></name><name><surname>Kadlubar</surname><given-names>FF</given-names></name></person-group><article-title>The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer</article-title><source>Environ Health Perspect</source><volume>98</volume><fpage>87</fpage><lpage>94</lpage><year>1992</year><pub-id pub-id-type="doi">10.1289/ehp.929887</pub-id><pub-id pub-id-type="pmid">1486868</pub-id><pub-id pub-id-type="pmcid">1519626</pub-id></element-citation></ref>
<ref id="b162-or-37-03-1321"><label>162</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin-Kuan</surname><given-names>M</given-names></name><name><surname>Nestler</surname><given-names>S</given-names></name><name><surname>Verguet</surname><given-names>C</given-names></name><name><surname>Bezen&#x00E7;on</surname><given-names>C</given-names></name><name><surname>Piguet</surname><given-names>D</given-names></name><name><surname>Mansourian</surname><given-names>R</given-names></name><name><surname>Holzwarth</surname><given-names>J</given-names></name><name><surname>Grigorov</surname><given-names>M</given-names></name><name><surname>Delatour</surname><given-names>T</given-names></name><name><surname>Mantle</surname><given-names>P</given-names></name><etal/></person-group><article-title>A toxicogenomics approach to identify new plausible epigenetic mechanisms of Ochratoxin A carcinogenicity in rat</article-title><source>Toxicol Sci</source><volume>89</volume><fpage>120</fpage><lpage>134</lpage><year>2006</year><pub-id pub-id-type="doi">10.1093/toxsci/kfj017</pub-id><pub-id pub-id-type="pmid">16251485</pub-id></element-citation></ref>
<ref id="b163-or-37-03-1321"><label>163</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin-Kuan</surname><given-names>M</given-names></name><name><surname>Cavin</surname><given-names>C</given-names></name><name><surname>Delatour</surname><given-names>T</given-names></name><name><surname>Schilter</surname><given-names>B</given-names></name></person-group><article-title>Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms</article-title><source>Toxicon</source><volume>52</volume><fpage>195</fpage><lpage>202</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.toxicon.2008.04.166</pub-id><pub-id pub-id-type="pmid">18649906</pub-id></element-citation></ref>
<ref id="b164-or-37-03-1321"><label>164</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x00F6;rrenhaus</surname><given-names>A</given-names></name><name><surname>Flieger</surname><given-names>A</given-names></name><name><surname>Golka</surname><given-names>K</given-names></name><name><surname>Schulze</surname><given-names>H</given-names></name><name><surname>Albrecht</surname><given-names>M</given-names></name><name><surname>Degen</surname><given-names>GH</given-names></name><name><surname>F&#x00F6;llmann</surname><given-names>W</given-names></name></person-group><article-title>Induction of unscheduled DNA synthesis in primary human urothelial cells by the mycotoxin Ochratoxin A</article-title><source>Toxicol Sci</source><volume>53</volume><fpage>271</fpage><lpage>277</lpage><year>2000</year><pub-id pub-id-type="doi">10.1093/toxsci/53.2.271</pub-id><pub-id pub-id-type="pmid">10696775</pub-id></element-citation></ref>
<ref id="b165-or-37-03-1321"><label>165</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boesch-Saadatmandi</surname><given-names>C</given-names></name><name><surname>Loboda</surname><given-names>A</given-names></name><name><surname>Jozkowicz</surname><given-names>A</given-names></name><name><surname>Huebbe</surname><given-names>P</given-names></name><name><surname>Blank</surname><given-names>R</given-names></name><name><surname>Wolffram</surname><given-names>S</given-names></name><name><surname>Dulak</surname><given-names>J</given-names></name><name><surname>Rimbach</surname><given-names>G</given-names></name></person-group><article-title>Effect of Ochratoxin A on redox-regulated transcription factors, antioxidant enzymes and glutathione-S-transferase in cultured kidney tubulus cells</article-title><source>Food Chem Toxicol</source><volume>46</volume><fpage>2665</fpage><lpage>2671</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.fct.2008.04.023</pub-id><pub-id pub-id-type="pmid">18547704</pub-id></element-citation></ref>
<ref id="b166-or-37-03-1321"><label>166</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfohl-Leszkowicz</surname><given-names>A</given-names></name><name><surname>Manderville</surname><given-names>RA</given-names></name></person-group><article-title>An update on direct genotoxicity as a molecular mechanism of Ochratoxin A carcinogenicity</article-title><source>Chem Res Toxicol</source><volume>25</volume><fpage>252</fpage><lpage>262</lpage><year>2012</year><pub-id pub-id-type="doi">10.1021/tx200430f</pub-id><pub-id pub-id-type="pmid">22054007</pub-id></element-citation></ref>
<ref id="b167-or-37-03-1321"><label>167</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adler</surname><given-names>M</given-names></name><name><surname>M&#x00FC;ller</surname><given-names>K</given-names></name><name><surname>Rached</surname><given-names>E</given-names></name><name><surname>Dekant</surname><given-names>W</given-names></name><name><surname>Mally</surname><given-names>A</given-names></name></person-group><article-title>Modulation of key regulators of mitosis linked to chromosomal instability is an early event in Ochratoxin A carcinogenicity</article-title><source>Carcinogenesis</source><volume>30</volume><fpage>711</fpage><lpage>719</lpage><year>2009</year><pub-id pub-id-type="doi">10.1093/carcin/bgp049</pub-id><pub-id pub-id-type="pmid">19237604</pub-id></element-citation></ref>
<ref id="b168-or-37-03-1321"><label>168</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x00E1;lez-Salgado</surname><given-names>A</given-names></name><name><surname>Pati&#x00F1;o</surname><given-names>B</given-names></name><name><surname>V&#x00E1;zquez</surname><given-names>C</given-names></name><name><surname>Gonz&#x00E1;lez-Ja&#x00E9;n</surname><given-names>MT</given-names></name></person-group><article-title>Discrimination of Aspergillus niger and other Aspergillus species belonging to section Nigri by PCR assays</article-title><source>FEMS Microbiol Lett</source><volume>245</volume><fpage>353</fpage><lpage>361</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.femsle.2005.03.023</pub-id><pub-id pub-id-type="pmid">15909368</pub-id></element-citation></ref>
<ref id="b169-or-37-03-1321"><label>169</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lioi</surname><given-names>MB</given-names></name><name><surname>Santoro</surname><given-names>A</given-names></name><name><surname>Barbieri</surname><given-names>R</given-names></name><name><surname>Salzano</surname><given-names>S</given-names></name><name><surname>Ursini</surname><given-names>MV</given-names></name></person-group><article-title>Ochratoxin A and zearalenone: A comparative study on genotoxic effects and cell death induced in bovine lymphocytes</article-title><source>Mutat Res</source><volume>557</volume><fpage>19</fpage><lpage>27</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.mrgentox.2003.09.009</pub-id><pub-id pub-id-type="pmid">14706515</pub-id></element-citation></ref>
<ref id="b170-or-37-03-1321"><label>170</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfohl-Leszkowicz</surname><given-names>A</given-names></name><name><surname>Manderville</surname><given-names>RA</given-names></name></person-group><article-title>Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans</article-title><source>Mol Nutr Food Res</source><volume>51</volume><fpage>61</fpage><lpage>99</lpage><year>2007</year><pub-id pub-id-type="doi">10.1002/mnfr.200600137</pub-id><pub-id pub-id-type="pmid">17195275</pub-id></element-citation></ref>
<ref id="b171-or-37-03-1321"><label>171</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin-Kuan</surname><given-names>M</given-names></name><name><surname>Nestler</surname><given-names>S</given-names></name><name><surname>Verguet</surname><given-names>C</given-names></name><name><surname>Bezen&#x00E7;on</surname><given-names>C</given-names></name><name><surname>Piguet</surname><given-names>D</given-names></name><name><surname>Delatour</surname><given-names>T</given-names></name><name><surname>Mantle</surname><given-names>P</given-names></name><name><surname>Cavin</surname><given-names>C</given-names></name><name><surname>Schilter</surname><given-names>B</given-names></name></person-group><article-title>MAPK-ERK activation in kidney of male rats chronically fed Ochratoxin A at a dose causing a significant incidence of renal carcinoma</article-title><source>Toxicol Appl Pharmacol</source><volume>224</volume><fpage>174</fpage><lpage>181</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.taap.2007.06.014</pub-id><pub-id pub-id-type="pmid">17651772</pub-id></element-citation></ref>
<ref id="b172-or-37-03-1321"><label>172</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunnick</surname><given-names>JK</given-names></name><name><surname>Elwell</surname><given-names>MR</given-names></name><name><surname>Huff</surname><given-names>J</given-names></name><name><surname>Barrett</surname><given-names>JC</given-names></name></person-group><article-title>Chemically induced mammary gland cancer in the National Toxicology Program&#x0027;s carcinogenesis bioassay</article-title><source>Carcinogenesis</source><volume>16</volume><fpage>173</fpage><lpage>179</lpage><year>1995</year><pub-id pub-id-type="doi">10.1093/carcin/16.2.173</pub-id><pub-id pub-id-type="pmid">7859345</pub-id></element-citation></ref>
<ref id="b173-or-37-03-1321"><label>173</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>F</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Devesa</surname><given-names>SS</given-names></name><name><surname>McGlynn</surname><given-names>KA</given-names></name><name><surname>M&#x00F8;ller</surname><given-names>H</given-names></name></person-group><article-title>Interpreting the international trends in testicular seminoma and nonseminoma incidence</article-title><source>Nat Clin Pract Urol</source><volume>3</volume><fpage>532</fpage><lpage>543</lpage><year>2006</year><pub-id pub-id-type="doi">10.1038/ncpuro0606</pub-id><pub-id pub-id-type="pmid">17031378</pub-id></element-citation></ref>
<ref id="b174-or-37-03-1321"><label>174</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jennings-Gee</surname><given-names>JE</given-names></name><name><surname>Tozlovanu</surname><given-names>M</given-names></name><name><surname>Manderville</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>MS</given-names></name><name><surname>Pfohl-Leszkowicz</surname><given-names>A</given-names></name><name><surname>Schwartz</surname><given-names>GG</given-names></name></person-group><article-title>Ochratoxin A: In utero exposure in mice induces adducts in testicular DNA</article-title><source>Toxins (Basel)</source><volume>2</volume><fpage>1428</fpage><lpage>1444</lpage><year>2010</year><pub-id pub-id-type="doi">10.3390/toxins2061428</pub-id><pub-id pub-id-type="pmid">20648226</pub-id><pub-id pub-id-type="pmcid">2905807</pub-id></element-citation></ref>
<ref id="b175-or-37-03-1321"><label>175</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>GG</given-names></name></person-group><article-title>Hypothesis: Does Ochratoxin A cause testicular cancer?</article-title><source>Cancer Causes Control</source><volume>13</volume><fpage>91</fpage><lpage>100</lpage><year>2002</year><pub-id pub-id-type="doi">10.1023/A:1013973715289</pub-id><pub-id pub-id-type="pmid">11899122</pub-id></element-citation></ref>
<ref id="b176-or-37-03-1321"><label>176</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vrabcheva</surname><given-names>T</given-names></name><name><surname>Usleber</surname><given-names>E</given-names></name><name><surname>Dietrich</surname><given-names>R</given-names></name><name><surname>M&#x00E4;rtlbauer</surname><given-names>E</given-names></name></person-group><article-title>Co-occurrence of Ochratoxin A and citrinin in cereals from Bulgarian villages with a history of Balkan endemic nephropathy</article-title><source>J Agric Food Chem</source><volume>48</volume><fpage>2483</fpage><lpage>2488</lpage><year>2000</year><pub-id pub-id-type="doi">10.1021/jf990891y</pub-id><pub-id pub-id-type="pmid">10888572</pub-id></element-citation></ref>
<ref id="b177-or-37-03-1321"><label>177</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knasm&#x00FC;ller</surname><given-names>S</given-names></name><name><surname>Cavin</surname><given-names>C</given-names></name><name><surname>Chakraborty</surname><given-names>A</given-names></name><name><surname>Darroudi</surname><given-names>F</given-names></name><name><surname>Majer</surname><given-names>BJ</given-names></name><name><surname>Huber</surname><given-names>WW</given-names></name><name><surname>Ehrlich</surname><given-names>VA</given-names></name></person-group><article-title>Structurally related mycotoxins Ochratoxin A ochratoxin B, and citrinin differ in their genotoxic activities and in their mode of action in human-derived liver (HepG2) cells: Implications for risk assessment</article-title><source>Nutr Cancer</source><volume>50</volume><fpage>190</fpage><lpage>197</lpage><year>2004</year><pub-id pub-id-type="doi">10.1207/s15327914nc5002_9</pub-id><pub-id pub-id-type="pmid">15623466</pub-id></element-citation></ref>
<ref id="b178-or-37-03-1321"><label>178</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thust</surname><given-names>R</given-names></name><name><surname>Kneist</surname><given-names>S</given-names></name></person-group><article-title>Activity of citrinin metabolized by rat and human microsome fractions in clastogenicity and SCE assays on Chinese hamster V79-E cells</article-title><source>Mutat Res</source><volume>67</volume><fpage>321</fpage><lpage>330</lpage><year>1979</year><pub-id pub-id-type="doi">10.1016/0165-1218(79)90028-4</pub-id><pub-id pub-id-type="pmid">481457</pub-id></element-citation></ref>
<ref id="b179-or-37-03-1321"><label>179</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostry</surname><given-names>V</given-names></name><name><surname>Malir</surname><given-names>F</given-names></name><name><surname>Ruprich</surname><given-names>J</given-names></name></person-group><article-title>Producers and important dietary sources of Ochratoxin A and citrinin</article-title><source>Toxins (Basel)</source><volume>5</volume><fpage>1574</fpage><lpage>1586</lpage><year>2013</year><pub-id pub-id-type="doi">10.3390/toxins5091574</pub-id><pub-id pub-id-type="pmid">24048364</pub-id><pub-id pub-id-type="pmcid">3798874</pub-id></element-citation></ref>
<ref id="b180-or-37-03-1321"><label>180</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouslimi</surname><given-names>A</given-names></name><name><surname>Bouaziz</surname><given-names>C</given-names></name><name><surname>Ayed-Boussema</surname><given-names>I</given-names></name><name><surname>Hassen</surname><given-names>W</given-names></name><name><surname>Bacha</surname><given-names>H</given-names></name></person-group><article-title>Individual and combined effects of Ochratoxin A and citrinin on viability and DNA fragmentation in cultured Vero cells and on chromosome aberrations in mice bone marrow cells</article-title><source>Toxicology</source><volume>251</volume><fpage>1</fpage><lpage>7</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.tox.2008.06.008</pub-id><pub-id pub-id-type="pmid">18638518</pub-id></element-citation></ref>
<ref id="b181-or-37-03-1321"><label>181</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeiffer</surname><given-names>E</given-names></name><name><surname>Gross</surname><given-names>K</given-names></name><name><surname>Metzler</surname><given-names>M</given-names></name></person-group><article-title>Aneuploidogenic and clastogenic potential of the mycotoxins citrinin and patulin</article-title><source>Carcinogenesis</source><volume>19</volume><fpage>1313</fpage><lpage>1318</lpage><year>1998</year><pub-id pub-id-type="doi">10.1093/carcin/19.7.1313</pub-id><pub-id pub-id-type="pmid">9683194</pub-id></element-citation></ref>
<ref id="b182-or-37-03-1321"><label>182</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castegnaro</surname><given-names>M</given-names></name><name><surname>Chernozemsky</surname><given-names>IN</given-names></name><name><surname>Hietanen</surname><given-names>E</given-names></name><name><surname>Bartsch</surname><given-names>H</given-names></name></person-group><article-title>Are mycotoxins risk factors for endemic nephropathy and associated urothelial cancers?</article-title><source>Arch Geschwulstforsch</source><volume>60</volume><fpage>295</fpage><lpage>303</lpage><year>1990</year><pub-id pub-id-type="pmid">2202269</pub-id></element-citation></ref>
<ref id="b183-or-37-03-1321"><label>183</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink-Gremmels</surname><given-names>J</given-names></name></person-group><article-title>Mycotoxins: Their implications for human and animal health</article-title><source>Vet Q</source><volume>21</volume><fpage>115</fpage><lpage>120</lpage><year>1999</year><pub-id pub-id-type="doi">10.1080/01652176.1999.9695005</pub-id><pub-id pub-id-type="pmid">10568000</pub-id></element-citation></ref>
<ref id="b184-or-37-03-1321"><label>184</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelderblom</surname><given-names>WC</given-names></name><name><surname>Kriek</surname><given-names>NP</given-names></name><name><surname>Marasas</surname><given-names>WF</given-names></name><name><surname>Thiel</surname><given-names>PG</given-names></name></person-group><article-title>Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats</article-title><source>Carcinogenesis</source><volume>12</volume><fpage>1247</fpage><lpage>1251</lpage><year>1991</year><pub-id pub-id-type="doi">10.1093/carcin/12.7.1247</pub-id><pub-id pub-id-type="pmid">1649015</pub-id></element-citation></ref>
<ref id="b185-or-37-03-1321"><label>185</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>PC</given-names></name><name><surname>Eppley</surname><given-names>RM</given-names></name><name><surname>Stack</surname><given-names>ME</given-names></name><name><surname>Warbritton</surname><given-names>A</given-names></name><name><surname>Voss</surname><given-names>KA</given-names></name><name><surname>Lorentzen</surname><given-names>RJ</given-names></name><name><surname>Kovach</surname><given-names>RM</given-names></name><name><surname>Bucci</surname><given-names>TJ</given-names></name></person-group><article-title>Fumonisin b1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice</article-title><source>Environ Health Perspect</source><volume>109</volume><supplement>Suppl 2</supplement><fpage>277</fpage><lpage>282</lpage><year>2001</year><pub-id pub-id-type="doi">10.2307/3435019</pub-id><pub-id pub-id-type="pmid">11359696</pub-id><pub-id pub-id-type="pmcid">1240676</pub-id></element-citation></ref>
<ref id="b186-or-37-03-1321"><label>186</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riley</surname><given-names>RT</given-names></name><name><surname>Wang</surname><given-names>E</given-names></name><name><surname>Schroeder</surname><given-names>JJ</given-names></name><name><surname>Smith</surname><given-names>ER</given-names></name><name><surname>Plattner</surname><given-names>RD</given-names></name><name><surname>Abbas</surname><given-names>H</given-names></name><name><surname>Yoo</surname><given-names>HS</given-names></name><name><surname>Merrill</surname><given-names>AH</given-names><suffix>Jr.</suffix></name></person-group><article-title>Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins</article-title><source>Nat Toxins</source><volume>4</volume><fpage>3</fpage><lpage>15</lpage><year>1996</year><pub-id pub-id-type="doi">10.1002/19960401NT2</pub-id><pub-id pub-id-type="pmid">8680751</pub-id></element-citation></ref>
<ref id="b187-or-37-03-1321"><label>187</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>FS</given-names></name><name><surname>Li</surname><given-names>GY</given-names></name></person-group><article-title>Simultaneous occurrence of fumonisin B1 and other mycotoxins in moldy corn collected from the People&#x0027;s Republic of China in regions with high incidences of esophageal cancer</article-title><source>Appl Environ Microbiol</source><volume>60</volume><fpage>847</fpage><lpage>852</lpage><year>1994</year><pub-id pub-id-type="pmid">8161178</pub-id><pub-id pub-id-type="pmcid">201401</pub-id></element-citation></ref>
<ref id="b188-or-37-03-1321"><label>188</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Dickman</surname><given-names>M</given-names></name><name><surname>Henderson</surname><given-names>G</given-names></name><name><surname>Jones</surname><given-names>C</given-names></name></person-group><article-title>Repression of protein kinase C and stimulation of cyclic AMP response elements by fumonisin, a fungal encoded toxin which is a carcinogen</article-title><source>Cancer Res</source><volume>55</volume><fpage>1655</fpage><lpage>1659</lpage><year>1995</year><pub-id pub-id-type="pmid">7712470</pub-id></element-citation></ref>
<ref id="b189-or-37-03-1321"><label>189</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragan</surname><given-names>YP</given-names></name><name><surname>Bidlack</surname><given-names>WR</given-names></name><name><surname>Cohen</surname><given-names>SM</given-names></name><name><surname>Goldsworthy</surname><given-names>TL</given-names></name><name><surname>Hard</surname><given-names>GC</given-names></name><name><surname>Howard</surname><given-names>PC</given-names></name><name><surname>Riley</surname><given-names>RT</given-names></name><name><surname>Voss</surname><given-names>KA</given-names></name></person-group><article-title>Implications of apoptosis for toxicity, carcinogenicity, and risk assessment: Fumonisin B(1) as an example</article-title><source>Toxicol Sci</source><volume>61</volume><fpage>6</fpage><lpage>17</lpage><year>2001</year><pub-id pub-id-type="doi">10.1093/toxsci/61.1.6</pub-id><pub-id pub-id-type="pmid">11294969</pub-id></element-citation></ref>
<ref id="b190-or-37-03-1321"><label>190</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hendricks</surname><given-names>K</given-names></name></person-group><article-title>Fumonisins and neural tube defects in South Texas</article-title><source>Epidemiology</source><volume>10</volume><fpage>198</fpage><lpage>200</lpage><year>1999</year><pub-id pub-id-type="pmid">10069261</pub-id></element-citation></ref>
<ref id="b191-or-37-03-1321"><label>191</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>P-K</given-names></name><name><surname>Cary</surname><given-names>JW</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Bhatnagar</surname><given-names>D</given-names></name><name><surname>Cleveland</surname><given-names>TE</given-names></name></person-group><article-title>The Aspergillus parasiticus polyketide synthase gene pksA, a homolog of Aspergillus nidulans wA, is required for aflatoxin B1 biosynthesis</article-title><source>Mol Gen Genet</source><volume>248</volume><fpage>270</fpage><lpage>277</lpage><year>1995</year><pub-id pub-id-type="doi">10.1007/BF02191593</pub-id><pub-id pub-id-type="pmid">7565588</pub-id></element-citation></ref>
<ref id="b192-or-37-03-1321"><label>192</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaucher</surname><given-names>GM</given-names></name></person-group><article-title>Mycotoxins-their biosynthesis in fungi: Patulin and related carcinogenic lactones</article-title><source>J Food Prot</source><volume>42</volume><fpage>810</fpage><lpage>814</lpage><year>1979</year><pub-id pub-id-type="doi">10.4315/0362-028X-42.10.810</pub-id></element-citation></ref>
<ref id="b193-or-37-03-1321"><label>193</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname><given-names>DM</given-names></name><name><surname>Metzler</surname><given-names>M</given-names></name><name><surname>Lehmann</surname><given-names>L</given-names></name></person-group><article-title>Mutagenicity of the mycotoxin patulin in cultured Chinese hamster V79 cells, and its modulation by intracellular glutathione</article-title><source>Arch Toxicol</source><volume>79</volume><fpage>110</fpage><lpage>121</lpage><year>2005</year><pub-id pub-id-type="doi">10.1007/s00204-004-0612-x</pub-id><pub-id pub-id-type="pmid">15536543</pub-id></element-citation></ref>
<ref id="b194-or-37-03-1321"><label>194</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>SG</given-names></name></person-group><article-title>Carcinogenesis: A broad critique</article-title><source>J Clin Pathol</source><volume>21</volume><fpage>534</fpage><year>1968</year><pub-id pub-id-type="doi">10.1136/jcp.21.4.534-b</pub-id></element-citation></ref>
<ref id="b195-or-37-03-1321"><label>195</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickens</surname><given-names>F</given-names></name><name><surname>Jones</surname><given-names>HE</given-names></name></person-group><article-title>Carcinogenic activity of a series of reactive lactones and related substances</article-title><source>Br J Cancer</source><volume>15</volume><fpage>85</fpage><lpage>100</lpage><year>1961</year><pub-id pub-id-type="doi">10.1038/bjc.1961.10</pub-id><pub-id pub-id-type="pmid">13722681</pub-id><pub-id pub-id-type="pmcid">2071115</pub-id></element-citation></ref>
<ref id="b196-or-37-03-1321"><label>196</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickens</surname><given-names>F</given-names></name><name><surname>Jones</surname><given-names>HE</given-names></name></person-group><article-title>The carcinogenic action of aflatoxin after its subcutaneous injection in the rat</article-title><source>Br J Cancer</source><volume>17</volume><fpage>691</fpage><lpage>698</lpage><year>1963</year><pub-id pub-id-type="doi">10.1038/bjc.1963.88</pub-id><pub-id pub-id-type="pmid">14111607</pub-id><pub-id pub-id-type="pmcid">2071218</pub-id></element-citation></ref>
<ref id="b197-or-37-03-1321"><label>197</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osswald</surname><given-names>H</given-names></name><name><surname>Frank</surname><given-names>HK</given-names></name><name><surname>Komitowski</surname><given-names>D</given-names></name><name><surname>Winter</surname><given-names>H</given-names></name></person-group><article-title>Long-term testing of patulin administered orally to Sprague-Dawley rats and Swiss mice</article-title><source>Food Cosmet Toxicol</source><volume>16</volume><fpage>243</fpage><lpage>247</lpage><year>1978</year><pub-id pub-id-type="doi">10.1016/S0015-6264(76)80520-2</pub-id><pub-id pub-id-type="pmid">689579</pub-id></element-citation></ref>
<ref id="b198-or-37-03-1321"><label>198</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahfoud</surname><given-names>R</given-names></name><name><surname>Maresca</surname><given-names>M</given-names></name><name><surname>Garmy</surname><given-names>N</given-names></name><name><surname>Fantini</surname><given-names>J</given-names></name></person-group><article-title>The mycotoxin patulin alters the barrier function of the intestinal epithelium: Mechanism of action of the toxin and protective effects of glutathione</article-title><source>Toxicol Appl Pharmacol</source><volume>181</volume><fpage>209</fpage><lpage>218</lpage><year>2002</year><pub-id pub-id-type="doi">10.1006/taap.2002.9417</pub-id><pub-id pub-id-type="pmid">12079430</pub-id></element-citation></ref>
<ref id="b199-or-37-03-1321"><label>199</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KS</given-names></name><name><surname>R&#x00F6;schenthaler</surname><given-names>RJ</given-names></name></person-group><article-title>DNA-damaging activity of patulin in Escherichia coli</article-title><source>Appl Environ Microbiol</source><volume>52</volume><fpage>1046</fpage><lpage>1054</lpage><year>1986</year><pub-id pub-id-type="pmid">2431653</pub-id><pub-id pub-id-type="pmcid">239171</pub-id></element-citation></ref>
<ref id="b200-or-37-03-1321"><label>200</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>Y</given-names></name><name><surname>Kubota</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name></person-group><article-title>Mutagenicity of carcinogenic mycotoxins in Salmonella typhimurium</article-title><source>Cancer Res</source><volume>38</volume><fpage>536</fpage><lpage>542</lpage><year>1978</year><pub-id pub-id-type="pmid">342092</pub-id></element-citation></ref>
<ref id="b201-or-37-03-1321"><label>201</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoental</surname><given-names>R</given-names></name></person-group><article-title>Trichothecenes, zearalenone, and other carcinogenic metabolites of Fusarium and related microfungi</article-title><source>Adv Cancer Res</source><volume>45</volume><fpage>217</fpage><lpage>290</lpage><year>1985</year><pub-id pub-id-type="doi">10.1016/S0065-230X(08)60270-5</pub-id><pub-id pub-id-type="pmid">2936065</pub-id></element-citation></ref>
<ref id="b202-or-37-03-1321"><label>202</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>Y</given-names></name></person-group><article-title>Toxicological features of T-2 toxin and related trichothecenes</article-title><source>Fundam Appl Toxicol</source><volume>4</volume><fpage>S124</fpage><lpage>S132</lpage><year>1984</year><pub-id pub-id-type="doi">10.1016/0272-0590(84)90144-1</pub-id><pub-id pub-id-type="pmid">6609858</pub-id></element-citation></ref>
<ref id="b203-or-37-03-1321"><label>203</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>Y</given-names></name><name><surname>Yabe</surname><given-names>T</given-names></name><name><surname>Hashimoto</surname><given-names>H</given-names></name><name><surname>Sekijima</surname><given-names>M</given-names></name><name><surname>Masuda</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>DJ</given-names></name><name><surname>Hasegawa</surname><given-names>R</given-names></name><name><surname>Ito</surname><given-names>N</given-names></name></person-group><article-title>Enhancement of GST-P-positive liver cell foci development by nivalenol, a trichothecene mycotoxin</article-title><source>Carcinogenesis</source><volume>13</volume><fpage>787</fpage><lpage>791</lpage><year>1992</year><pub-id pub-id-type="doi">10.1093/carcin/13.5.787</pub-id><pub-id pub-id-type="pmid">1586991</pub-id></element-citation></ref>
<ref id="b204-or-37-03-1321"><label>204</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafarge-Frayssinet</surname><given-names>C</given-names></name><name><surname>Decloitre</surname><given-names>F</given-names></name><name><surname>Mousset</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>M</given-names></name><name><surname>Frayssinet</surname><given-names>C</given-names></name></person-group><article-title>Induction of DNA single-strand breaks by T2 toxin, a trichothecene metabolite of Fusarium: Effect on lymphoid organs and liver</article-title><source>Mutat Res Genet Toxicol</source><volume>88</volume><fpage>115</fpage><lpage>123</lpage><year>1981</year><pub-id pub-id-type="doi">10.1016/0165-1218(81)90010-0</pub-id></element-citation></ref>
<ref id="b205-or-37-03-1321"><label>205</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schothorst</surname><given-names>RC</given-names></name><name><surname>van Egmond</surname><given-names>HP</given-names></name></person-group><article-title>Report from SCOOP task 3.2.10 &#x2018;collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states&#x2019;. Subtask: trichothecenes. Subtask: Trichothecenes</article-title><source>Toxicol Lett</source><volume>153</volume><fpage>133</fpage><lpage>143</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.toxlet.2004.04.045</pub-id><pub-id pub-id-type="pmid">15342090</pub-id></element-citation></ref>
<ref id="b206-or-37-03-1321"><label>206</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eriksen</surname><given-names>GS</given-names></name><name><surname>Pettersson</surname><given-names>H</given-names></name></person-group><article-title>Toxicological evaluation of trichothecenes in animal feed</article-title><source>Anim Feed Sci Technol</source><volume>114</volume><fpage>205</fpage><lpage>239</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.anifeedsci.2003.08.008</pub-id></element-citation></ref>
<ref id="b207-or-37-03-1321"><label>207</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pestka</surname><given-names>JJ</given-names></name></person-group><article-title>Deoxynivalenol: Toxicity, mechanisms and animal health risks</article-title><source>Anim Feed Sci Technol</source><volume>137</volume><fpage>283</fpage><lpage>298</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.anifeedsci.2007.06.006</pub-id></element-citation></ref>
<ref id="b208-or-37-03-1321"><label>208</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yazar</surname><given-names>S</given-names></name><name><surname>Omurtag</surname><given-names>GZ</given-names></name></person-group><article-title>Fumonisins, trichothecenes and zearalenone in cereals</article-title><source>Int J Mol Sci</source><volume>9</volume><fpage>2062</fpage><lpage>2090</lpage><year>2008</year><pub-id pub-id-type="doi">10.3390/ijms9112062</pub-id><pub-id pub-id-type="pmid">19330061</pub-id><pub-id pub-id-type="pmcid">2635619</pub-id></element-citation></ref>
<ref id="b209-or-37-03-1321"><label>209</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>J-C</given-names></name><name><surname>Ohtsubo</surname><given-names>K</given-names></name><name><surname>Izumiyama</surname><given-names>N</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Yamamura</surname><given-names>H</given-names></name><name><surname>Ueno</surname><given-names>Y</given-names></name></person-group><article-title>The acute and chronic toxicities of nivalenol in mice</article-title><source>Fundam Appl Toxicol</source><volume>11</volume><fpage>38</fpage><lpage>47</lpage><year>1988</year><pub-id pub-id-type="doi">10.1016/0272-0590(88)90268-0</pub-id><pub-id pub-id-type="pmid">3209016</pub-id></element-citation></ref>
<ref id="b210-or-37-03-1321"><label>210</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bony</surname><given-names>S</given-names></name><name><surname>Olivier-Loiseau</surname><given-names>L</given-names></name><name><surname>Carcelen</surname><given-names>M</given-names></name><name><surname>Devaux</surname><given-names>A</given-names></name></person-group><article-title>Genotoxic potential associated with low levels of the Fusarium mycotoxins nivalenol and fusarenon X in a human intestinal cell line</article-title><source>Toxicol In Vitro</source><volume>21</volume><fpage>457</fpage><lpage>465</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.tiv.2006.10.014</pub-id><pub-id pub-id-type="pmid">17161579</pub-id></element-citation></ref>
<ref id="b211-or-37-03-1321"><label>211</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thuvander</surname><given-names>A</given-names></name><name><surname>Wikman</surname><given-names>C</given-names></name><name><surname>Gadhasson</surname><given-names>I</given-names></name></person-group><article-title>In vitro exposure of human lymphocytes to trichothecenes: Individual variation in sensitivity and effects of combined exposure on lymphocyte function</article-title><source>Food Chem Toxicol</source><volume>37</volume><fpage>639</fpage><lpage>648</lpage><year>1999</year><pub-id pub-id-type="doi">10.1016/S0278-6915(99)00038-1</pub-id><pub-id pub-id-type="pmid">10478832</pub-id></element-citation></ref>
<ref id="b212-or-37-03-1321"><label>212</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craddock</surname><given-names>VM</given-names></name><name><surname>Hill</surname><given-names>RJ</given-names></name><name><surname>Henderson</surname><given-names>AR</given-names></name></person-group><article-title>Stimulation of DNA replication in rat esophagus and stomach by the trichothecene mycotoxin diacetoxyscirpenol</article-title><source>Cancer Lett</source><volume>38</volume><fpage>199</fpage><lpage>208</lpage><year>1987</year><pub-id pub-id-type="doi">10.1016/0304-3835(87)90215-1</pub-id><pub-id pub-id-type="pmid">3690508</pub-id></element-citation></ref>
<ref id="b213-or-37-03-1321"><label>213</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wijnands</surname><given-names>LM</given-names></name><name><surname>van Leusden</surname><given-names>FM</given-names></name></person-group><article-title>An overview of adverse health effects caused by mycotoxins and bioassays for their detection. Research for man and environment</article-title><source>RIVM report 257852,004 2000</source><uri>http://rivm.openrepository.com/rivm/bitstream/10029/9410/1/257852004.pdf</uri></element-citation></ref>
<ref id="b214-or-37-03-1321"><label>214</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bony</surname><given-names>S</given-names></name><name><surname>Olivier-Loiseau</surname><given-names>L</given-names></name><name><surname>Carcelen</surname><given-names>M</given-names></name><name><surname>Devaux</surname><given-names>A</given-names></name></person-group><article-title>Genotoxic potential associated with low levels of the Fusarium mycotoxins nivalenol and fusarenon X in a human intestinal cell line</article-title><source>Toxicol In Vitro</source><volume>21</volume><fpage>457</fpage><lpage>465</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.tiv.2006.10.014</pub-id><pub-id pub-id-type="pmid">17161579</pub-id></element-citation></ref>
<ref id="b215-or-37-03-1321"><label>215</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>K</given-names></name><name><surname>Aminova</surname><given-names>L</given-names></name><name><surname>Murayama</surname><given-names>Y</given-names></name></person-group><article-title>Fusarenon-X induced apoptosis in HL-60 cells depends on caspase activation and cytochrome c release</article-title><source>Toxicology</source><volume>172</volume><fpage>103</fpage><lpage>112</lpage><year>2002</year><pub-id pub-id-type="doi">10.1016/S0300-483X(01)00586-8</pub-id><pub-id pub-id-type="pmid">11882350</pub-id></element-citation></ref>
<ref id="b216-or-37-03-1321"><label>216</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bondy</surname><given-names>GS</given-names></name><name><surname>McCormick</surname><given-names>SP</given-names></name><name><surname>Beremand</surname><given-names>MN</given-names></name><name><surname>Pestka</surname><given-names>JJ</given-names></name></person-group><article-title>Murine lymphocyte proliferation impaired by substituted neosolaniols and calonectrins - Fusarium metabolites associated with trichothecene biosynthesis</article-title><source>Toxicon</source><volume>29</volume><fpage>1107</fpage><lpage>1113</lpage><year>1991</year><pub-id pub-id-type="doi">10.1016/0041-0101(91)90208-9</pub-id><pub-id pub-id-type="pmid">1796475</pub-id></element-citation></ref>
<ref id="b217-or-37-03-1321"><label>217</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>CJ</given-names></name><name><surname>Cannon</surname><given-names>M</given-names></name></person-group><article-title>Inhibition of eukaryotic ribosomal function by the sesquiterpenoid antibiotic fusarenon-X</article-title><source>Eur J Biochem</source><volume>84</volume><fpage>103</fpage><lpage>111</lpage><year>1978</year><pub-id pub-id-type="doi">10.1111/j.1432-1033.1978.tb12146.x</pub-id><pub-id pub-id-type="pmid">648514</pub-id></element-citation></ref>
<ref id="b218-or-37-03-1321"><label>218</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>MO</given-names></name></person-group><article-title>Mycotoxin review-2. Fusarium</article-title><source>Mycologist</source><volume>16</volume><fpage>158</fpage><lpage>161</lpage><year>2002</year><pub-id pub-id-type="doi">10.1017/S0269915X02004135</pub-id></element-citation></ref>
<ref id="b219-or-37-03-1321"><label>219</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yazar</surname><given-names>S</given-names></name><name><surname>Omurtag</surname><given-names>GZ</given-names></name></person-group><article-title>Fumonisins, trichothecenes and zearalenone in cereals</article-title><source>Int J Mol Sci</source><volume>9</volume><fpage>2062</fpage><lpage>2090</lpage><year>2008</year><pub-id pub-id-type="doi">10.3390/ijms9112062</pub-id><pub-id pub-id-type="pmid">19330061</pub-id><pub-id pub-id-type="pmcid">2635619</pub-id></element-citation></ref>
<ref id="b220-or-37-03-1321"><label>220</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marasas</surname><given-names>WF</given-names></name><name><surname>van Rensburg</surname><given-names>SJ</given-names></name><name><surname>Mirocha</surname><given-names>CJ</given-names></name></person-group><article-title>Incidence of Fusarium species and the mycotoxins, deoxynivalenol and zearalenone, in corn produced in esophageal cancer areas in Transkei</article-title><source>J Agric Food Chem</source><volume>27</volume><fpage>1108</fpage><lpage>1112</lpage><year>1979</year><pub-id pub-id-type="doi">10.1021/jf60225a013</pub-id><pub-id pub-id-type="pmid">161914</pub-id></element-citation></ref>
<ref id="b221-or-37-03-1321"><label>221</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>JL</given-names></name></person-group><article-title>Some major mycotoxins and their mycotoxicoses - An overview</article-title><source>Int J Food Microbiol</source><volume>119</volume><fpage>3</fpage><lpage>10</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2007.07.019</pub-id><pub-id pub-id-type="pmid">17719115</pub-id></element-citation></ref>
<ref id="b222-or-37-03-1321"><label>222</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoental</surname><given-names>R</given-names></name><name><surname>Cavanagh</surname><given-names>JB</given-names></name></person-group><article-title>Mechanisms involved in the &#x2018;dying-back&#x2019; process - an hypothesis implicating coenzymes</article-title><source>Neuropathol Appl Neurobiol</source><volume>3</volume><fpage>145</fpage><lpage>157</lpage><year>1977</year><pub-id pub-id-type="doi">10.1111/j.1365-2990.1977.tb00579.x</pub-id></element-citation></ref>
<ref id="b223-or-37-03-1321"><label>223</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoental</surname><given-names>R</given-names></name><name><surname>Joffe</surname><given-names>AZ</given-names></name></person-group><article-title>Lesions induced in rodents by extracts from cultures of Fusarium poae and F. sporotrichioides</article-title><source>J Pathol</source><volume>112</volume><fpage>37</fpage><lpage>42</lpage><year>1974</year><pub-id pub-id-type="doi">10.1002/path.1711120108</pub-id><pub-id pub-id-type="pmid">4835338</pub-id></element-citation></ref>
<ref id="b224-or-37-03-1321"><label>224</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoental</surname><given-names>R</given-names></name><name><surname>Joffe</surname><given-names>AZ</given-names></name><name><surname>Yagen</surname><given-names>B</given-names></name></person-group><article-title>Irreversible depigmentation of dark mouse hair by T-2 toxin (a metabolite of Fusarium sporotrichioides) and by calcium pantothenate</article-title><source>Experientia</source><volume>34</volume><fpage>763</fpage><lpage>764</lpage><year>1978</year><pub-id pub-id-type="doi">10.1007/BF01947311</pub-id><pub-id pub-id-type="pmid">658295</pub-id></element-citation></ref>
<ref id="b225-or-37-03-1321"><label>225</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouanes</surname><given-names>Z</given-names></name><name><surname>Abid</surname><given-names>S</given-names></name><name><surname>Ayed</surname><given-names>I</given-names></name><name><surname>Anane</surname><given-names>R</given-names></name><name><surname>Mobio</surname><given-names>T</given-names></name><name><surname>Creppy</surname><given-names>EE</given-names></name><name><surname>Bacha</surname><given-names>H</given-names></name></person-group><article-title>Induction of micronuclei by Zearalenone in vero monkey kidney cells and in bone marrow cells of mice: Protective effect of Vitamin E</article-title><source>Mutat Res</source><volume>538</volume><fpage>63</fpage><lpage>70</lpage><year>2003</year><pub-id pub-id-type="doi">10.1016/S1383-5718(03)00093-7</pub-id><pub-id pub-id-type="pmid">12834755</pub-id></element-citation></ref>
<ref id="b226-or-37-03-1321"><label>226</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoental</surname><given-names>R</given-names></name></person-group><article-title>Letter: Role of podophyllotoxin in the bedding and dietary zearalenone on incidence of spontaneous tumors in laboratory animals</article-title><source>Cancer Res</source><volume>34</volume><fpage>2419</fpage><lpage>2420</lpage><year>1974</year><pub-id pub-id-type="pmid">4843540</pub-id></element-citation></ref>
<ref id="b227-or-37-03-1321"><label>227</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfohl-Leszkowicz</surname><given-names>A</given-names></name><name><surname>Chekir-Ghedira</surname><given-names>L</given-names></name><name><surname>Bacha</surname><given-names>H</given-names></name></person-group><article-title>Genotoxicity of zearalenone, an estrogenic mycotoxin: DNA adduct formation in female mouse tissues</article-title><source>Carcinogenesis</source><volume>16</volume><fpage>2315</fpage><lpage>2320</lpage><year>1995</year><pub-id pub-id-type="doi">10.1093/carcin/16.10.2315</pub-id><pub-id pub-id-type="pmid">7586128</pub-id></element-citation></ref>
<ref id="b228-or-37-03-1321"><label>228</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Program</surname><given-names>NT</given-names></name></person-group><article-title>National Toxicology Program: Carcinogenesis Bioassay of Zearalenone (CAS No. 17924&#x2013;92-4) in F344/N Rats and B6C3F1 Mice (Feed Study)</article-title><source>Natl Toxicol Program Tech Rep Ser</source><volume>235</volume><fpage>1</fpage><lpage>155</lpage><year>1982</year><pub-id pub-id-type="pmid">12778201</pub-id></element-citation></ref>
<ref id="b229-or-37-03-1321"><label>229</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>S-H</given-names></name><name><surname>Lee</surname><given-names>C-H</given-names></name><name><surname>Jang</surname><given-names>M-R</given-names></name><name><surname>Son</surname><given-names>Y-W</given-names></name><name><surname>Lee</surname><given-names>S-M</given-names></name><name><surname>Choi</surname><given-names>I-S</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name></person-group><article-title>Aflatoxins contamination in spices and processed spice products commercialized in Korea</article-title><source>Food Chem</source><volume>107</volume><fpage>1283</fpage><lpage>1288</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.foodchem.2007.08.049</pub-id></element-citation></ref>
<ref id="b230-or-37-03-1321"><label>230</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Samson</surname><given-names>RA</given-names></name><name><surname>van Reenen-Hoekstra</surname><given-names>ES</given-names></name><name><surname>Van Oorschot</surname><given-names>CAN</given-names></name></person-group><chapter-title>Introduction to food-borne fungi</chapter-title><source>Centraalbureau voor Schimmelcultures</source><publisher-name>Institute of the Royal Netherlands Academy of Arts and Sciences</publisher-name><year>1981</year></element-citation></ref>
<ref id="b231-or-37-03-1321"><label>231</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x00FC;rgen</surname><given-names>R</given-names></name></person-group><article-title>Mycotoxins in foodstuffs</article-title><source>Appl Microbiol Biotechnol</source><volume>1</volume><fpage>183</fpage><lpage>190</lpage><year>1975</year></element-citation></ref>
<ref id="b232-or-37-03-1321"><label>232</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Egmond</surname><given-names>HP</given-names></name><name><surname>Schothorst</surname><given-names>RC</given-names></name><name><surname>Jonker</surname><given-names>MA</given-names></name></person-group><article-title>Regulations relating to mycotoxins in food: Perspectives in a global and European context</article-title><source>Anal Bioanal Chem</source><volume>389</volume><fpage>147</fpage><lpage>157</lpage><year>2007</year><pub-id pub-id-type="doi">10.1007/s00216-007-1317-9</pub-id><pub-id pub-id-type="pmid">17508207</pub-id></element-citation></ref>
<ref id="b233-or-37-03-1321"><label>233</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binder</surname><given-names>EM</given-names></name></person-group><article-title>Managing the risk of mycotoxins in modern feed production</article-title><source>Anim Feed Sci Technol</source><volume>133</volume><fpage>149</fpage><lpage>166</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.anifeedsci.2006.08.008</pub-id></element-citation></ref>
<ref id="b234-or-37-03-1321"><label>234</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paterson</surname><given-names>RRM</given-names></name><name><surname>Lima</surname><given-names>N</given-names></name></person-group><article-title>How will climate change affect mycotoxins in food?</article-title><source>Food Res Int</source><volume>43</volume><fpage>1902</fpage><lpage>1914</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.foodres.2009.07.010</pub-id></element-citation></ref>
<ref id="b235-or-37-03-1321"><label>235</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckeman</surname><given-names>M</given-names></name><name><surname>Skj&#x00F6;ldebrand</surname><given-names>C</given-names></name></person-group><article-title>Clusters/networks promote food innovations</article-title><source>J Food Eng</source><volume>79</volume><fpage>1418</fpage><lpage>1425</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.jfoodeng.2006.04.024</pub-id></element-citation></ref>
<ref id="b236-or-37-03-1321"><label>236</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wansink</surname><given-names>B</given-names></name></person-group><article-title>Changing eating habits on the home front: Lost lessons from World War II research</article-title><source>J Public Policy Mark</source><volume>21</volume><fpage>90</fpage><lpage>99</lpage><year>2002</year><pub-id pub-id-type="doi">10.1509/jppm.21.1.90.17614</pub-id></element-citation></ref>
<ref id="b237-or-37-03-1321"><label>237</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabak</surname><given-names>B</given-names></name><name><surname>Dobson</surname><given-names>AD</given-names></name><name><surname>Var</surname><given-names>I</given-names></name></person-group><article-title>Strategies to prevent mycotoxin contamination of food and animal feed: A review</article-title><source>Crit Rev Food Sci Nutr</source><volume>46</volume><fpage>593</fpage><lpage>619</lpage><year>2006</year><pub-id pub-id-type="doi">10.1080/10408390500436185</pub-id><pub-id pub-id-type="pmid">17092826</pub-id></element-citation></ref>
<ref id="b238-or-37-03-1321"><label>238</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magan</surname><given-names>N</given-names></name><name><surname>Aldred</surname><given-names>D</given-names></name></person-group><article-title>Post-harvest control strategies: Minimizing mycotoxins in the food chain</article-title><source>Int J Food Microbiol</source><volume>119</volume><fpage>131</fpage><lpage>139</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2007.07.034</pub-id><pub-id pub-id-type="pmid">17764773</pub-id></element-citation></ref>
<ref id="b239-or-37-03-1321"><label>239</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergstr&#x00F6;m</surname><given-names>R</given-names></name><name><surname>Adami</surname><given-names>H-O</given-names></name><name><surname>M&#x00F6;hner</surname><given-names>M</given-names></name><name><surname>Zatonski</surname><given-names>W</given-names></name><name><surname>Storm</surname><given-names>H</given-names></name><name><surname>Ekbom</surname><given-names>A</given-names></name><name><surname>Tretli</surname><given-names>S</given-names></name><name><surname>Teppo</surname><given-names>L</given-names></name><name><surname>Akre</surname><given-names>O</given-names></name><name><surname>Hakulinen</surname><given-names>T</given-names></name></person-group><article-title>Increase in testicular cancer incidence in six European countries: A birth cohort phenomenon</article-title><source>J Natl Cancer Inst</source><volume>88</volume><fpage>727</fpage><lpage>733</lpage><year>1996</year><pub-id pub-id-type="doi">10.1093/jnci/88.11.727</pub-id><pub-id pub-id-type="pmid">8637026</pub-id></element-citation></ref>
<ref id="b240-or-37-03-1321"><label>240</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blot</surname><given-names>WJ</given-names></name><name><surname>Harrington</surname><given-names>JM</given-names></name><name><surname>Toledo</surname><given-names>A</given-names></name><name><surname>Hoover</surname><given-names>R</given-names></name><name><surname>Heath</surname><given-names>CW</given-names><suffix>Jr</suffix></name><name><surname>JF</surname><given-names>Jr Fraumeni</given-names></name></person-group><article-title>Lung cancer after employment in shipyards during World War II</article-title><source>N Engl J Med</source><volume>299</volume><fpage>620</fpage><lpage>624</lpage><year>1978</year><pub-id pub-id-type="doi">10.1056/NEJM197809212991202</pub-id><pub-id pub-id-type="pmid">683235</pub-id></element-citation></ref>
<ref id="b241-or-37-03-1321"><label>241</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tretli</surname><given-names>S</given-names></name><name><surname>Gaard</surname><given-names>M</given-names></name></person-group><article-title>Lifestyle changes during adolescence and risk of breast cancer: An ecologic study of the effect of World War II in Norway</article-title><source>Cancer Causes Control</source><volume>7</volume><fpage>507</fpage><lpage>512</lpage><year>1996</year><pub-id pub-id-type="doi">10.1007/BF00051882</pub-id><pub-id pub-id-type="pmid">8877047</pub-id></element-citation></ref>
<ref id="b242-or-37-03-1321"><label>242</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birner</surname><given-names>P</given-names></name><name><surname>Oberhuber</surname><given-names>G</given-names></name><name><surname>Stani</surname><given-names>J</given-names></name><name><surname>Reithofer</surname><given-names>C</given-names></name><name><surname>Samonigg</surname><given-names>H</given-names></name><name><surname>Hausmaninger</surname><given-names>H</given-names></name><name><surname>Kubista</surname><given-names>E</given-names></name><name><surname>Kwasny</surname><given-names>W</given-names></name><name><surname>Kandioler-Eckersberger</surname><given-names>D</given-names></name><name><surname>Gnant</surname><given-names>M</given-names></name><etal/></person-group><article-title>Austrian Breast &#x0026; Colorectal Cancer Study Group: Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer</article-title><source>Clin Cancer Res</source><volume>7</volume><fpage>1669</fpage><lpage>1675</lpage><year>2001</year><pub-id pub-id-type="pmid">11410505</pub-id></element-citation></ref>
<ref id="b243-or-37-03-1321"><label>243</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>SH</given-names></name><name><surname>Hsieh</surname><given-names>LL</given-names></name><name><surname>Luo</surname><given-names>FC</given-names></name><name><surname>Weinstein</surname><given-names>IB</given-names></name></person-group><article-title>Amplification of the EGF receptor and c-myc genes in human esophageal cancers</article-title><source>Int J Cancer</source><volume>42</volume><fpage>502</fpage><lpage>505</lpage><year>1988</year><pub-id pub-id-type="doi">10.1002/ijc.2910420406</pub-id><pub-id pub-id-type="pmid">2459070</pub-id></element-citation></ref>
<ref id="b244-or-37-03-1321"><label>244</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>JS</given-names></name><name><surname>Slodkowska</surname><given-names>EA</given-names></name><name><surname>Symmans</surname><given-names>WF</given-names></name><name><surname>Pusztai</surname><given-names>L</given-names></name><name><surname>Ravdin</surname><given-names>PM</given-names></name><name><surname>Hortobagyi</surname><given-names>GN</given-names></name></person-group><article-title>The HER-2 receptor and breast cancer: Ten years of targeted anti-HER-2 therapy and personalized medicine</article-title><source>Oncologist</source><volume>14</volume><fpage>320</fpage><lpage>368</lpage><year>2009</year><pub-id pub-id-type="doi">10.1634/theoncologist.2008-0230</pub-id><pub-id pub-id-type="pmid">19346299</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-or-37-03-1321" position="float">
<label>Figure 1.</label>
<caption><p>Chemical structure of Aflatoxin B1.</p></caption>
<graphic xlink:href="OR-37-03-1321-g00.jpg"/>
</fig>
<fig id="f2-or-37-03-1321" position="float">
<label>Figure 2.</label>
<caption><p>Chemical structure of Citrinin.</p></caption>
<graphic xlink:href="OR-37-03-1321-g01.jpg"/>
</fig>
<fig id="f3-or-37-03-1321" position="float">
<label>Figure 3.</label>
<caption><p>Chemical structure of Ergotamine.</p></caption>
<graphic xlink:href="OR-37-03-1321-g02.jpg"/>
</fig>
<fig id="f4-or-37-03-1321" position="float">
<label>Figure 4.</label>
<caption><p>Chemical structure of Fumonisin B1.</p></caption>
<graphic xlink:href="OR-37-03-1321-g03.jpg"/>
</fig>
<fig id="f5-or-37-03-1321" position="float">
<label>Figure 5.</label>
<caption><p>Chemical structure of Ochratoxin A.</p></caption>
<graphic xlink:href="OR-37-03-1321-g04.jpg"/>
</fig>
<fig id="f6-or-37-03-1321" position="float">
<label>Figure 6.</label>
<caption><p>Chemical structure of Patulin.</p></caption>
<graphic xlink:href="OR-37-03-1321-g05.jpg"/>
</fig>
<fig id="f7-or-37-03-1321" position="float">
<label>Figure 7.</label>
<caption><p>Chemical structure of T-2 toxin.</p></caption>
<graphic xlink:href="OR-37-03-1321-g06.jpg"/>
</fig>
<fig id="f8-or-37-03-1321" position="float">
<label>Figure 8.</label>
<caption><p>Chemical structure of Deoxynivalenol.</p></caption>
<graphic xlink:href="OR-37-03-1321-g07.jpg"/>
</fig>
<fig id="f9-or-37-03-1321" position="float">
<label>Figure 9.</label>
<caption><p>Chemical structure of Satratoxin H.</p></caption>
<graphic xlink:href="OR-37-03-1321-g08.jpg"/>
</fig>
<fig id="f10-or-37-03-1321" position="float">
<label>Figure 10.</label>
<caption><p>Chemical structure of Zearalenone.</p></caption>
<graphic xlink:href="OR-37-03-1321-g09.jpg"/>
</fig>
</floats-group>
</article>